Text

Rev 12 to LGS Units 1 & 2 Odcm
	ML20080N117
Person / Time
Site:	Limerick
Issue date:	04/30/1994
From:	Boyce R; PECO ENERGY CO., (FORMERLY PHILADELPHIA ELECTRIC
To:	;
Shared Package
ML20080N087	List: ML20080N085; ML20080N106; ML20080N112; ML20080N117; ML20080N129; ML20080N140; ML20080N146;
References
	PROC-940430, NUDOCS 9503060155
	Download: ML20080N117 (185)
	v • d • e

- - - - - -

.,.3 A _

v PECO ENERGY l t

n Limerick !

Generatinc Station -

L,

__3

]

i 3

_ _ _ . _ . _ . . . - . . . . . _ _ - _ - - .- J r

n i

I

~

~~

950306o155 950215 PDR R ADOCK 05000352 ;

PDR _ _ _ _ _ _ ______ ____ _ _____ _ _ 1

tg t

PORC- YES SQR YES-NQA. NO 50.59- YES RESP.MGR. YES LIMERICK GENERATING STATION UNITS 1 AND 2 OFFSITE DOSE CALCULATION MANUAL l Revision 12 t

w PHILADELPHIA ELECTRIC COMPANY' DOCKET NOS.-50-352 AND 50-353 .

"3 ..

l D

Approval:0

\ Plant Manager"

=

,}

1 i

PURPOSE The purpose of the;Offsite Dose Calculation Manual is to establish methodologies and procedures for calculating doses to individuals in areas at and beyond the SITE BOUNDARY due-to radioactive affluents from Limerick Generating Station.

k

r < c g ;, ,

~ '

'] .

ODCM RSv.f12 b/'" i P 4/94;o a

p Table of' Contents

~

< "Page Part I - RADIOLOGICAL EFFLUENT CONTROLS 1.0 DEFINITIONS ' 1 2.0 ? BASIS.FOR EFFLUENT MONITORING. CONTROLS 6 o

6 --

2.1 METEOROLOGICAL MONITORING-INSTRUMENTATION 2.2- MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS. 6 2.3 RADIOACTIVE LIQUID _ EFFLUENT MONITORING' INSTRUMENTATION 6- 1

-i '

.2.3.1 Concentration 9 2.3.2 Dose 9' 2.3.3 Liquid Radwaste Treatment System. 10 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10 2.4.1 Dose Rate 10 2.4.2 Dose - Noble Gases 11 2.4.3 Dose - Iodine-131,_ Iodine-133, Tritium, and Radionuclides in Particulate Form. 12 2.4.4 Ventilation Exhaust Treatment. System 12-2.4.5 Venting and Purging 13 2.4.6 Total Dose 13:

2.5 MONITORING PROGRAM 13 2.5.1 Land Use Census 14 2.5.2 Interlaboratory Comparison Program 14-APPLICABILITY 14

' l - 2. 6 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS -16 17 l 3.1 METEOROLOGICAL MONITORING INSTRUMENTATION i

v

.m-

, g ; -- - -

Yi ' ,

ODCM:.Rsv. 12 4/94 Page

3. 2. RADIOACTIVE LIQUID EFFLUENT: MONITORING INSTURMENTATION 21 ,

E 3.2 21' Radioactive Effluent! Monitoring l Instrumentation Controls 12 1 3.2.2 Concentration 24

-l

.j- 3.2.3 Dose- 28 3.2.4 Liquid Radwaste Treatment System. 29 <

l 3.3 GASEOUS EFFLUENTS ,-

4 3.3.1 Radioactive Gaseous Effluent Motoring ,

j Instrumentation 30 3.3.2 SITE BOUNDARY Dose Rate ;35_ ;

l j 3.3.3- Dose - Noble Gases 39~

3.3.4 Dose - Iodine-131,-Iodine-133, Tritium,-and Radionuclides in Particulate Forn ,40

.l 3.3.5 Ventilation Exhaust Treatment System 41 '-

l l 3.3.6 Venting or Purging 42 l 3.3.7 Total, Dose 43 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING l 3.<4.1 Monitoring Program 144-l 3.4.2 Land Use Census 57-l 3.4.3 Interlaboratory Comparison Program- 58'

l 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 59 j'3.6 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 60 l 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS 62 i

'i 11

J - . ODCM Rsv.-12 H

~

_' 4/94' LIMERICK GENERATING STATION OFFSITE DOSE ~ CALCULATION MANUAL l i

TABLE CONTENTS l

.Page d

, l Part II - CALCULATION METHODOLOGIES a63

. l 1.0- LIQUID. EFFLUENTS 63

-l 1.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 64 l 1.2 LIQUID EFFLUENT MONITOR SETPOINT-DETERMINATION

/ l'.2.1 Radwaste Discharge Monitor 64 l

1.2.2 Service Water Radiation Monitor 67 l-1.2.3 RHR Service Water Monitor 68 l

10 CFR'50 69 l 1.3 LIQUID EFFLUENT DOSE CALCULATIONS

l. 1.3.1_ Member of the Public Dose -' Liquid Effluents 69. ,

l 1.4 LIQUID EFFLUENT DOSE PROJECTION '74 75' E

l 2.0 GASEOUS EFFLUENTS ,

l 2.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS '75 75 l 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION

~

j 2.2.1 North. Vent Noble Gas Effluent Monitors 77 l 2.2.2 South Vent Noble Gas Effluent Monitors 79-l 2.2.3 Noble Gas Effluent Fractional Contribution. 81 2.2.4 Noble Gas Effluent Default Setpoints 82-l 2.2.5 WRAM Noble Gas Effluent' Monitor 86 l

91

'l 2.3 GASEOUS EFFLUENT DOSE EVALUATIONS 2.3.1 Site Boundary Dose Rate - Noble Gases 92- N l

2.3.2 Site Boundary Dose Rate - Radiciodine and Particulates 94 l

2.3.3 Noble Gas Air Dose 95 t l l 2.3.4 Radioiodine and Particulate Dose Calculations 10 CFR 50 96 l

iii

,e--u- . . - , . , - - -.

'3

- ODCM = R:;v. 12_-

L4/94-

. Page 2.3.5 Annual Dose. Evaluation 99 "l-l 2.4 GASEOUS EFFLUENT DOSE PROJECTION 102

.j ?3.0 'SPECIAL DOSE ANALYSIS 103

~103 l 3.1 TOTAL DOSES TO MEMBERS'OF THE PUBLIC

-104 j'3.2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY l 4.O RADIOLOGICAL ENVIRONMENTAL MONITORING-PROGRAM , .-106' j ' 4.1 SAMPLING PROGRAM 106 l 4.2 INTERLABORATORY COMPARISON PROGRAM , 106 APPENDICES -

r l Appendix A - Technical Specification /ODCM- 159 l Appendix B - Radiological Environmental Monitoring 162

' Program - Sample Type, Location and Analysis A

4 d

iv l

~

ODCM R;v.c 12=

4/94-

' LIST OF TABLES' 7

I'1.1 Surveillance Frequency Notation I 3.1-1' Meteorological Monitoring; Instrumentation' .

I 3.1-2 Meteorological Monitoring. Instrumentation Surveillance Requirements.

.I 3.2-1 Radioactive Liquid Effluent Monitoring l Instrumentation-I 3.2-2-Radioactive Liquid Effluent Monitoring Instrumentation

Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1' Radioactive ~ Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation ,

Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program 2

I 3.4-2 Reporting Levels for Radioactivity Concentrations In

! Environmental Samples ,

h I 3.4-3 Detection Capabilities For Environmental Sample. Analysis-

!: II 1.1 Ingestion Individual Dose Factors (Daipj) For Liquid-Effluents II 1.2 Assumptions Used In Limerick Effluent Dose '

Evaluations t

II 2.1 Dose Factors for Noble Gases ,

4 II 2.2 Ingestion Individual Dose Factors.(DFk,1,n) For Gaseous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)

A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v

i

.,. .._,.:.-,,--.,,--.,a- -. , ,- L. . - - - ,

- ODCM R2,v. 12 4/94 p

1

.. LIST OF FIGURES I

I 2.2-la Map Defining Exclusion Areas for Radioactive-Gaseous and Liquid Effluents I 2.2-1b Map Defining Low Population Areas for Radioactive

~ Gaseous and Liquid Effluents I 3.1-1 Meteorological Tower Location II 1.3.1-1 LGS Dilution vs River Flow-(Outfall)

II 1.3.1-2' LGS Dilution vs River Flow (Citizen's Utility)-

.II 1.3.1-3 LGS Dilution vs River Flow (Phoenixville).

II 1.3.1-4 LGS Dilution vs River. Flow (Philadelphia Suburban)

II 1.3.1-5 LGS Dilution vs River. Flow (Crew Course)

II 1-1 Liquid Effluent Flow Diagram II 2-1 Gaseous Effluent Flow Diagram - North St'ack II 2-2 Gaseous. Effluent Flow Diagram - South. Stack

., II 2 Gaseous Effluent Flow Diagram - Hot Maintenance Shop B-1 ' Environmental Sampling Location on Site or Near ?

the Limerick Generating Station B-2 Aquatic and Terrestrial Environmental Sampling Location -

at Intermediate Distances from the Limerick Generating 1 Station B-3 Airborne and TLD Environmental Sampling Locations'at Intermediate Distances-from the Limerick Generating Station B-4 Environmental Sampling Locations at Remote Distances from the Limerick Generating Station s

y 4 t I

vi

. , , ,..v , , - ,. - ,,y-.. . -, , . - - ._

p- ---

L' PART I RADIOLOGICAL EFFLUENT CONTROLS 4

4

\

ODCM Rsv.'121

' lli a1 4' ,

li Peg 4 /94 l-

'1.0 DEFINITIONS The following terms are taken from LGS Unit 1, Unit 2 TechiShecs.

1.1 ACTION ACTION shall be that part ofl a specification which prescribes remedial measures. required under designated conditions.

1.2: CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the' adjustment, as necessary, of the channel output such that it responds with the necessary range and-accuracy to known values of.the parameter which the; channel monitors. The CHANNEL CALIBRATION shall encompass the~ ,

entire channel including the sensor and alarm and/or trip '

functions, and shall include the CHANNEL FUNCTION TEST. The

~

CHANNEL CALIBRATION.may be performed by any series of sequential, overlapping or total channel steps such that the-entire channel is calibrated.

1.3 CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation. This determination shall include,-where possible, comparison of the channel indication and/or status with other' indications and/or status derived from independent-instrument channels measuring the same parameter.

1.4 CHANNEL FUNCTIONAL TEST ,

A CHANNEL FUNCTIONAL TEST shall be:

a. Analog-channels - the injection of a simulated signal into the channel as close to the sensor as practicable to verify OPERABILITY including alarm and/or trip:

functions and channel failure trips.

1

b. Bistable channels - the injection of a simulated signal-into the sensor to verify OPERABILITY including alarm and/or trip-functions..

The CHANNEL FUNCTIONAL TEST may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is tested.

1

r ,.

4 jji .ODCM Rsvi 121

' a 2:

Pig

-4 /94^

l{. . l' K

^

y: .

-1.5i CONTINUOUS SAMPLING Per ASTM Standard-(1987)Section II (Water and Environmental- i

, Technolog), Volume.11.03,. Article D1356; is defined as" sampling without interruptions throughout an operation or for a predetermined' time." A' CONTINUOUS SAMPLE is.the opposite of'a GRAB SAMPLE. The. time-period involved to' secure'(shut- >

c: down) ventilation:or.re-establish sampling of_the release; pathway: shall meet the intent of CONTINUOUS SAMPLING.

Consistent with industry: standards, the time allowance shalli not exceed 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months . -

1.6 DOSE EOUIVAT.RMT I-131 DOSE EQUIVALENT.I-131 shall be that concentration of I-131, i microcuries per' gram, which alone would produce the same thyroid dose as the quantity and isotopic mixture of I-131,.I-132, I-133, I-134 and I-135 actually present. The thyroid dose conversion factors used.for this calculation shall'be those ^!

listed in Table III of TID-14844, " Calculation of Distance Factors for Power.and Test Reactor Sites."

I 1.7 FREOUENCY NOTATION l

l The FREQUENCY NOTATION specifisd for the performance of' ,

Surveillance Requirements shell correspond to the intervals i defined in1 Table'I1.1.

l 1.8 MEMBERISI OF THE PUBLIC t

MEMBER (S) OF THE PUBLIC shall include all persons who are not-occupationally associated with the plant. This. category does not include employees of the utility,.its contractors, or vendors. Also excluded from this category are persons who ;

enter the site to service equipment or to make deliveries. l This category does-include persons who use portions of the site for recreational, occupational or other purposes not associated' with the plant. ,

1.9 OFFSITE DOSE CALCULATION MANUAL i

The OFFSITE DOSE CALCULATION _ MANUAL (ODCM) shall contain~the

e methodology and parameters used in the calculation of offsite' doses resulting from radioactive gaseous and liquid' effluents, in the calculation of gaseous.and-liquid effluent monitoring :

Alarm / Trip Setpoints, and in the-conduct of the Radiological-Environmental Monitoring Program., The ODCM shall also contain' (1) the Radioactive Effluents Controls and Radiological Environmental Monitoring Programs required by Technical Specification 6.8.4 and (2) descriptions of the- :

f s.

;i Ili s -

2l1 ODCM Rsv.'12 .i a3 l

= pig4 /94' ll ,,

information that should beMincluded.in the Annual. Radiological Environmental' Operating and Semi-annual-Radiological' Effluent .

4 .:

Release Reports required by Technical Specificati'ns o 6.'9.1.7- 1 and'6.9.1.8. '(3) description of meteorological monitoring I

controls. .1 I

1.10 OPERABLE - OPERABILITY I

A system,' subsystem, train, component'or device shall be OPERABLE or have OPERABILITY when it istcapable of'perforNing.

.its.specified functions (s) and.when~all necessary attendant

. instrumentation, controls, electrical power, cooling or seal water, lubrication or other auxiliary equipment that are _

required for the system, subsystem, train, component or. device-to perform its function (s)'are'also capable of: performing their ,

related support-function (s).

1.11 OPERATIONAL CONDITION - CONDITION An OPERATIONAL CONDITION, i.e., CONDITION, shall be any'one inclusive combination of mode switch position and average reactor coolant temperature as defined in the Technical Specifications.

1.12 PURGE - PURGING PURGE or PURGING shall.be.the controlled process of dischargingi air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to

, purify ths , confinement.

1.13 RATED THERMAL POWER See current LGS Tech Spec definition.

l l'.14 REPORTABLE EVENT A REPORTABLE EVENT shall be any of those conditions specified- ,

in Section 50.73 of 10 CFR Part 50.-

2:

1.15 SITE BOUNDARY The SITE BOUNDARY shall be that line as defined in Figure 12.2-la.

k i

1 s

e CDCM R;v.:12- j

[ 34~ .,

pig4 /94 j- l 1.16 SOURCE CHECK A SOURCE CHECK shall be.the. qualitative assessment of channel-response when the channel sensor is exposed to a. radioactive source.

1.17 THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer a rate to the reactor coolant.

1.18 UNRESTRICTED AREA An UNRESTRICTED AREA shall be any area at.or beyond the SITE ~

BOUNDARY access to which-is not controlled'by the licensee for-purposes of protection of individuals from exposure to radiation and radioactive materials, or any are within the SITE' '

BOUNDARY used for residential quarters'or,for industrial, commercial, institutional, and/or recreational purposes.

1.19 3&JiTIJATION RYHAUST TREATMENT SYSTEM A VENTILATION EXHAUST TREATMENT SYSTEM shall be'any system-designed and installed-to reduce gaseous radioiodine or-radioactive material in particulate form in effluents by-passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA filters:for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to.the environment (such a_ system is not-

considered to have any effect on noble gas effluents).

Engineered Safety Feature (ESP) atmospheric cleanup-systems-are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components.

I 1.20 VENTING

! VENTING shall be the controlled process of discharging air or-gas from a confinement to maintain temperature, pressure,s humidity, concentration or other operating-condition, in such a 4

manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process.

y ,

1

't t-3 , -- - , . . . -w, m U ,,_ . - , , . .. . _ _ . , _ _ _ _______i___'

, - _= .

l ODCM R v. 12: '

2 5-

-l. Pag 4 /94 TABLE II.1 SURVEILLANCE FREOUENCY NOTATION NOTATION FREQUENCY l S (Shift) At least once per.12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months .

l D (Daily) At least'once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

l 'W (Weekly) At'least once per 7 days.

-l M (Monthly) At_least once per 31 days.

l Q (Quarterly)

At least once per 92 days.

l. SA (Semi-annual) At least once per 184 days.

l A (Annual) At least once per 366 days.

E At least once per 18 months (550 days).

R At least once per 24 months'(731 days).

S/U Prior to each reactor startup.

P- Prior to each radioactive release.

N.A. Not applicable.

l 1

l l

l I

1

-I

>_-,_- . _ - . _._.. I

,qN ,w,

- ~. -- n ;. ,

~ - ~ = - - - , ..~ , - , . .

9 9hdI"W/0}-c 1

.ODCM ' Rav.= ' 12 ~

~

<h, y ;f .

a. 6 q * , '

N'

$

Pag14 /94 2 -

1: ,

I

,2.0- BASIS'FOR EFFLUENT MONITORING-CONTROLS '

+

' m'; .

METEOROLOGICAL' INSTRUMENTATION 2 .11 J '

'The OPERABILITY-of'the meteorological' monitoring ..

' instrumentation ' ensures that ~ sufficient meteorological- data is!

~

available;for estimating potentialiradiation-doses to the

-public:as a result of. routine or accidentalThisLeapability.is:

release.of radioactive materials'to-the. atmosphere. ,

D required ~to evaluate the needifor initiating measures:to-

' ' protect the. health and safety:of the-public. :This 'A

. instrumentation,is consistent'with the'recommendationsLof Regulatory Guide 1.'23."Onsite Meteorological Prcgrams,"

February, 1972.

' Site dat'a compiled-since January 1972 provide correlation .

between. Elevation li(Tower 1) and Elevation 1 (Tower 2),.and

' Lbetween Elevation 2 (Tower.1)-and Elevation.2;(Towerf2)..'This ;

= correlation serves as justification for'the use"of the appropriate Tower 2. instrument as a1 back-up to ' the Tower: 1 ,

instrument as shown in Table I3.1-1 and Table I3.1-3..

2.'2 MAPS-DEFINING UNRESTRICTED AREAS AND~ SITE' BOUNDARY'FORs RADIOACTIVE GASEOUS AND LIOUID EFFLUENTS Information regarding radioactive gaseous and liquid. effluents, -

i which will1 allow identification of structures and. release points as well as definition of. UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF'THE PUBLIC,.

shall be shown in Technical Specifications Figures 5.1.3-la and 5.1.3-1b.

The exclusion area ~and low population zone shall.be as shown ini l Figures I2.2-la and I2.2-1b.- -

2.3' RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION The radioactive liquid' effluent instrumentation 11s"provided'to 4 monitor and control, as applicable, the releasesTof radioactive.

materials in liquid effluents during actual or potential releases of liquid effluents.. The alarm / trip setpoints for these instruments shall be calculated in accordance withithe G procedures in the ODCM part II to ensure that the alarm / trip will occur prior to exceeding the limits of 10'CFRLPart:20.c 3

. The OPERABILITY 1and use of'this-instrumentation is consistent.1 with the requirements of General Design ~CriteriaH60, 63, and1649 of Appendix A to-10 CFR Part 50.

i: -

k

^

W .. - . - . .

_ . _ . . . . _ _ _ . _ - _ . . _ _ - _ --- . ~ . _ _ . . . - -

, - g: ODCM Rev. 12' 3 8 Pcg/944

-l FIGURE T2.2-1b LOW POPULATION ZONE 4

s mq.

g ~ e p;gw . .. w.r a

M w. % aw - ro= u.tp d) (*y g

1.r,, -

v -

. *3

*i~

,C i *k -

1>

r ,% -

-Lyg ;

a

^

-~ ;

l .Q} -

.- .s-1 .w ~

. _-tg ( .g

<[$

.25' j, .d

,. * ; i .-

l N e. ::

4$

a.. \

.. ~ ' ,,

1

^-

.b h, ' -

24 Ih/

..E:IIf

e '

If

'is

9MO ,. -

, ?.tidi; ::C '

(f 'SE. ,\\ '

191 2

.3.Q

~ r, i

. ,.?Ja _

~

e

_ _ _ . _ _ _ _ _ _ - - _ - _ _ - - _ - - _ _ - - - _ . , . - - - - - - - . . . , . - . - - . . . . . . . - - , - - -- - - - --n.~. -- . - + - - , - -

< ,- _ _ ~_ __ __ _ . _ _ .

- % gy .

. c y .;,

My e

.l} ODCM Rrv.>12?

3 n '9

' Pag4 /94

1

'2.3.1 CONCENTRATION This control is provided to ensure that the concentration of

~

radioactive materials released in liquid waste affluents to -

UNRESTRICTED AREAS-will be less than the concentration levels specified inL10.CFR Part 20,-Appendix B, Table II, Column-2.-

This limitation provides additional. assurance that;the. levels of radioactive materials in bodies of water'in UNRESTRICTED AREAS.will result in exposures within (1) the'Section II.A-design objectives of' Appendix I, '10 CFR Part 50,- to a MEMBER OF::

THE PUBLIC, and'(2) the limits'of 10 CFR 20.106(e) to:the population..'The concentration' limits-for: dissolved or. ..

entrained noble gases are based upon.the assumption that Xe-135.'

is.the controlling radioisotope and:its MPC in air was -

- . converted to an equivalent concentration in water-using.the methods described-in the International Commission on Radiological Protection (ICRP) Publication 2.

The required detection capabilities for radioactive materials in liquid' waste samples are tabulated in terms of.the~1ower limits of detection (LLDs). Detailed discussion of _ the .ILD, and other detection limits can be found in HASL Procedures Manual,.HASL-300 (revised annually), Currie,-L.A., " Limits'for Qualitative Detection and Quantitative Determination -

Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968).

and Hartwell, J.K., " Detection Tdmi ts - for Radionnalytical

' Counting Techniques." Atlantic Richfield Hanford Comnany Renort ARH-SA-215 (June, 1975).

2.3.2 DQSX

- Thiscontrol'Isprovidedtoimplement;the..requirementsof Sections II.A, III.A, and IV.A of Appendix I,_10 CFR Part 50.

n The control implements the guides: set forth in Section II.A of-F Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guidet set forth'in Section IV.A of Appendix I to_ assure'that the releases of radioactive material'in liquid offluents-will be kept "as low as reasonably achievable". Also, for fresh water sites with drinking water supplies which:can be potentially affected by plant operations, there istreasonable assurance that the' operation of the facility will not result in radionuclide concentrations in,che finished: drinking water that

are in excess of the requirements-of 40 CFR Part 141. The dose '

calculation methodology and parameters in the ODCM implement -

the requirements in Section III.A'of Appendix I that.

conformance with the. guides of Appendix-I be shown by.

calculational procedures based on models and data,2such that:

the actual exposure of a MEMBER OF.THE PUBLIC through.

appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with -

the methodology provided in Regulatory Guide 1.109,

> " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with ,

e

-____n___._____._i_.__________.__. _ _ . , , , , , , , _, ,, , , , . . _ _ _ , , , , s ,, , _

i ,

J 'l1

" ODCM R3v.5123-

, Paga 10 ,

4/94 ;

l.

j 10 CFR Part 50,' Appendix I,"; Revision 1, October,11977 and l Regulatory-Guide 1.113, " Estimating Aquatic Dispersion of I Effluents from Accidental.and Routine Reactor Releases for the I Purpose of Implementing Appendix I," April, 1977.

l 2.3.3 LIOUID RADWASTE TREATMENT SYSTEM The requirement that the appropriate portions of this system be used when specified provides assurance that the releases.of l r

radioactive materisis in liquid effluents-will be kept "as low as reasonably achievable". This specification implements the' requirements of 10 CFR 50.35a, General Design-Criterion 60 of Appendix A to 10 CFR Part 50fand the design objective given in'Section II.D-of Appendix I to 10 CFR Part 50. The specified q limits governing the use of appropriate portions of the liquid ;

radwaste treatment system were specified as a suitable fraction- '

g of the dose' design objectives set forth in Section II.A of .1 Appendix I,l10 CFR Part 50, for liquid effluents. j I

i3 2.4 RADIOACTIVE CASEOUS EFFLUENT MONITORING INSTRUMRNTATION

.h The radioactive _ gaseous effluent instrumentation is provided to. ,

monitor and_ control, as applicable, the releases of radioactive J L._ materials in gaseous effluents during actual or potential i The alarm / trip setpoints for 1 i releases of gaseous effluents.

3 these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alann/ trip will occur prior to exceeding the limits of 10 CFR Part 20. The OPERABILITY and use'of this instrumentation is consistent with the repirements of General Design Criteria 60, 63, and 64 of

' Appendix A to-10'CFR Part'50.

3 2.4.1 DOSE RATE This control is provided to ensure _that the dose at any time at-and beyond the SITE BOUNDARY from gaseous. effluents'from the site will be within the annual dose limits of 10 CFR Part 20 to UNRESTRICTED AREAS. -The annual dose limits are the' dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table-II, Column I. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY,"to annual average concentrations exceeding the limits specified in. Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106(b)(1)).'.For MEMBERS

', OF THE PUBLIC who=may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usually be.

sufficiently low to compensate for any increase in the atmospheric diffusion factor for above that for the SITE BOUNDARY. Examples of calculations for such MEMBERS OF THE'_

PUBLIC, with the appropriate occupancy factors, are given in the ODCM. The specified release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE i- BOUNDARY to less than or equal to 500 mrems/ year to the total 4

-v S . - ., -- - , , , - - - - - - - - ,~.e - er - ,+,-<m - m

'1 .ODCM Rsv. 12L t m Pagi ll.

14/94-9'

.l body or to less than or: equal tx) 3000 mrems/ year to the skin.

These release' rate limits also restrict, at allttimes, the corresponding thyroid dose rate above background to a child via

'the inhalation pathway to:less than or equal to 1500 mrems/ year.

This control applies to the release of radioactive materials in

- gaseous-effluents from all reactors.at the site.:

The required detection. capability.for radioactive materials in-L. gaseous waste samples are tabulated in termslof.the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be-found in HASL Procedures Manuali EASL-300 (revised annually), Currie, L.A., " Limits'fori Qualitative Detection and Quantitative-Determination -

Application to Radiochemistry," Anal. chem. 40. 586-93 (1986),

and Hartwell. J.K.. " Detection Limits for Radionnalvtical Countina Techniques." Atlantic Richfield Hanford connany ReDort ARH-SA-215 (June 1975).

2.4.2 DOSE =- NOBLE CARES This control is provided to implement the requirements of Sections II.B, III.A, and IV.A of Appendix I, 10 CFR'Part 50.

The control implements the guides set forth in Section II.B of Appendix I. The ACTION statements provide the required

[ operating flexibility and at the same time. implement the guides

- set forth in Section IV.A of Appendix I to assure-that the releases of radioactive material in gaseous effluents will be kept "as low as reasonably achievable". .The surveillance Requirements implement the rep irements~in Section III.A of:

Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on appropriate pathways.

in unlikely to be substantially underestimated. The' dose calculation established la the ODCM.for calculating the doses

. due to the actual release rates of radioactive noble gases in'

gaseous effluents are consistent with the methodology.provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose cf i- Evaluating Compliance with 10 CFR Part 50, Appendix I,?

l Revision I, October 1977 and Regulatory Guide.l.111, " Methods H for Estimating Atmospheric Transport and' Dispersion of Gaseous Effluents in Routing Releases from Light-Water Cooled Reactors," Revision 1,. July 1977 with site specific dispersion curves and-deposition methodology. The ODCM equations provided' for determining the air doses at an beyond the SITE BOUNDART are based-upon the. historical average atmospheric conditions.--.

i

' ,L, ~ ~ "^ '~

^ ~ - ~ ^- ' ' ' '

x, w ..

-l

.ODCM Rsv.112'

'Pagn 12- ?

Q 4/94? ~l I

2.4.3 DOBE - IODINE-131. IODINE-133. TRITIUM, AND RADIONUCLIDES-IN. j PARTICUIATE FORM '

_This control;is provided to implement the requirements.of'

+ Sections II.C, III.A, and IV.A of Appendix I, 10 CFR Part 50.

The controls are the guides set'forth in Section II.C_of i' Appendix I. The ACTION statements' provide the required operating. flexibility and at the same time implement the guides' set:forth in Section IV.A of Appendix I to assurenthat the releases of radioactive materials ~in gaseous affluents will:be- )

kept "as low as is reasonably achievable." -The.CCCM !

'j

~

calculational methods specified:in the Surveillance' 7

Requirements implement the requirements in'Section III.A of '

Appendix I be shown by calculational procedures based-on models and data, such that the actual exposure of a MEMBER.0F THE-3 PUBLIC through appropriate pathways.is unlikely to be substantially underestimated.-.The ODCM calculational methods j for calculating the doses due to the actual release rates of- j

the subject. materials are consistent with the methodology i provided in Regulatory Guide-1.109,' Calculation of Annual Doses E 'to Man from Routine Releases of Reactor Effluents for the ,

Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix 4 I," Revision I, October 1977 and Regulatory Guide 1.111,

" Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents.in Routine Releases from Light-Water-Cooled ~ -)

Reactors," Revision'1,. July 1977.with site specific dispersion 'l curves and deposition methodology. These equations also-provide for determining the actual doses based upon:the historical average atmospheric conditions.. The release' rate specifications for iodine-131, iodine-133, tritium, and .j radionuclides in particulate form with half-lives greater than 8 days are dependent on the existing radionuclides pathways to man in areas at'and beyond the SITE BOUNDARY. The pathways -1 which were examined'in the. development of these calculations. 'i were: (1) individual inhalation of airborne radionuclides, (2)-

deposition of radionuclides onto green leafy vegetation"with subsequent consumption by man, (3) deposition onto grassy' areas; where milk animals and meat-producing animals graze.with-consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of man. ,

2.4.4 VENTILATION EXHAUST TREATMENT SYSTEM The requirement that the appropriate portions ~'of this system be used,' when specified, provides reasonable assurance.that the releases of radioactive materials in gaseous effluents will be ,

kept "as low as is reasonably achievable." This control .

implements the requirements of 10 CFR 50.36a, General Design Criteria 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section -II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use

v~. ~

,, i L- , , .

ODCM Rt.v.:12

' ~l' . Pag 3 13-I s

)

4/94 p v

-of appropriate portions of'the systems were specified'as'a-suitable fraction.of the dose design objectives set-forth inf 1 Section-II.B and II.C of Appendix'I, 10-CFR Part 50,;for-

< gaseous effluents I2.4.5 VENTING OR PURGING ~

> This control provides reasonable assurance that releases from- s

-)

drywell purging operationo will not' exceed the annual dose-7 limits of 10 CFR Part 20 for UNRESTRICTED AREAS.. ;

2.4.6 TOTAL DOSE i

This control is provided to meet the dose limitations of.

40 CFR Part'190 that have been incorporated into.10 CFR Part 20 <

by 46 CFR.18525. The control requires the preparation.and. l L submittal of a Special Report whenever the calculated doses !

. from plant radioactive effluents arceed twice the~ design: '

objective doses of Appendix I.- For sites containing up'to four reactors, it is-highly unlikely=that the resultant dose to a. :

MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR'190 !

if the individual reactors remain within the-reporting requirement level.

^

The Special Report will describe a course of action'that=should!

result in the limitation of the annual dose to a MEMBER OF THE' '

i PUBLIC to within the740 CFR Part 190 limits.- For-the purposes of the Special Report,' it may be assumed'that the dose' ' ,

commitment to'the MEMBER OF THE PUBLIC from.other uranium fuel-cycle sources is negligible, with the exception that dose contributions from other nuclear. fuel cycle facilities at the -

same site or within a radius of 5 miles must be considered. . If -

the dose to'any MEMBER OF THE PUBLIC 7 1s estimated to exceed 2the .

requirements of 40 CFR Part 190, the Special-Report with'a request for a variance (provided the release condition resulting'in violation of 40'CFR Part 190'have not'already been. :

corrected), in~accordance with the provisions of'40 CFR-190.ll' .

and 10 CFR 20.405c, is considered'to be a timely request and.

, fulfills the requirements of 40 CFR Part 90 until:NRC staff action is completed. An individual.is'not. considered a MEMBER !

OF THE PUBLIC during any period in which he/she'is engaged-in carrying out any operation that is part of.the nuclear-fuel ,

cycle. t 2.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The Radiological Environmental Monitoring Prog am'(RENE)'

, required by this control provides representative measurements of radiation and of radioactive materials in_those exposure pathways and for those radionuclides that lead to the-highest potential radiation exposures of MEMBER OF THE PUBLIC resulting from the station operation. This monitoring program implementsSection IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected ,

t

N l ODCM-Ruv.f12 :I

^l tr

'Pcg3 14:

l

~l- 4/94 on the basis of the effluent measurements and modeling of the environmentalfexposure pathways.

The required detection capabilities.for environmental' sample analyses are tabulated in terms of the lower limits of- i detection (LLDs). The LLDs required by Table.I3.4-3 are l considered optimum for routine environmental measurements in '

industrial laboratories. It should be recognized that-the LLD. j is defined as an a priori (before thecfact)-limit representing-' '

the capability of a measurement system and not an after the ;

fact limit for a particular measurement. j DetaileddiscussionoftheLLD,and'otherdetectionlimits[can; be found in HASL Procedures Manual, EASL-300'(revised annually);. Currie L.A., " Limits for-Qualitative-Detection and~

Quantitative Determination - Application to Radiochemistry,"

Anal. Chem. 40, 586-93 (1968), and Hartwell, J.K., " Detection Tdmits'for Radionnalvtical Countina Techniaues,"' Atlantic Richfield Hanford Cnmnany Renort ARM-SA-215 (June, 1975). l 1

2.5.1 LAND USE CENSUS This control.is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified'and that l modifications to the monitoring program are made if required by; -'

the results of-the census. The best information from the door-to-door survey, aerial survey or consulting _with local ~ ,

agricultural: authorities: or any combination of these methods '

shall be used. This: census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting !

the census to gardens of greaterfthan 500 square feet provides assurance that significant exposure pathways via;1eafy vegetables will be' identified and monitored ~since a. garden of this size is the minimum required to produce the quantity (26. 1 Kg/ year) of leafy vegetables assumed in Regulatory Guide 1.109- !

for consumption by a child. To determine this minimum garden' ;

size, the following assumptions were used: (1) that 20% of the' l garden was used for growing broad leafy vegetation ~(i.ei. "

similar to lettuce and cabbage), and-(2) a vegetation yield of 2 kg/ Square meter.

2.5.2 INTERLABORATORY COMPARISON PROGRAM The requirement for participation in an Interlaboratory Comparison Program ensures that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices.are performed as part of the quality assurance program for environmental monitoring-in order to demonstrate that the results are reasonably valid for the purpose of Section IV.B.2 of Appendix I to 10 CFR Part 50.

2.6 APPLICABILITY 4 l

2.6.1 Compliance with the controls contained in the succeeding l controls section is required during the OPERATIONAL CONDITIONS l

i l

J

c '

-l-'

ODCM R v. : 12 P2ga 15- ,

' l '. ,

4/94 !

,j

.or'other conditione;specified.therein; except that upon failure l to meet the controls, the associated ACTION requirements shall H be met.

2.6.2 Non compliance with.a. control-shall exist when'the requirements ~ ,

of the control and associated ACTION requirements are not >

performed within the specified time intervals.- If the control

-l is restored prior to expiration of.the specified time intervals, completion of the ACTION requirements is not.

required.

2.6.3 There are no actions in the ODCM which would require an operational condition change.

2.6.4 There are no restrictions on changing operating conditions in. I any of the controls on the ODCM.

2.6.5 . Surveillance Requirements shall be met during the OPERATIONAL i 4

CONDITIONS or other conditions specified for individual controls unless otherwise stated in:an individual-Surveillance Requirement. r 2.6.6 Each Surveillance Requirement shall be performed withinithe 1 specified interval'with a maximum allowable extension not to exceed 25% of the surveillance interval.

2.6.7 Failure to perform a Surveillance Requirement within the allowed surveillance interval defined by' control 2.6.6, shall' constitute noncompliance with the OPERABILITY requirements for a control. The time limits of the ACTION requirements are applicable at the time it is identified that a' Surveillance Requirement has not been performed.1 The ACTION requirements may be delayed for up to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months to. permit the completion of.

the. surveillance when the allowable. outage time limits of the ACTION requirements are less than:24 hours. . Surveillance requirements do not have to be performed on inoperable equipment.

The associated bases from the' LGS Technical' Specifications applies to this section.

i e

l

. , .~ . ..- _ - . - _ _ _ _

(p - '

"ODCM Rrv. 12 .

l' Paga:16

.] .

4/94-' ,

- 3 . 0 '-

' METEOROLOGICAL-MONITORING INSTRUMENTATION '+

l CONTROLS 3.1 The meteorolcgical monitoring; instrumentation channels shown in Table I3.1-1 shall be OPERABLE. ,

.' APPLICABILITY: At all times.

ACTION:

-With l'ess than the minimum required instrumentation ~~

channels operable for more than 7. days, prepare and:

submit.a Special Report to the Commission' pursuant.to LGS Technical Specification 6.9.2 withir, the next 10 dhys outlining the cause of the malfunct. ion and'the-plans for restoring the instrumentation to OPERABLE status.

SURVEILLANCE REOUIREMENTS 3.1-1 Each of the above required meteorological monitoring instrumentation channels shall be demonstrated OPERABLE- '

by the performance of.the CHANNEL CHECK and CHANNEL ..

CALIBRATION operations at the. frequencies shown in Table' -

I3.1-2.

1 1

e 9

'4 i

I 1

4 '- I 1

'l l

.I

ODCM R3v.1 12 l- Paga 17

l. 4/94 emmte 13.1-1 METEOROLOGICAL MONITORING INSTRUMENTATION MINIMUM Tower 1 Tower 2 INSTRUMENT INSTRUMENT (Primary) (Backup) OPERABLE

1. Wind Speed

a. Elevation 1 30 feet 159 feet 1

b. Elevation 2 175 feet 304 feet 1

2. Wind Direction -

a. Elevation 1 30 feet 159 feet 1

b. Elevation 2 175 feet 304 feet 1 l 3. Air Temperature Difference (AT)

a. Elevations 266 feet- 300 feet-26 feet 26 feet 1 Tante I3.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEIT.T.ANCE REQUIREMENTS Channel Channel INSTRUMENT Check CALIBRATION

1. Wind Speed

a. Elevation 1 (Tower 1 and Tower 2) D SA

b. Elevation 2 (Tower 1 and Tower 2) D SA

2. Wind Direction

a. Elevation 1 (Tower 1 and Tower 2) D SA

b. Elevation 2 (Tower 1 and Tower 2) D SA l

I ! 3. Air Temperature Difference (AT) l a. Elevations 266 - 26 ft (Tower 1) D SA

b. Elevations 300 - 26 ft (Tower 2) D SA NOTE:

The meteorological towers shall be located as shown on Figure I3.1-1. For backup sources of data retrieval, refer to Table I3.1-3.

l

~

- O D C M R ; v . -.' 1 2 Y -

Page 18 x _ ;;

, 4/94- '

TABLE I3.1-3 ,

' METEOROLOGIr AT. TOWER DATA RETRIEVAL .

INSTRUMENT TOWER 1 TOWER 2 DATA LOGGER DATA Strip Chart i Strip' Chart # RM-21A Channel 9 l Wind Speed 1 (TWR1)

a. Elev. 1 XR-MS-012C XR-MS-020B. RM-21A 14 (TWR2) l Wind Speed 5 (TWRl) *

, b. Elev. 2 XR-MS-012B XR-MS-020A RM-21A 21 (TWR2) l Wind Dir. 0.(TWRl)

a. Elev. 1 XR-MS-012C XR-MS-020B RM-21A 13 (TWR2)'

l Wind Dir. 4 (TWR1)

b. Elev. 2 XR-MS-012B XR-MS-020A RM-21A- 20 (TWR2) 1 Multi pt Rec # Multi-pt Rec 9 DELTA T XR-MS-091 XR-MS-092 . 7 (TWRl). ,'

i Point 2 Point 2 RM-21A 23 (TWR2)

[ j PRIMARY OPTION:

l R DATA IS UNAVAILABLE FOR TOWER 1 (Strip Chart l's XR-MS-012C, XR-MS-012B, Multi-Point.

j Recorder .fXR-MS-01 point 2), .

l THEN verify corresponding data'available on Tower 2 (Strip Chart 8's XR-MS-020A, XR-MS-D20B, l Multi-Point Recorder #XR-MS-092 point 2)..

l

l l SECONDARY OPTION:

R data is not available from Strip Charts or Multi-Point Recorders,-

THEN verify data on RM-21A. i j TERTIARY OPTION:

R RM-21A is not available, .

THEN verify data on' Data Logger-(corresponding channel numbers).

- - _ _ . _ - .- - - . - - -. . _- n , .

--- -- ~ , . ~ - , , . - ' . _ . _ _

- , - ~ - - - - - - _ _ . . - - .' x - - . , . _ - _ _ _ _-__-.

r, . - =

ODCM Rav.-12

,l} Paga 19

," _ 4/94

.l-J-

_Ficure 13.1-1 Meteorological' Tower Location

~. .

i WiU'[5 ,. '( j(N/Fg'/4)M?d9'.'/.M@.Mi.

j- A 't .

(- l '$ \\\ '\\"~%[6E! .M - - ~ ~ .

) ' 'AN.jd* .:'J:

s.,7s ,

"' h '* W'. .'*'-

3 3

t. ~. . .;

L .. \

. .' , triru p n.

.:otactcit r ' .

. ' 'l ~

.t

,gf '[%: .7., 7 ]

, s. .

Tar!R #1 .

s

)U 3r ( 8?b' . .,k I * ~~l ' 4 h '.

, \ '\ 'h t e,'

(\~, V P,l } <*/.] 8, _, ~ -M','? .. M . ?h4 i?d

\5

' M DNYN i

i $ ' M ( ' P 5 ! .p' ann.a- m ~-

Ik' \

11 .

Q.'

1 n..s4\ %i h ccS:t i 14. a .;* W o MMC' b-sw .?

/ . 4. \. 9,,i . - s,,s3 a."< ll.si.ss w s E E'" %"7L .. .t., 4 i

~

\ . . .

., b_ h , "--Mr d

t. \ )}

' 220U 7 .-.

.: E }.f?l

\

'J \ '\ \ Y;. 5!'$4 ': l'l.

~

t:-

- \ ) b _

0 'w-$o;.'2 , e ,Y~

. iic::::f.Fif - l' L'/%' .j'. --

s 1

UliiW"" "J~ %~ .!

r,j -

%3

~

g

!r- *

-I--e o k a.s - .-

a "i '. L**n* \ . As 4 . . ' P'h _ * = _;

~

b i \\ :.. '

., k l METEOROLOGICAL %

Tawin s? \

i

.g n .- --:}. .

Q~ . ic.', =g,M 00KY

' ./ .

% Y,g..: h[,25UhSTAT10N

\ \ w-s I.\NNd*T X. v f *l.g\..,

..,4.,'. .- , y.7 .:n h -rN k j Idi*/'.\.V/ 'd! C.' 's ,'.;

> :, ..m , i

, ( . ' -

3*MI'# M'%.*'\ % '-

~

5::: f y \ ' 6g

N,...:

{.,. 4, Q[..s d(

s %- --

g.* O ;> . a . e.. -

s.'i i e. L.p,-

. ---- U N,$ s; .l.,=g%

.# #p#3'9,.E.If!,

,,.s

-(. ,,I (i+=3 ~

,,,,, -jg . ic.=-

.-3. --

.. .. ** i y y* . , ..

.*~b * *'h

( .

.. -. M {- .-

t

, ..O.*%.q, . -- M).-- -

,td\'d

e. .

k ~! ! ' i - M..

. S. . . . . . /%,. ,

O s __ _ _ _ - _ _ _ - - - _ - _ _ - _ _ _ . -

1

y

.ODCM R;v. 12

} Paga 20 ,

[ 4/94'

~

'3.2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.2.1 The radioactive. liquid effluent monitoring instrumentation.

channels shown in Table I3.2-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that Control I3.2.2 is not exceeded. -The alarm /setpoints* of these channels shall be determined and adjusted in accordance with the methodology and q parameters in the ODCM - Part-II, Section.1.2.

L i L APPLIQABILITY: At'all times. ,

l ACTION:

a. With a radioactive liquid effluent monitoring instrumentation channel alarm / trip setpoint less conservative than required Ly the above control, immediately suspend the release of radioactive liquid effluents monitored by the affected channel, and declare the channel. inoperable.

b. With less than the minimum number of radioactive liquid . ,

effluent monitoring' instrumentation channels OPERABLE, take 1 the ACTION shown in Table I3.2-1. Restore the inoperable .

instrumentation to OPERABLE. status within the time specified in the ACTION or explain in the next Semiannual Radioactive

-Effluent Release Report why this inoperability was not corrected within the time specified.

SURVEILLANCE REOUIREMENTS 3.2.1-1 Each radioactive liquid effluent monitoring instrumentation channel:.shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST-performance at the frequencies shown in Table I3.2-2.

Excluding the flow rate measuring devices which are not-determined and adjusted in.accordance with the ODCM.

l l

W i- '

jf' 'ODCM Rsv. 12-E Paga-21

^

jf 4/94 t

TABLE I3.2-1 3

RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION MINIMUM j

CHANNELS INSTRUMENT OPERABLE ACTION

1. Gross-Radioactivity Monitors Providing Automatic' Termination'of Release

a. Liquid Radwaste Effluent Line 1 100'

b. A/B RHR Service Water Effluent'Line 1/ loop 101

2. Gross Radioactivity Monitors Not Providing' Automatic Termination of Release

a. Service Water Effluent Line. I 101 0

h 3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line 1 102

b. Discharge Line 1 102:

ACTION STATEMENTS Action 100- With less than the Minimum Required Channels operable, . .

effluent releases may continue for up to 14 days'provided that prior to initiating a release:

a. At least two independent samples are analyzed in

( accordanceiwith Table 13.2-3, and I

b. At least two technically' qualified members of the.

facility stuff independently verify the release rate calculations and discharge-line valving; otherwise, suspend release of~ radioactive effluents-via this pathway.

Action 101- With less than the' Minimum Required Channels operable,,

j l effluent releases via this pathway may. continue _for up to 30 days provided that, at least once per 8-hours, grab.

samples are collected and analyzed'for radioactivity by gamma isotopic analysis-(Principal Gamma Emitters,'I-131, and Dissolved / Entrained Gases) as a Lower Limit'of Detection as specified in' Table 13.2-3 or gross

f. radioactivity (beta and gamma). Gross Beta is analyzed at an LLD of at least IN7 microcurie /ml. Gross Gamma is l analyzed at an LLD of at least SN7 microcurie /ml.

Action 102- With less than the Minimum Required Channels operable,. l effluent releasea via this pathway may continue for up to 30 days provided the flow rate is est h ted at least once ;

per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months during actual releases. Pump curves generated in situation may be used to estimate flow.

l ODCM Rav. 12 i Page 22 _

l 4/94 TABLE I3.2-2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUNRMTATION SURVEIt.rAMCE RROUInnamMTS CHANNEL CHANNEL SOURCE CHANNEL FUNCTIONAL INSTRUMENT CHECK CHECK CALIBRATION TEST ,

1. Gross Radioactivity Monitors Providing Automatic Termination of Release

a. Liquid Radwaste Effluent.Line _P' P R(3) Q(1),

b. RHR Service Water. System Effluent Line' D M R(3)- Q(1)

2. Gross Radioactivity Monitored Not Providing Automatic Termination of Release s

a. Service Water System Effluent Line D M R(3) Q(2)

3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line D(4) N.A. R Q

b. Discharge Line D(4) N.A. R Q t

V W

ODCM Rsv.112 l

Pcga 23 l- 4/94 TABLE I3.2-2 (Continued)

TABLE NOTATIONS l l

(1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that !

automatic isolation of this pathway and control room alarm annunciation-will occur if any of the following. conditions exists:.

1.- Instrument indicates measured levels above the alarm / trip setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

(2) The CHANNEL FUNCTIONAL TEST shall also demonstrate that

- control room alarm annunciation occurs if any of the following conditions exists:-

l

1. Instrument indicates measured levels above the alarm H

( .

setpoint. . .l

- 2. Circuit failure.

e 3.- - Instrument indicates a downscale failure.- 4 (3) The. initial CHANNEL CALIBRATION shall be performed using reference standards certified by.the National Institute of i Standards and' Technology (NIST) obtained from suppliers that' l participate'ja measurement assurance activities with NIST.

These standards shall permit calibrating the system over its

~

For intended range of energy and measurements range.

subsequentLCHANNEL CALIBRATION, sources'that have been :

related to the. initial calibration shall be used. '

(4) CHANNEL CHECK shall consist of verifying indication of flow during periodr of release.- CHANNEL CHECK shall be made at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months on days on which batch releases are ;

made.

I 2

4 A

?

5

)

4

- se e nhm e we- e- - - s , t tg %

, - . . - , ~ . . . -

~ODCM R3v. 12-l:

'~ .Psga 24-

l'. 4/94.

CONCENTRATION CONTROLS 3.2.2 The concentration of' radioactive'materialLreleased in

. liquid effluents to UNRESTRICTED AREAS-(see Figure I2.2-

-la,b) shall be^ limited to the concentrations specified-in

.10 CFR Part 20, Appendix B,-Table II,-Column 2 for ;

. radionuclides other than dissolved or antrained nobles gases. For dissolved or entrained noble gases, the concentration shall be. limited to 2E-4 microcuries/ml-total activity. ,

APPLICABILITY:.At all times. 3 ACTION:

With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to within the above limits or terminate the release.

SURVEILLANCE REOUIREMENTS ,

3.2.2-1 Radioactive liquid wastes shall be' sampled and analyzed according to the sampling.and analysis program of Table I3.2-3.

3.2.2-2 The results of-the radioactivity analyses shall be used in accordance with the methodology and parameters in the ODCM Part II. Section 1.3 to assure that the concentrations at the point of release are maintained within the limits of Control-I3.2.2.

l l

.j- ODCM R3v. 12-

~

Paga 25 w- fl 4/94: ,

)

. TABLE I3.2-3 RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM )

Lower Limit '

- : Minimum Type of of Detection-Liquid Release Sampling- Analysis Activity _ - ( LLD )*

Type Frequency Frequency Analysis (uci/M1) ,

A. Batch Waste P P Principal Gamma SE-7 ;

Release Each Batch Each Batch Emitters' '

Tanks b I-131 1E-6 1.-Floor or P M- Dissolved and 1E-5 Equip. Drain One Batch /M Entrained Gases Sample Tanks (Gamma Emitters) -

2. Laundry P M- H-3 1E-5 ,

d Drain Sample Each Batch Composite Tank Gross Alpha 1E-7 P Q Sr-89,.Sr-90 SE-8 Each Batch Composite d Fe-55 1E-6 B. Continuous W W Principal Gamma SE '

Release' Grab Sample Emitters *

-I-131 1E-6

1. RHR Service W W Dissolved and' 1E-5 Water System Grab Sample Entrained Gases Effluent Linef (Gamma Emitters)

2. Service Water W M H-3 1E-5 System Grab Sample Composite d Effluent Linef Gross Alpha 1E-7 W Q Sr-89. Sr-90 SE-8 -

Grab Sample Composite d Fe-55 1E-6

(#n + . .

N ODCM'R;v.(12c 1

?lL

.Paga 26' 4

m.4 p .

4/94 3>+ - .

TABLE 13.2-3~(Continued) . .l 9

- ' TABLE NOTATIONS ]

f a. , The LLD is' defined aus .the smallest: concentration of. radioactive material in a sampleLthat.will. yield.a net: count,-above system-background.,-.that will be detected with 95% probability.fwith only-m 5% probability of falsely concluding that;a blank observation

represents a "real" signal.-

1 z' j ' For a measurement system, which may include" radiochemical.

separation:

l- 2.71 + 4.66s g(1-exp(-A At )z) -

'l E'V 2.22E6 Y exp (-AAt )( AAta )'

3 Where:- .

LLD is the a priori lower limit.of detection as defined above

( as microcuries per unit mass or volume),

' s.a is the stahdard deviation of the background counting rate or' of the counting rate of blank sample as appropriate (as countsi per minute),.

E is the' counting efficiency, as counts per disintegration, V is.the sample size, in units'of mass or volume,.

2.22E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical. yield, when applicable, A is the-radioactive decay constant for th'e particular-radionuclide,. and At for the plant effluents is the elapsed time between.the end of,the sample collection and the time of counting.

Atg for the plant effluents is the elapsed time between the end j L of the sample collection and the start of' sample ' collection. 1 Typical value's of E, V, Y, and At should'be used in calculation.. 1 It should be recognized that the LLD is defined as an a nriori~(before~ i the fact) limit representing the capability-of a measurement system and not as an after the fact limit for a particular measurement.

L l

'ODCM R;v.L12 J .P2g3 27 o l-4/94 TABLE'I3.2-3 (Continued) 2 TABLE NOTATIONS

b. A' batch 1 release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyrca, each batch shall be isolated, and then thoroughly mixed to assure representative l sampling.

c. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Mn-54, Fe-59, Co .

58, co-60, En-65, Mo-99, Cs-134, Cs-137, Ce-141 and-Ce-144.- This i list does not'mean that only these nuclides are to be considered. '

Other gamma peaks that are identifiable,'together.with those of the above nuclides, shall also be analyzed and reported in the l Semiannual Radioactive Effluent Release Report pursuant to Control 3.6.

I

d. The term " Composite Sample" means a combination of individual- !

samples obtained at regular intervals over a time period. .Either. l the volume of each individual sample is proportional to discharge .j flow rates, or the sampling interval (for constant volume i samples) is proportional to flow rates over the time period used to produce the-composite.

e. A continuous release is the discharge of liquid wastes of j 'nondiscrete volume, from a volume of a system that has an-input H flow during the continuous release.

~

f. Whenever effluent releases are in excess of the monitor's setpoint.

I l

l l'

l

+ - .

4

'ODCM Rev.112

=l' Pagt 28 ,

w, 4/94i -l

, l-l a- 9 DOSE 1 CONTROLS 3.2.3-The' dose'.or dose commitment to a' MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released from the, i

' site to UNRESTRICTED AREAS (See Figure I2'.2-la) shall-be limited

a. During any calendar quarter.to'less than or. equal to 3 mrems to the total body and to less than or. equal to 10 mrams to any organ, and.

b. During any calendar year to less1than or equal to 6 mrems to the. total body and to less than-or equal to 20 mrems to any organ.

APPLICABILITY: At all times.

4-ACTION:

With the calculated dose from the' release of

! radioactive materials in liquid effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical- '

Specification 6.9.2, a Special' Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce

~

the releases and the proposed corrective actions to be taken to' assure that subsequent releases will be-in compliance with the above limits. This Special Report shall also include the radiological impact on finished .

drinking water supplies at the nearest downstream

- drinking water source.

SURVEILLANCE REOUIREMENTS 3.2.3-1 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current calendar year shall be determined using l

ST-0-104-878-0 at least once per 31 days.

L

. = , - .. _

$ ODCM R;v. 12 ll '

Pcg3 29

.l 4/94 LIOUID RADWASTE TREATMENT SYSTEM CONTROLS 3.2.4 The l! quid radwaste treatment system shcl1 be IN SERVICE and appropriate portions of the system shall be.used to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid effluent, from the site, to' UNRESTRICTED AREAS (See Figure I2.2-la) would exceed 0.06 mrem to the total body.or 0.2 mrem to any organ in a 31-day period.

APPLICABILITY: At all times.

ACTION:

a. With radioactive liquid waste being discharged without treatment or in excess of the above limits, pursuant to Technical Specification 6.9.2, prepare a Special Report which includes the following information:

1. Explanation of what liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoperability.

2. Action (s) taken to restore the inoperable-equipment.to OPERABLE status, and

3. Summary description of action (s) taken.to prevent a recurrence.

I b. Submit report to Commission within 30 days.

SURVEILLANCE REOUIREMENTS 3.2.4-1 Dose due to liquid releases from the site to UNRESTRICTED AREAS shall be projected at least once l per 31 days using ST-0-104-878-0.

ODCM R v.112 Pag 3 30~

[

q; .4/94:

1 3.3 RADIOACTIVE CASEOUS EFFLUENT MONITORING INSTRUMENTATION.

CONTROLS

- f3.3.1'The' radioactive-gaseous effluents monitoring instrumentation

~l channels in Table I3.3-1 shall be_ OPERABLE with their alarm / trip setpoints set to ensure that the limits The' of=ODCM alarm / trip _..

Control Part I Section 3.3.2 are not exceeded. '

setpoints of the applicable channels'shall be determined in- ,

accordance with the methodology:and parameters in_the ODCM.

Part II,.Section 2.2..

APPLICABILITY: -As shown in Table I3.3-1.

I ACTION:

a. With a radioactive gaseous effluent monitoring instrumentation channel alarm / trip setpoints less. -

conservative than required by Part II Section 2.2,_

immediately suspend the release of. radioactive gaseous-effluents monitored by the affected channel.or declare the channel inoperable.

b. With less than the minimum number of radioactive- ,

gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.3-1.

Restore the inoperable instrumentation to OPERABLE.

status within the time specified in.the-ACTION. If-the~ inoperable instrumentation is not restorediwithin the time specified in the ACTION statement: create an-AR in -PIMS to ensure an explanation'is written by the g

i responsible System Engineer and is included in SAERR l l by the HP Effluent Physicist.

SURVEIt T.ANCE REQUIREMENTS 3.3.1-1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE-

by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table I3.3-2. ,

4 4

Y e t- ---

e ri--- --- - - -

. l ODCM R v. 12 Pag 3 31 l 4/94 TARTR 13.3-1 RADIOACTIVE CAREOUS EFFLUENT MONITORING INSTRUMRMTATION MINIMUM CHANNELS INSTRUMENT OPERARLE APPLICARILITY ACTION l SOUTH STACK EFFLUENT MONITORING SYSTEM

a. Noble Gas Activity Monitor 1

111

b. Iodine Sampler _ 1

112

c. Particulate Sampler 1

112

d. Effluent System Flow Rate Monitor 1

113 Sampler Flow Rate Monitor

113 4

e. 1 f

l NORTH STACK EFFLUENT MONITORING SYSTEM i

a. Noble Gas Activity Monitor 1

114

b. Iodine Sampler 1

112

c. Particulate Sampler 1

112 !

113 t d. Effluent System Flow Rate Monitor 1

i e. Sampler Flow Rate Monitor 1

113 l HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR **

a. Iodine Sampler 1- 112

b. Particulate Sampler 1 ** 112

c. Effluent System Flow Rate Monitor 1 ** 113

-d. Sampler Flow Rate Monitor 1 ** 113

/;

j'8 The (A or B) North stack Normal Range Radiation Monitors OR the Wide Range Accident l_ ' Monitor (Low Range) may be used to satisfy requirements for the North Stack Effluent Monitoring System.

NOTE: With regard to Actions lil, 112, 113, and 114; with less than the minimum Required Channels operable for greater than 30 days prepare and submit a Special Report to the Effluent Physicist within the next 10 days outlining the cause of the malfunction and the plans for

_l_ restoring the instruments to OPERABLE Status.- Sampling shall continue until the minimum

_l channel operability requirement is met. ,

At all times.

~l**

During operation of the hot maintenance shop ventilation system.-

o

'ODCM-R::v. 12 Jlc '

Paga.32 4/94

- ll TABLE 13.3-1IContinued)

TABLE NOTATIONS ACTION STATEMENTS ACTION 111 - With'less than the minimum Required Channels-l-(SS Noble Gas) OPERABLE, effluent releases via this pathway.

may continue for up to 30 days provided grab I samples are taken per ST-5-026-580-* at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and these samples are f analyzed for gross activity within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

ACTION 112* - With less than the minimum Required Channels l-(Iodine & Part.) OPERABLE, offluent releases'via.this pathway may continue for up'to 30 days provided l samples are continuously collected with auxiliary sampling equipment per St-5-076-815-*, ST-5-076-820-* as required'in Table I3.3-3.

IE the Sample Pump is operable, a particulate-and iodine sample can be obtained; I

AND the Minimum Channels Operable requirements are satisfied.

ACTION 113* - With less than the minimam Required Channels (Eff. & Smpl. OPERABLE, offluent releases via NS, SS or HMS Flow Rate) may continue for up,to 30 days provided the, flow rate is estimated by adding the nominal-flow rates indicated in PEID M-26 for-each in-service. fan. This-shall be documented in

~

j the NCR operations Shift Log at least once J per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months . j ACTION 114 - With less than the minimum Required Channels l (NS Noble Gas) OPERABLE, effluent releases via this pathway. i may continue for up to 30 days provided grab j g'

j samples are taken per ST-5-026-580-0 at-least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and these samples are analyzed for gross activity within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months . i The Mechanical Vacuum Pumps may not be operated during this LCO. 1

If release point is the Hot Maintenance Shop, Then secure ventilation because no means exist to alternately sample the ventilation.

i p

I

_ _ - _ _ _ _ _ _ _ _ _ _ , . ..- . ..~.- . . . . . . , , . . . . . .. . . . _ . _. - -

i q.-

ODCM'R*.v. 12-l Page 33 l- .4/94 4

TART 2 I3.3-2 1

RADIOACTIVE GASEQUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS 1

CHANNEL MODES IN WHICH CHANNEL SOURCE CHANNEL FUNCT. SURVEILLANCE INSTRUMENT . CHECK CHECK CALIBR. TEST IS-REQUIRED 1.- SOUTH STACK EFFLUENT MONITORING SYSTEM

a. Noble Gas Activity Monitor D .M R(2) Q(1) b.-Iodine Sampler .W(3) N.A. N.A. N.A. *

c. Particulate Sampler. N.A. N.A. N.A. *

.W(3)

d. Effluent System Flow Rate Monitor D N.A. R Q *

. e. Sampler Flow Rate . Monitor: 'D N.A. R- -Q'

e 2. - NORTH STACK EFFLUENT MONITORING SYSTEM # !

a. Noble Gas Activity Monitor D. M R(2) Q(1)

N.A.

b.-Iodine' Sampler W(3) N.A.- N.A.

c._ Particulate Sampler W(3) N.A. N.A. N.A.

d. Effluent System Flow Rate Monitor D N.A. R Q *

e. Sampler Flow Rate Monitor D N. A. - R Q *-

3. HOT NAINTENANCE' SHOP VENTILATION-EXHAUST RADIATION ~ MONITOR a.-Iodine Sampler W(3) N.A. N.A. N.A. **

b. Particulate Sampler W(3); N.A. -N.A. N.A. **

c. Effluent System Flow Rate Monitor- D N.A. R Q **

d. Sampler Flow Rate Monitor D N.A. R Q **

9 Wide Range' Accident Monitor (WRAM) surveillance is specified in Technicol Specification 4.3.7.5.

l *' At all times.

.. j j-**:During operation of the hot maintenance shop ventilation exhaust system.

4 i4, . -- _ . . . - - - . , , . , , . , , . , - . , , , _

, , .,_.,._,,,,-c ,_ , - ~ , w

~

ODCM Rsv.jl2; ;

k e Paga 34 1 ll7 4/94! d TABLE T3.3-2(Continued)' l TAELE NOTATIONS !

(1) The CHANNEL FUNCTIONAL' TEST ~shall'also demonstrate that .l control room alarm annunciation occurs if any of the. J following conditions-exists: a l

1. ~ Instruments indicate measured levels above the alarm / trip setpoint. i

2. Circuit failure. !

3. Instrument indicates a downscale failure. 1

4. Instrument controls not set in operate mode. 1 1

(2) The. initial CHANNELLCALIBRATION shall'be. performed using

~

one or more of the reference standards. certified by the ')

National Institute of Standards and Testing (NIST) or using i standards-that have been'obtained from suppliers that l participate in measurement assurance activities with NIST.

These standards shall permit calibrating the system over its. intended range of energy and measurement range. For l subsequent CHANNEL CALIBRATION,' sources that are traceable. a to the' initial calibration shall be used.

(3) The iodine' cartridges and particulate flit'ers will.be changed and-analyzed at least once per 7 days.

~

l i

i i

4

- _ _ _ _ _ _ - _ m .s,- 1--- -r -- r

JOh.:M.Rsv.12' Ll- Paga 35-

, j-4/94

_CAREOUS EFFLUENTS

, CONTROLS

.3.3.2-The dose rate due to radioactive materials released in

~

gaseous effluents from the site to areas at an: beyond the

.- l '

SITE BOUNDARY (See Figure I2.2-la) shallLbeilimited to:

~

1 l

a. For noble gases: less than or equal.to 500 ,

mrems/yr'to the total body:and:less-than or equal

. to 3000 mrems/yr to the skin, and For' iodine-131, iodine-133, tritium,'and.for all, b.

radionuclides'in particulate. form with half-lives

- greater than 8 days: less than or equal-to 1500 mrems/yr to any organ. (Inhalation-pathways only.) ,

APPLICABILITY:- At all times. ,

ACTION:

With the dose. rate (s) exceeding the above limits, immediately restere the re.'. ease rate to within the above limits.

SURVEIT.T.ANCE REQUIREMENTS

'3.3.2-1.The dose rate due to noble. gases in gaseous effluents:shall'be determined to be within the- -

j above limits using ST-0-104-879-0. When North or South Stack Noble Gas setpoints are~ exceeded, the Common Dose Model computer program is'used to determine dose rates due to Noble Gases..

3.3.2-2 The dose rate due to iodine-131,-iodine-133, tritium, and all radionuclides in particulate form with half-lives. greater than 8 days in gaseous.

effluents shall be' determined to be within the above' representative limits using samples ST-0-104-879-0 and performing by analyses-obtaining in 4 -

accordance with the sampling and analysis program. ,

specified in Table I3.3-3.

4

?

i W -u--7'- =wi r-eemeym->, .,-w-- r- -- * - E '--- - - - - - - - - - - - - - - - - - . -- - - - - - - - - - - - - - - - - - - - ---.a- * - - - - -

T oODCM'Rsv. 12

'l-. Paga 36

. ;; . 1. 4/94 TABLE T3.3 RADIOACTIVE GASEOUS WASTE SAMPLING-AND ANALYSIS PROGRAM Lower Limit Minimum- Type of of Detection Gaseous Release ' Sampling Analysis -Activity :(LLD)* ,

o Type Frequency ' Frequency -Analysis- -(uCi/M1) l r

-A. Containment P P Principal. Gamma 1E-4 Purge .Each Batch Each Purge Raitters',f Release ' Grab Smpl.

B. North Stack / Continuous d

Q Gross Alpha 1E-11 South Stack Comp. Part. Sr-89, Sr-90 1E-11 Sample '

s Mb Grab Smpl. M6 Noble Gas 1E-4 i H-3 1E-6 j Continuousd 9F 2 Char. Sapl. I-131 1E-12 l I-133 1E-10 :

Part. Smpl. ' Principal' Gamma .

3 Emitters 1E-11 Continuous d Continuous Noble Gas

' Noble Gas Beta or Gamma 1E-6 Monitor :(Based on

'~Xe-133)

C. Hot Mainten. Continuoun d Q Gross Alpha 1E Comp. Part. Sr-89, Sr-90 1E-11 Smpl. ;

i d

Continuous W' Char. Smpl. I-131 1E-12 I-133 1E-10 Part. Smpl. Principal Gamma Emitters 1E-11 4

i I

l 1

y y, m ,.

, -j_ ,

j?

ODCMJRsvk 12 j O~f

'e -

Paga'37; 4

.. ji

. 4/94

& 9-

(( TABLE T3.3-3-(Continue'd)

/ "$ TABLE NOTATIONS a.' The-LLD'is defined,.as the smallest concentration-of:

radioactive material in a sample that will yield a net count, above system background, that.will'be detected with 95%

probability with'onlyc5% probabilityLof: falsely 1 concluding-that a blank ~ observation represents a "real" signal. 'It

.should be.' recognized that*the LLD is. defined as an n' priori, (before;the; fact) limit representing the capability;of a-measurement system and not as an after the fact' limit for a particular, measurement. ,

For a particular measurement system,' (which may include-radiochemical separation):

2.71 + 4.66sa '(1-exp(-AAta ))

LLD =

.E

V .2.22E6

Y exp -(-AAt )( AAta) 3 Where:

LLD is;the a orlori lower limit of detection as' defined above-(uci/cc or ucl/mL),. ,

s a is the standard: deviation.of the background counting l rate:

or of-the' counting rate of blank' sample as appropriate-(as-cpm), shall be based on the actual observed variance of-the .

background. counting rate or-of the counting rate of the blank-samples (as appropriate) rather than on"an unverified ,

theoretically predicted variance.

E is the counting efficiency, as cpdis,.

V is-the sample' size,.'in unitsjof cc or'ml,- >

2.22E6 is the number of dpm/uci

~

Y is the fractional radiochemical yield, when applicable, A is the radioactive decay constant for the particular' <

radionuclide, and' At, for the plant effluents is the elapsed time between the .

end of the sample collection and the time ~of counting.-

for the plant effluents is the elapsed time between'the.

.At,d en of the sample collection and the start of sample s

collection.

Typical values.of E, V, Y, and At should be used in-calculational.

3 s

- wv c .. ..

. ODCM R v.112:

-p

~

Paga-38 .,

~'

q~ .4/94

' TABLE I3 3-3'(Continued) 4 TABLE NOTATIONS

, b.. sampling and analyses shall~also be performed following-shutdown, startup, or a THERMAL POWER-change; exceeding-15% of- 3 the RATED: THERMAL POWER within a 1-hour' period using- !

. RT-5-000-876-*. This' requirement does not apply if-(1). .

analysis show that the DOSE-EQUIVALENT I-131' concentration in-the primary coolant has not increased'more than a-factor'of 3; ,

and (2) the main condenser offgas pre-treaument' radioactivity

~

l monitor shows.that effluent. activity has not increased more !

~

than a factor of 3. . .l

c. Samples shall be changed at least once per 7 daysiand analyses shall'lus completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months .after changing,.or'after '

removal from sampler. Sampling shall:also.be performed at i

least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months for at least 7 days following each~

shutdown, startup or THERMAL POWER change exceeding 15% of. i o

RATED THERMAL ~ POWER'in 1 hour1.157407e-5 days 2.777778e-4 hours 1.653439e-6 weeks 3.805e-7 months and analyses completed within:48. j hours'of changing. When' samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months ~are I analyzed, the corresponding LLDs may be increased by a factor ',

of 10. This requirement does not apply if (1) analysis shows! l

that the DOSE EQUIVALENT I-131 concentration in the primary- l coolant has not increased more than a factor of 3; and (2) the.

noble gas monitor shows that affluent activity has not increased more than a factor of:3.

d. The ratio of the sample flow rate to the sampled stream flow '

rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Controls ,

3.3.2,.3.3.3, and 3.3.4. j

e. 'The principal gamma emitters for which the LLD specification l applies include:the following radionuclides: Kr-87,.Kr-88, Xe-

_j' 133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions 4- and Mn-54, Fe-59, Co-58,-Co-60, En-65, Mo-99,cI-131, Cs-124, Cs-137, Ce-141 and Ce-144 for particulate emissions. .This list does not mean thattonly these nuclides are to be- l considered. Other gamma peaks which are identifiable, together with the above nuclides, shall also'be analyzed and reported in the Semiannual Radioactive Effluent Release Report, pursuant to Control 3.6

f. Under the provisions of footnote e. above, only noble gases

? need to be considered.

! .g. Required for the hot maintenance shop ventilation. exhaust only during operation of the hot' maintenance shop ventilation exhaust system.

- ._ _ . ___D

I

ODCM R3v.M12~

ll '

" POg3: 39'

~4/94 l

x DOSE - NOBLE CASES

.. \

EQHTROLS !

3.3.3 The' air dose due to noble gases released in gaseous effluents, y from.the site to areas at and beyond the SITE BOUNDARY (See Figure.I2.2-la) shall be limited to the.following:

a. During any calendar quarter: Iless'than orfequal-to' >

10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation, and

b. 'During any calendar year: . less than or equal to. .

20 mrads'for gamma radiation and-less than'or_ equal ~to 40 mrads for beta radiation..

APPLICABILITY: At all times.

ACTION:

a. With the calculated air dose'from radioactive noble gases in gaseous effluents exceeding any of the above limits,-prepare and submit to the Commission'within 30 ,

days, pursuant to Technical Specification 6.9.2, a-Special Report which identifiesfthe cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be~taken-to assure that subsequent releases will_be in compliance with-the above limits.

SURVEITIANCE REOUIREMENTS 3.3.3-1 Cumulative dose contributions-for the' current quarter s and current calendar year for noble gases shall'be.

determined using ST-0-104-879-0, ST-0-104-881-0, ST-0-104-883-0 every 31 days, f

L v + , - - ~ -- -

-n-a -- - - _ - _ _ _ - - - -

=

., - 2

~ODCM R".v.:12 q~'-- Paga'40 .1 i ' '4/94

'I DOBE - IODINE - 133, TRITIUM, AND' RADIONUCLIDES IN PARTICUTATE FORM ,

4 CONTROLS 3.3.4 The' dose to-u MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium and al1~ radionuclides in particulate form with-half-lives greater.than 8 days in'gasecus effluents released from the site to areas'at or beyond the SITE BOUNDARY (See Figure 12.2-la) shall'be limited to.the'following:.

a. During any calendar quarter: less than or equal to. ,

15 mrems to any organ and, >

-s

b. During any calendar year:

less than or: equal to 30 mrems to any organ.

APPLICABILITY: At all times.

ACTION: . .

a. With the calculated' dose from the release of iodine-131, iodine-133, tritium and all radionuclides in.

particulate form with half-lives greater than 8 days in gaseous affluents exceeding any of the above limits, prepare and submit to the Commission'within 30- ~,

days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit and defines the corrective 1 actions that have been.taken to reduce the releases and the '

proposed corrective-actions to be taken to assure that subsequent releases will be in compliance with the-above limits. .

i SURVEIT.T.ANCE REOUIREMRNTS 3.3.4-1 Cumulative dose contributions for the' current calendar-quarter and current calendar year for iodine-131,...

iodine-133, tritium and radionuclides in particulate form with half-lives greater than 8 days shall be determined using ST-0-104-879-0 once per 31 days.

4 -3 6

d 4

i e6--- w c rr - , - - - . -

. - - - . _ - + - > -- -__ _ _ _ . _ _ _ _ . _ _ _ _ _ . _ _ _ _ _ _ _ _ _ - . _ - _ _ _ _'

. . . _ . . . - _ . . ._ _ - . . _ m . .

y : ~fy ? ,

ODCM Rsv. 12;,

s l- Paga : 41'-

~

8-e-

' 4/94

. VENTILATION EXHAUST TREATMENT SYSTEM CONTROLS l 3'.3.5 The VENTILATION EXHAUST. TREATMENT. SYSTEM:shall'be:IN SERVICE-and appropriate portionsiof the system shall.be used to reducee radioactive material in gaseous waste, prior to their discharge when the projected doses due to gaseous effluent releases, from the. site to creas at.and beyond-the SITE-BOUNDARY (See Figure I2.2-la) when averaged'over 31 days would-exceed 0.6 mrem to-f any organ in a 31-day period.,

APPLICABILITY:. At'all times.

ACTION:.

With gaseous waste being discharged without treatment, or.

i.

a.

in excess of the above . limits, prepare and' submit tx) the >

Commission within 30 days,' pursuant'to Technical -

Specification 6.9.2,.a Special Report._which includes the-following information '

l. Explanation of why gaseous radwaste was-being

' discharged'without treatment,_ identification of any inoperable equipment or subsystems, and the reason for the inoperability. ' j i 2. Action (s)'taken.to restore the inoperable equipment [to" ;

OPERABLE. status, and t.

3. Summary description of action (s) taken.to prevent a recurrence. ,

. SURVEITLANCE REOUIREMENTS 3.3.5-1 Doses due to' gaseous releases fromlthe site to areas-at and beyond the_ SITE BOUNDARY'shall be projected at 1 l least once per 31 days using.ST-0-104-879-0.

i a

c '

4 l :"

l' si L

o .

?

s s a t

l -.

~ .. m . , ,. -

ODCM Rsv. 12

.[ Paga 42 4/94

[

VENTING OR PURGING CONTROLS I 3 . 3 .' 6 The VENTING or PURGING of the Mark II containment.shall be through the standby gas treatment system.

APPLICABILITY: Whenever the containment is vented or purged.*

ACTION:

a. With the requirements of the above specification not satisfied, suspend all VENTING and PURGING of the 4= containment.

SURVEIT TANCE REOUIREMENTS 3.3.6-1 The containment shall be determined to be aligned for -

VENTING or PURGING through the standby gas treatment -l system within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months prior to start of and at least l once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months during VENTING or PURGING of the containment.

3.3.6-2 ' Prior to use of the purge system through the standby {

j gas treatment system assure that:

a. Both standby gas treatment system trains are OPERABLE whenever the purge system is in use, and

b. Whenever the purge system is in use during OPERATIONAL COND7. TION 1 or 2 or 3, only one of the standby gas treatment system trains shall be used to prevent damage to both trains should a LOCA occur (LCO 3.6.5.3-ACTION a applies during this configuration).

Except after Containment is deinerted and purged while the -

reactor is in OPCON 4 or 5 QE for the one inch /two inch vent valves to the Reactor Enclosure Equipment Compartment Exhaust Filters when used for containment pressure control and nitrogen make-up operations.

~

4 5 . , . ~ . - , . - - - - - - . .

ODCM R;;v.12

% Paga 43 4/94 J

' RADIOACTIVE EFFLUENTS TOTAL DOSE CONTROLS

- 3.3.7 The annual (calendar year) dose or dose commitment to any '

MEMBER OF THE PUBLIC, due to releases of. radioactivity and.

radiation, from uranium fuel cycle sources shall be 1 M ted to less than or equal-to 25 mrems to the total body or any. organ, except the thyroid, which shall be limited to less than or equal to 75 mrems.

APPLICABILITY: At all times.

, ACTION:

a. With the calculated doses from the release of radioactive i materials in liquid or. gaseous effluents exceeding twice the limits of ODCM Controls I3.2.3.a, I3.2.3.b, I3.3.3.a, I3.3.3.b, "

I3.3.4.a or I3.3.4.b, calculations.shall.be'made including.

h direct radiation contributions from the. reactor units and from outside storage tanks to determine whether the above limits of

. ODCM Control 3.3.7 have been exceeded. If such is the case, prepare and submit to the' Commission within 30. days, pursuant to-Technical-Specification 6.9.2, a Special Report that defines the corrective action to be taken to reduce subsequent releases'to

~

prevent recurrence of exceeding the above limits and includes the schedule for achieving conformance with the above limits. .

This Special Report, as defined in 10 CFR 20.405c, shall include

'- an analysis that estimates the radiation exposure (dose) to a-MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathways and direct radiation,-for the-calendar year that includes the release (s) covered by.this >

report. It shall also describe levels of radiation and concentration of radioactive material involved, and the cause of the exposure levels or concentrations. If'the estimated dose (s) exceeds the above limits, and if-the release = condition resulting in violation 40 CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Submittal of the report is considered a timely request, and a variance is i-granted until staff action on the request is complete. r i SURVEILLANCE REOUIREMENTS l

3.3.7-1 Cumulative dose' contributions from liquid and gaseous >

effluents shall be determined using ST-0-104-878-0, ,

ST-0-104-879-0.

3.3.7-2 If the cumulative dose contributions exceed the limits. ,

defined in 3.3.7a,- Cumulative dose contribution from direct radiation from unit operation shall be determined <

using ST-0-104-878-0, ST-0-104-879-0.

4 r f

'ODCM R;v. 12

.~ l Ptg3:44

'l 4/94

3.4 RanIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP)

CONTROLS 3.4.11The monitoring program shall be conducted as specified in-Table I3.4-1.

APPLICABILITY: At'all times.

ACTION:

a.- With the radiological environmental monitoring program not being conducted as-specified in Table I3.4-1, prepare and submit to the-Commission, in the Annual i Radiological Environmental Operating Report per ODCM l l' Control 3.5, a description of the. reasons for not.

conducting the program as required and the-plans for-preventing a recurrence.

b. With the level of radioactivity _as the result of plant ;

effluents in an environmental sampling medium at a :

specified location exceeding the reporting levels of Table I3.4-2 when averaged over:any calendar quarter,,

prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that identifies.the cause(s) for: exceeding-the limit (s) and defines the corrective actions to be taken to reduce. radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the .

l calendar year limits of ODCM Controls I3.2.3,-I3.3.3 and.

I3.3.4. - When more than one of the radionuclides in Table I3.4-2 are detected in the sampling medium,-this I report shall be submitted if:

concentration (1)

concentration- (2)

. reporting level-(1) reporting level (2)***"#

When radionuclides other than those in Table I3.4-2 are detected and are the result of plant effluents, this

report shall be submitted if the potential annual dose 4 to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of ODCh Controls I3.2.3, I3.3.3-and I3.3.4. This report is not required if the measured level of radioactivity was not the result of plant effluents; however; in such an event, the condition.

shall be reported and described in the Annual Radiological Environmental Operating Report.

't e

6 1

l

ODCM Rsv. 12- !

]l Pega 45

~ 4/94; ;

jjj '

' RADIOLOGICAL ENVIRONMENTAL MONITORING (Continued)

c. With milk or fresh. leafy vegetable samples unavailable from one or more of the sample locations required by Table-I3.4-1, identify locations for obtaining replacement samples and add them.to the radiological environmental monitoring program within 30 days. The specific locations from.which samples were. unavailable may then be deleted from,the monitoring program.

Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the Semiannual-Radioactive Effluent Release Report,'a complete, legible copy of the entire ODCM, including a revised figure (s).and table for the ODCM reflecting the new' location (s).

SURVEIf.TANCE ' REOUIREMENTS 3.4.1-1 The radiological environmental monitoring samples.

' shall.be collected (using ST-0-104-800-0). pursuant to Table I3.4-1 from the specific locations given.in the table and figure (s) in the ODCM and shall be analyzed pursuant to the requirements of Table,I3,4-1, the detection capabilities required by the Table I3.4-3'.

+

h l-i I.

2 l.

l ODCM R;v.112~'

l l

- PIge 46~ -

l .4/94 l

TABLE I3.4-1 f

i j RanIOIDGICAL ENVInnNMRMTAL MONITORING PROcRAM l

NUMBER OF REPRESENTATIVE.

EXPOSURE PATHWAY SAMPLES AND' SAMPLING AND-' TYPE AND FREQUENCY.

SAMPLE LOCATION (*) COLLECTION FREQ. : OF ANALYSIS AND/OR SAMPLE

1. DIRECT RADIATION S) 40 routine. monitoring stations At least Quarterly Ganana dose at'least

either with two or more dosi- quarterly.

. meters or with one instrument for

! measuring and. recording dose rate continuously.placed as-follows:

(1) An inner ring of stations,- 4 one in each meteorological sector, in the general area-of-the SITE BOUNDARY: (2)~An outer ring of stations, one in each meteorological: sector,iin the 3-9 mile range from the site;.

(3)'The balance of-the stations

, placed in special interest: areas such as population centers, nearby residences, schools ~and in 1 or'2 areas to serve-as control ,

stations.

4

__ - _. n - - _v______-_-_ -___-__-_.___________._____-_-m ___________________.2 P a_- _ - _ w -N1.- 'M'

ODCM R;v.: 12 l

.Page-47 l- 4/94 TABLE I3.4-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*) COLLECTION FREQ. OF ANALYSIS

2. AIRBORNE !

Radioiodine and Samples from 5 locations: Continuous-. sampler. unaioiodine canisters:

Particulates a.3 samples from close'to the- operation with sample I-131 analysis 3 SITE BOUNDARY locations (in collection weekly, or weekly, different. sectors) of'the more frequently if required by dust- Particulate S==mler:

highest calculated annual average ground level x/Q. loading *. Gross beta radio-activity analysis b.1 sample from.the vicinity- following filter

community having one of the highest calculated annual - change: d ground' level.x/Q.. Ga w isotopic l sample from.a control loca- analysis' of

~ tion; as for-example 15-30'km composite-(by'-

distant and in.the least pre- . location) at least valent wind direction.- quarterly 4

5 I

n

- + - ,

k- --

wL--- -- ---A-___ --__._-.u.--_--_.:__----.--- - _ . - - - . .

.=

~

l ODCM R v.-12 ,

Page 48 l 4/94' TABLE 13.4-1 (Continued) ,

RADIOLOGICAL ENVInnuMENTAL MONITORING PRocDEM ,

s NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND- TYPE AND FREQUENCY-SAMPLE LOCATION (*) COLLECTION FREQ. OF ANALYSIS AND/OR SAMPLE

3. WATERBORNE

a. Surface f 1 sample upstream-Composite sample G===na isotopic analysis' 1 sample downstream over.1-month _ monthly. Composite for- .

periode, tritium analysis quarterly.-

b. Ground Samples from 1 or 2 sources h Quarterly.-

j only if likely to be affected 2.

c. Drinking 1 sample-of each on'l to 3'of Morithly. I-131 analysis on each-of the nearest water-supplies (Composite) composite when the dose-that could be affected by its calculated for the. con-discharge.:. sumption of the water is greater than 1 arem per.

1 sample from a control year.$ Composite for gross location beta and gamma isotopic

analysis monthly. Comp-- -

osite for. tritium analysis quarterly.

d. Sediment from i sample-from downstream area- ' Semiannually. Ganuma isotopic. analysis' with existing or potential; semiannually.

i shoreline l

l' o

l L

t -_ __, _ _ - _ - _ _ - _ _ _ _ _

j ODCM Rev. 12-

~

$w Page 49

[- ! 4/94-I l-l TABLE 13.4-1 (Continued) l l RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE

, EXPOSURE PAThMAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY _

AND/OR SAMPLE SAMPLE LOCATION (*) COLLECTION-FREQ. OF ANALYSIS

4. INGESTION

a. Milk Samples from milking animals Semimonthly when Gama isotopic

and I-131 in 3' locations within 5 km animals are on analysis semimonthly when distance having the highest pasture, monthly .ani mal s are on. pasture dose potential. If'there are at other times. (April 1 - Oct. 1):

none, then 1 sample from monthly at other... times.

I milking animals.in.each of 3' areas between 5 to 8 km distance where dose are cal-

- culated to be greater than 1 mrem per year.'

1 sample from milking animals' at'a control location (15-

'30 km distance) and in the T least wind direction.-

b. Fish and 1 sample of two recreationally Sample in season, Gama isotopic

Invertebrates important species in vicinity nor semiannually. -analysis on edible of plant! discharge area. 1 .if they are not portions.

. sample of'same species in area seasonal.

not influenced by plant discharge.

f

-, a v=- 4 r -

3

g -e a

ODCM R;v.-12' A j .' ---

Pcge'50- .

'l 4/94; _ -~ /

TABLE 13.4-1 (Continued)

DanIOIDGIraT ENVInnMMENTAL MONITORING PROGRAM .

NUMBER OF REPRESENTATIVE

. EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE'AND FREQUENCY SAMPLE - LOCATION (*) COLLECTION FREQ. OF ANALYSIS AND/OR SAMPLE

4. INGESTION (Continued)

c. Food Products Samples of 3 different-kinds of Monthly when avail-'- Ga-na isotopic

and '

broad leaf vegetation grown able, if milk sampling' I-131 analysis.

nearest each of 2 different. is not preformed.

offsite locations.of highest predicted annual average ground level D/Q if milk sampling-is not preformed. .

1-sample of:each of the similar Monthly when avail- Gamma isotopic

and broad leaf vegetation grown able, if milk sampling I-131-analysis..

15-30-km distance in the least: is not performed.

' prevalent wind' direction if milk -

sampling is not performed.

4 7

4 n .x - . . -__-______-._=.___--__---___.L--_--_L.-_

__ .._-----.____.u---__.____.~_-.____

. - _ _ _ _ _ + - _ - . - - _ _ - . _ - .

ODCM Rev.-.12 j Paga 51 4/94 l

RADIOLOGICAL ENVIRONMENTAL MONITORING TABLE I3.4-1 (Continued)

TABLE NOTATIONS

a. specific parameters of distance and direction sector form the :

centerline of the two reactors and additional. description where :

pertinent, shall be provided for each and every sample Deviations location in Table I3.4-1 in a table and-figure (s) in the ODCM.

are permitted from the required sampling schedule if specimens ll '

are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons.- If specimens are unobtainable due to

sampling equipment malfunction, every effort shall be made to complete corrective action prior to.the end of the next sampling period. . All deviations ~from the sampling schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. It-is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media.of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen.for the particular pathway in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program. Pursuant to.

Technical specification 6.14, submit as a part of or concurrent with the next Semiannual ~ Radioactive Effluent Release Report a complete legible copy of the ODCM including a revised figure (s) and table for the ODCM reflecting the new location (s).

b. One or more instruments,: such as a pressurized ion chamber, for measuring'and recoding dose rate continuously may be used in j place of, or in addition to, integrating dosimeters. For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet .l are considered as two or more dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. n 7

c. . Methodology for recovery of radioiodine shall be described in the-ODCM.

d. Airborne particulate sample filters shall be analyzed'for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling ~to allow for ,

radon and thoron daughter decay. If gross. beta activity is air t

particulate samples is greater that 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on the' individual samples.

e. Gamma isotopic analysis means the identification and j

quantification of-gamma-emitting radionuclides that may be attributable to the effluents from the facility.

l t

l

}

C

ODCM Rsv. 12- ;

-l. Pzg3 52 j' _4/94

f. The " upstream sample" shall'be taken at a distance beyond significant influence of the discharge. The " downstream sample" shall be taken in an area beyond but near the mixing zone.. >

g. A composite sample is one in which the quantity (aliquot)_of=

liquid sampled is proportional to the quantity of flowing liquid and-in which the method of sampling employed results in a specimen that is representative of the liquid flow. In.this program composite sample aliquots shall-be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g., monthly) in order to assure obtaining a representative sample.

h. Groundwater samples shall be taken when this source is tapped.for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.

i. The dose shall be calculated for the maximum organ and age group, using ST-0-104-878-0.

4 I

i l

l l

l 1

I a

1 i

e+- . - --

l

' N ODCM Rsv.112

, _ I -- P: ga 53 4/94

.1 ,

TABLE T3.4-2 REPORTING LEVELS FOR RADIOACTIVITY ~ CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reporting Levels AIRBORNE FOOD WATER PARTICULATE or FISH MILK PRODUCTS

. ANALYSIS' (pCi/L) GASES (pCi/m3 ) (pCi/kg, wet) (pCi/L)-(pCi/kg,. wet).

'H-3 '20,000*

r Mn-54 1,000 30,000 Fa-59 400 10,000

--Co-58 1,000 30,000 Co-60 300 10,000 En-65 300 20,000 Zr-Nb-95 400**

I-131 2 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Co-137 50 20 2,000 70 2,000

. Ba-La-140 200** 300

For drinking water samples. This is 40 CFR Part 141 value. If-no-drinking pathway exists, a value of 30,000 pCi/L may b, 2 sed.

- Total for parent and daughter.

i s

f + --. . , - - , _. ___ -

.ODCM R v. 12-l Pcga 54 i 4/94- l

, -l l TABLE'I3.4-3 ,

I DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS *)

Lower limit of Detection (T.T A 1(b)(c)

AIRBORNE -FOOD WATER- PARTICULATE or FISH MILK PRODUCTS SEDIMENTS ANALYSIS (pCi/L). GASES (pCi/m3) (pCi/kg, (pCi/L) (pCi/kg, (pCi/kg, wet) wet) dry)

< Gross Beta 4 0.01 H-3 2,000 Mn-54 15 130 Fs-59 30 260 Co-58,60 15 130 Zn-65 30 260

'Zr-95 30 Nb-95 15 .

I-131 1)N 0.07 1 60 Co-134 15 0.05 130 15 60 150 '

Cs-137 18 0.06 150 18 80 180

'Ba-140 60 60 La-140 15 15 j

l ~

ODCM R3v. , L .Paga 55-4/94 I_

TABLE I3.4-3 iContinuedi' TABLE NOTATIONS

-(a)- This list dose not mean that only these nuclides are to

~

considered. Other peaks that are identifiable at 954 confidence level, together with those of the above nuclides, shall also_be.

analyzed and reported in,the Annual Radiological' Environmental Operating-report' pursuant to ODCM Control 3.5.

Required detection. capabilities for thermoluminescent dosimeters

~

!(b) used for environmental measurements are given in Regulatory- .

Guide 4.13.

-(c) The LLD is defined, for. purposes of these controls, as the' .

smallest concentration of radioactive material in a sample that will yield a' net count (above system background) that will be detected with 95% probability with only 54 probability of falsely concluding that a blank observation represents a'"real" signal.

For a particular measurement system (which'may include-1 - radiochemical separation):

4.66s a 4 LLp-E V 2.22 Y exp (-AAt)

Where:

LLD is the a orlori lower limit of detection as defined above (as picocuries per unit. mass or volume),

s is the standard deviation of the background counting rate or ofa the' counting rate of blank sample as appropriate (as counts per minute),

E is the counting efficiency (as counts per disintegration),

I- V is the sample size (in units of mass or volume), ,

2.22 is the number of disintegrations per minute per picoeurie, Y is the fractional radiochemical yield (when applicable),

A is the radioactive decay constant for the particular radionuclide,'and.

At for the environmental samples is the elapsed time between sample collection (or end'of the sample collection period) and 3

time of counting.

Typical values of E, V, Y, and At should be used in calculation. -

n -m ,,c -

+,-

ODCM R;v. 12 is D'

L l,_

Pagn 56

-l- 4/94 l

TABLE 13.4-3 ~ (Continued)

TABLE NOTATIONS It should be recognized that the LLD is defined as an a nriori (before the fact) limit representing the capability.of a measurement. system and not as an after the fact. limit for a particular measurement. Analyses shall be performed in such.a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render _these LLDs unachievable. In such cases, the contributing factors'shall be identified and described in the Annual Radiological Environmental Operating Report pursuant-to.ODCM Control-3.5.

_(d) LLD for drinking water samples.

t

-~ - .

ODCM Rsv. 12

~l Prga 57 4/94

.[

RADIOLOGICAL ENVIRONMENTAL MONITORING LAND USE CENSUS CONTROL 3.4.2.A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location (in each.of the 16 meteorological sectors) of the nearest garden

of greater than 50 m2 (500 ft2) producing broad leaf or vegetables.

APPLICABILITY; At all times.

ACTION:

a. With a land use census identifying a location (s) which yields a calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new location (s) in the next Semiannual Radioactive Effluent Release Report, pursuant to ODCM Control ~3.6.

b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently being obtained in accordance with ODCM Control 3.4.1, add the new location (s) to'the radiological environmental monitoring program within 30 days. The sampling location (s), excluding the control station location, having the lowest calculated dose or dose commitment (s) (via the same exposure pathway) may be deleted from this monitoring program after October 31 of the year in which.this land use census was conducted. Pursuant to Technical Specification 6.14, submit as a part of or concurrent within the next Semiannual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s).

SURVEILLANCE REOUIREMENTS l 3.4.2-1 The land use census shall be conducted during the growing season at least once per.12 months using that.information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use .

census are documented in ST-0-107-991-0 and-are included in the Annual Radiological Environmental Operating Report "

pursuant to ODCM Control 3.5.

Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Qs in lieu of'the garden census. ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c. shall be followed, including analysis of control samples.

l

ODCM R2v. 12-l Paga 58 l

4/94 RADIOLOGICAL ENVIRONMENTAL MONITORING INTERLABORATORY COMPARISON PROGRAM CONTROL 3.4.3 In accordance with LGS Technical-Specification 3.12.3, analyses shall be performed on radioactive materials supplied as part'of an Interlaboratory Comparison Program which has been approved by the Commission.

APPLICABILITY: At'all times.

ACTION:

With analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.

SURVEILLANCE REOUIREMENTS 3.4.3-1 The Interlaboratory Comparison Program shall be documented in ST-0-104-990-0 and described in the ODCM part II, section 4.2. A summary of the results shall be included in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.

d v

l l

ODCM'Rsv. 12 l: Paga 59-l 4/94 I

ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT

3.5 Routine Annual Radiological Environmental Operating Report covering the operation of Unit 1 and Unit 2 during the previous calendar year shall be submitted prior to May 1 for each year. The initial report was submitted prior to May 1 of the year following initial criticality (1984). A single report is submitted for a multiple-unit station. The Annual Radiological Environmental Operating i-Report shall include summaries, interpretations, and an analysis of trends of the results report period, including a comparison (as appropriate), with preoperational studies, operational controls and ,

-previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment. The reports shall also include the results of land use census required ,

by ODCM Control 3.4.2. The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revision 1, November 1979.

In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons'for the missing results.- The missing data e shall be submitted as soon as possible in a supplementary report.

The report shall also include _the following: a summary description of the radiological environmental monitoring program and at least j two legible maps. One map shall cover stations near the SITE ,

~

. BOUNDARY; a second shall include the more detailed distant stations.

Covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor plant; the results of licensee participation in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling schedule of Table I3.4-1; and discussion of all analyses in which the LLD required by Table I3.4-3 was not i achievable. ,

l a

1 I

i

=

, ODCM R2v'. 12

? k. Paga 60 !

4/94 'l

\

AnMINISTRATIVE CONTROLS a' I

'3.6 SEMT ANNUAL RADIOACTIVE EFFLUENT RETRASE REPORT l i

A Routine. Semiannual Radioactive Effluent Release Reports covering the operation of Unit 1 and Unit 2 during the previous 6 !

-months of operation shall be submitted within 60 days after January 1 and July 1 of each year. The period of the firstST j report shall begin with the date of initial criticality.

107-992-0 shall be used to generate ths report. A single unit submittal'is made for the 2 unit station. The submittal combines. i those sections that are common to all units at the station. . The i Semiannual Radioactive Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous affluents and solid waste released from the facility as outlined ,

in Regulatory Guide 1.21, " Measuring, Evaluation, and Reporting H Radioactivity in Solid Wastes and Releases of Radioactive '

l Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of l Appendix B thereof. 'l l

The Semiannual Radioactive Effluents Release Report to be l submitted 60 days after January 1 of each year shall include an l annual summary of hourly meteorological data collected over the .

t previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape-of wind speed, wind direction and atmospheric stability, and precipitation (if i measured), or in the form of joint frequency distributions of J

wind speed, wind direction, atmospheric stability. In lieu of 1 i submission with the first half year Semiannual Radioactive l l Effluent Release Report, the licensee has the option of retaining I i this summary of required meteorological data on site in a file l that shall be provided to the NRC upon request. This same report i shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from both units during the previous calendar year. . This same report shall also i l

include an assessment of the radiation doses from radioactive

<. liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities-inside the SITE BOUNDARY (Figures I2.2-la and I2.2-lb)

- during the report period. All assumptions used in making these assessments shall be included in these reports. The assessment of radiation doses shall be performed in accordance with the i methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).

4 4

, .+ -- - . - . , , .

v., o

hJA , J- .. ,i,,-c., 4 s 4+.ukJJA-J- m a-- 4- a4=-+- iia -+e

^ '

ODCM Rsv. 12 j' Paga 61 4/94 l

- The Semiannual Radioactive Effluent' Release Report to be submitted 60 days after January 1 of each year shall also include an assessment of radiation' doses to the hypothetically highest exposed MEMBER OF THE,PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Dose Radiation Protection Standards for Nuclear Power Operation.

contribution from liquid and gaseous effluents is calculated based ,

on Regulatory Guide 1.109, Rev 1, October 1977.

The Semiannual Radioactive Effluent Release Reports' includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report' period:

a. Container volume,

b. Total curie quantity (specify whether determined by measurement or estimate),

c. Principle radionuclides (specify whether determined by measurement or estimate),

1

d. Source of waste and processing employed (e.g., dewatered.

spent resin, compacted dry waste, evaporated. bottoms),

e. Type of container (e.g., LSA, Type A, Type B, Highway ,

Route controlled), and

f. SOLIDIFICATION agent or absorbent (e.g., cement; urea '

formaldehyde).

l The Semiannual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to >

UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period.

The Semiannual Radioactive Effluent Release Reports includes any j changes made during the reporting period to procedure RW-C-100

> (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by_the land use census pursuant to ODCM Control 3.4.2. i The Semiannu'al Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits.

s

' ~ODCM'Rsv. 12 >

e-

[ Paga 62:

q. 4/94

.3.7 -MAJOR CHANCES TO RADIOACTIVE WARTE TRRATMENT SYSTEME j

Licensee-initiated major changes to the radioactive waste systems (liquid, gaseous,_and solid):

.a. Shall be-reported to the' Commission in the Semiannual Radioactive Effluent Release Report for the period in which the change'was made_ effective. The discussion of each change shall contain:

1. A summary of the evaluation that led to the

. determination that the change could be made in accordance with-10 CFR 50.59; .;

2. sufficient detailed information to totally support the reason-for the change without' benefit of additional or supplemental information;

3. A detailed description of the equipment, components, and processes involved and the

, interface with other plant systems i

4

4. An evaluation of the change which shows the

- predicted releases of radioactive materials in' l liquid and gaseous effluents and/or quantity of R i

i solid waste that differ from those previously_-

predicted in the-license application and -i amendments thereto;- l

- .- N

5. An evaluation of the change which shows the expected maximum exposures to individual in the UNRESTRICTED AREA and to the general ppulation that differ from those previously est h ted in the license application.and amendments-thereto;

6. A comparison of the predicted releases:of l radioactive materials,,in liquid and gaseous i

effluents and in. solid waste, to the actual releases for the period prior to when the changes 4 are to be made; An estimate of the exposure to plant operating _

t 7.

personnel as a result of the change; and j

8. Documentation of the fact that the. change was reviewed and found acceptable by the PORC.

b. Shall be reviewed and accepted by the PORC prior to implementation.

c. Shall be documented by ST-0-RRR-990-0. 1 4

A 9

4

PART II ,

CALCULATION METHODOLOGIES

[ ODCM R$v. 12 Pago 63 in '

j- 4/94 b

11 . 0 LIOUID EFFLUENTS 1.1- RADIATION MONITORING INSTRUMENTATION'AND CONTROLS-The liquid effluent monitoring instrumentation and controls at Limerick forLeontrolling and monitoring normal ,

radioactive material releases in accordance with the Limerick Technical Specifications are summarized as follows:

1) Liould~Radwaste System The liquid radwaste discharge monitor (RISH63-0K604) provides aus alarm.and automatic termination of radioactive material releases from.the liquid radwaste system as required by Technical-Specification 6.8.4.d.1. Additional design features of the_ liquid radwaste system which prevent-4 inadvertent releases to the environment include 1) redundant discharge valves,-2) single discharge line-with loop seal _and siphon breaker _to eliminate probability of' inadvertent discharges, 3) Low cooling Tower Blowdown flow interlock which isolates the radwaste discharge line. ,

2): . Service Water System: The service Water. discharge monitor (RISH10-1K605 AND RISH10-2K605) provides an alarm upon-indication.of activity 11n the service water-

~

system as required by Technical Specification.

6.8.4.d.1. While the service water system is not~a normal release pathway,_the monitor provides an-indication ~of potential problems due to excessive leakage of the heat exchangers. In addition, the service water side of.the fuel pool heat exchangers.is_

kept at a-higher pressure than the shell side to prevent potential radioactive contamination of the service water.

3) RHR Service Water System: The RHR Service Water' Radiation (RHRSW) Monitors (RISH12-0K619A, RISH12-OK619B, RISH12-1K619C, RISH12-1K619D, RISH12-2K619C

- AND RISH12-2K619D) provide alarm and automatic termination of radioactiveimaterial release from the RHRSW system, as required by Technical Specification 6.8.4.d.1. While the RHRSW system is not a normal release pathway, the monitors provide indication of potential problems due to, excessive leakage of the heat exchangers, i.

. _- , _. .. - -___.._u__

, ' Ilf ODCM Rbv; 12-e- Paga.64

l -4/94-1 ~. 2 LIQUID EFFLUENT MONITOR SETPOINT DETERMINATION

+' Per the requirements-of Technical Specification 6.8.4.d.1, alarm setpoints shall be~ established for;the liquid effluent monitoring instrumentation to ensure that the release concentration limits of Specification 6.8.4.d.2' and 6.8.4.d.3 are met.(1.e., the concentration of radioactive ~ material released in liquid affluents to UNRESTRICTED AREAS-shall be limited to the concentrations specified in 10 CFR 20, Appendix B, Table II,. Column 2, for radionuclides and 2.0E-04 pC1/ml for dissolved or entrained noble gases).

1.2.1 Radwaste Discharae Monitor and Discharae Flow Rate

- RISH63-0K604 E The setpoint for the liquid lradwaste discharge monitor and flow rate element are determined by1 o the following equations. The radweste discharge monitor high-high alarm / isolation setpoint is calculated at least monthly based on isotopes detected in the' liquid radwaste sample-tanks-released during the previous month or on'any specific sample tank being released'(EC% ),1the.

Required minimum cooling tower blowdown flow at time of discharge (CTBD), and average liquid _

radwaste-discharge flow (RR). The flow rate.

I determination is calculated for each release and.

the MPC fraction calculated-includes, in tho' concentration mix, the~most recent results from

' 1) the quarterly-composite for-SR-89', SR-90 and Fe-55, and 2) the monthly composite for.H-3, and-

. 3) the sample (s) for dissolved and entrained noble gases.

If the calculated setpoint is less than the .

existing setpoint, the setpoint will be reduced to the next value. ;If the calculated.setpoint is greater than the existing setpoint,.the setpoint-may remain at the lower value or increasedLto.the-calculated value.

If there were no sample tanks; released-or no activity detected:during the previous month,:then-the calculation is performed using release.datai from the most recent month during which isotopes-were detected. In addition, if there were no sample tanks released-during the previous _ month, chemistry supervision.may substitute more restrictive values (e.g., tritium) based on.the plant sampling data.

"l l.

' ODCM R0v. 12 pig 3 65 l l

4/94- 1 i

1.2.1-1 Setooint Determination - RISH63-CK604 The setpoint for the liquid radwaste discharge. monitor is determined by the l following equation:

'.I CPNgwi s (S) (RR) [E (Cf we,) /NPCjue,) ] (E Cj,.) (RR+ CTED) (1,1)

_ ,ggG l *)

(RR+CTBD) .

(S) (E) (RR) (E3 C ,_/MPCgy}

i where:

,. CPM cue; = Calculated liquid radwaste discharge monitor (RISH63-0K604) count rate attributable to the gamma emitting 4 radionuclide, cpm 4

EC,,,,, = the sum of the concentration of the identified gamma emitting nuclides (mci /ml),

CTBD = the required minimum cooling tower.

blowdown rate at time of discharge (9Pm),

RR = average liquid radwaste discharge flow (gpm),

c BKGg ,3 = background count rate of liquid radwaste discharge monitor-(CPM),

E = the gross detection efficiency of the liquid radwaste discharge monitor (pci/ml/ cpm), and S = 5; margin of safety factor to assure that the release is terminated prior to 10 CFR 20 limits being exceeded.

Included in this factor are errors associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and the contribution of other release paths (service Water and RHRSW) which are not normally contaminated.

= the effective gamma MPC ratio for the E(C' " /MPC" )

mixture of radionuclides in the liquid radwaste discharge line (unitless).

, - . - . . ----.~n ,

l' ODCM R^v. 12 Paga 66' j

?l' 4/94- j 1

i where C 3 ,,,

= the concentration of each~ identified gamma emitting radionuclide i in the liquid effluent (undiluted) (mci /ml)

I

= the MPC value corresponding to M PC ""' radionuclide l'from 10 CFR 20 Appendix !

B, Table II, Column 2 (dissolved and j entrained noble gases MPC = 2.0E' i

pci/ml) -(pC1/ml).

F l E(Ci n,u/MPC a ,) = the effective nongamma MPC ratio for the mixture of radionuclides in the liquid a radwaste discharge line (unitiess) l where:

= the concentration of each identified l C a.,

nongamma radionuclide i in the liquid effluent (undiluted) (pC1/ml)*

'l MPC n ,u

= The MPC value corresponding to radionuclide i form 10 CFR 20, Appendix j B, Table II, Column 2 (dissolved and ,

entrained noble gases MPC = .2E-' #Ci/ml) !

(pci/ml)'

NOTE: The concentration mix'must include the most recent sample' l data for H-3, Sr-89, Sr-90, Fe-55 and gross alpha.

1.2.1-2 Flow Rate Determination t

NOTE: If the effective MPC ratio for the mixture l of radionuclides [E(C,/MPC,Y)]-is $1.0, l THEN a flow rate setpoint determination is not required, &HD l there is no limit on discharge flow rate.

IE a flow rate determination is required,

THEN the setpoint for the liquid radwaste flow rate is

' determined for each release by the following equation:

"# (SF) [E ( MPC3 ) -1]

where:

FLOWg ,3 = flow limit for radwaste discharge line (gpm).

=

CTBD = required minimum cooling tower blowdown flow for time of release (gpm).

SF = 5; margin of safety factor to assure ~that the release does not exceed 10 CFR 20 limits.

a._-.-- __ __ . . - - _ _

.;3 '

<w ~.

J: ,

,- 'ODCM'Rdv.;12: ,

~ ~

P2g3 67 x N l: ,4/94 a

?

E( C,/MPC,) =- the effective MPC ratio for the mixture'of radionuclides in the liquid radwaste discharge line:(unitiess) .

-where C, = the concentration of'each identified radionuclide.

1 in the liquid effluent (undiluted) (pCi/ml)*' ;

MPC, = the MPC value corresponding to radionuclide'i from-10 CFR 20 Appendix B, Table II,. Column 2, (dissolved and entrained noble gases MPC = 2E

pCi/ml)(pci/ml).

NOTE: The concentration mix must include the most recent sample data for H-3,:Sr-89, Sr-90, Fe-55.and dissolved and entrained noble gases. ,

Service Water Radiation Monitor - RISH10 1K605.1 1.2.2 .

2K605 The Service Water Radiation Monitor high-high ,

setpoint is determined by the following; equation. .

The monitor high-high alarm setpoint is calculated monthly based on the background count rate.. If

< the calculated setpoint is less.than the' existing monitor setpoint, the setpoint will be reduced.to-the new'value. If the calculated setpoint is greater than the existing setpoint, the setpoint~. ,

may remain at-the' existing setpoint or increased to the now.value. .To assure that_a high .

background count rate does not prevent adequate monitor sensitivity.to meet the requirementsaof-Technical Specifications 6.8.4.d.2 and 6.7.4.d.3, a maximum background count rate of 300 CPM shall tm'

used for the alarm setpoint~ determination.

1.2.2 Setpoint Determination The setpoint for the-Service Water Radiation Monitor is' determined by the following equation:

CPM, s 3,,,(CRB,,,) (1-3) i where:

CPM ~ = Calculated Service Water Radiation Monitor-(RISH12- ,

1K605, -2K605) count' rate, CPM.

]J ODCM R v.-12 i Pago'68

~

{l^ 4/94 2,. = 3,-multiplier to establish'

. monitor.setpoint count rate above background' count rate (unitiess)- ;

CRB ,=- Service Water monitor (RISH12-:

1K605, -2K605) count rate attributable to background ' '

radiation, CPM 1.2.3 RHR Service Water Monitor'-RISH12-0K619A, -OK619B,' i

-1K619C, -1K619D, -2K619C, -2K619D 7 The RHR Service Water Radiation' Monitor high-high '

setpoint is determined by the.following.. equation.

.The monitor high-high; alarm / isolation setpoint is calculated monthly based on the background count' rate. If the-calculated'setpoint is less than'the ,

-existing. monitor setpoint, the setpoint will be l reduced to the new value. If the calculated setpoint is greater than the existing setpoint, the setpoint may remain at the existing setpoint ,

or increased to the new value.. To assure that a high background count rate does not-prevent. a adequate monitor sensitivity to meet.the .

requirements of-Technical Specifications'6.8.4.d.2' and 6.7;4.d.3, a maximum-background count rate'of 300 CPM shall be used for the alarm setpoint i determination.

4 1

1.2.3-1 Setpoint Determination .

I The setpoint for the RHR Service Water. l Radiation Monitor is determined by the l following equation:

)

CPNm s Z w (CRBw) (l'-4 ) .

i where:

CPM,,, = Calculated RHR Service Water-Radiation Monitor.(RISH12-OK619A,'-0K619B, -1K619C,:-

IK619D, -2K619C, -2K619D)

- count rate,' CPM.

Z,,, = 3, r.ultiplier to establish monitor setpoint count rate; above background count rate

-(unitiess). J 4

l

.f

Um j2 ODCM R0v. 12 l

+

. _Paga'69 I.

L ' 4/94 CRB,,, = RHR Service WateriRadiationL Monitor (RISH12-0K619A, - j OK619B, -1K619C, -1K619D, - i 2K619C,'-2K619D) count rate' attributable to background.

radiation, CPM.- -j 2

1.3' Liould Effluent Dose Calculation - 10 CPR 50 1.3.1 Members of the Public Dose ODCM I3.2.3 limits'the dose or dose commitment to ,

MEMBERS OF THE PUBLIC'from radioactive materials '

in liquid effluents from' Limerick Generating Station tos :

- during any. calendar quarter, 5 3 arem to total body ' '

$10 mrom to any organ

- during any calendar year.

. s 6 mrom to total body-520 mrom to total organ.

Per ODCM I3.2.3.1 the cumulative dose-contribution. .:

from liquid affluents for the current calendar quarter year shall be~ determined at least once per 31: days in accordance'with;the following calculation methods..:These equations are for thei

, three aquatic environment exposure pathways (potable water, fish, shoreline. exposure) in tho'

-Limerick aquatic environment. Only real pathways--

are addressed'for each receptor. The receptors-4 -and associated pathways are listed below. - Doses .

from each.real pathway are summed to give dose.at t the receptor.. The monthly results are accumulated 1 to give the quarterly doses and the quarte .y- .

results are accumulated to give the. annua; Joses.

{

R:ceptor Dist. Pathways Location (mi) Potable Water Fish Shoreline I

LGS Outfall 0 X X

. Citizen's Utility 2.5 X X X

'Phoenixville Water 9.0 X X X ;

~Phil. Sub. Water' 13.6 X X acrew Course- 37.8 X 5

e i

I

~

c -1

'l; ODCM R;v. 12 Pzga 70

L' 4/94-~

'1.3.1-1 Potable Water Pathway' l

R,,,j = 110 0 g7 EOjD,j,y exp (-Ajita))' (1-6)

)

1.3.1-2 Fish (Aquatic Food) Pathway _

R,,j = 1100 *#

EOjBj,D,j,j exp(-Aj tao ) (1-6)

M,F i 1.3.1-3 Shoreline Deposition Pathway R,j = 110, 00 0 ** E OjTj ,j,j D 'exp (-Al *p) [1-exp (-Aj n asas+s)) 3 (g_7)

M,F i where B = equilibrium bioaccumulation' factor for nuclide i in 3

pathway p, expressed as the-ratio of the concentration in-

. biota, in pC1/kg, to the radionuclide concentration in '

water, in pC1/ liter (liters /kg) e I

'l l

l

-1 I

1 l

m ODCM:R;v. 12 ;

~f PSg3: 71-

-l-4/94 '

BIOACCUMULATION FACTORS (pCi/kg/pC1/11ter)~ ,

FRESNWATER SALTWATER ELEMENT . FISH FISH H 9.0E-1 9.0E-1 C 44.6E 3 1.8E 3 .,

Na. -1.0E 2 6.7E-2 P 3.0E 3 2.9E 4 Cr 2.0E 2 o4.0E 2 >

Mn 4.0E 2 5.5E 2 Fe 1.0E 2 3.0E 3 Co 5.0E 1 1.0E 2 Ni .1.0E 2 1.0E 2- ,

Cu 5.0E 1 6.7E 2 '

En 2.0E 3 2.0E 3 Br 4.2E 2 1.5E-2 Rb 2.0E 3 8.3E O 3.0E 1 Sr 2.0E O

< Y 2.5E 1 2.5E 1 Er 3.3E O 2.0E 2 >

Nb 3.0E 4 3.0E 4 Mo 1.0E 1 1.0E 1 Tc 1.5E 1 1.0E 1 Ru 1.0E 1 3.0E O t 1.0E 1 1.0E 1 i

. Rh Te 4.0E 2 1.0E 1 I 1.5E 1 1.0E.1 Cs 2.0E 3 4.0E 1 c Ba 4.0E O 1.0E 1 LA 2.5E 1 2.5E 1 Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E.1 Nd 2.5E 1 2.5E 1 W 1.2E 3 3.0E 1 Np 1.0E 1 1.0E 1 R3f 1) U.S.N.R.C Reg. Guide 1.109, Rev. 1, Table A-1

2) Letter LTR 881209L001, from R.J. Clark, U.S.N.R.C., to G.A. Hunger, Philadelphia Electric Co., December 9, 1988, transmitting evaluation of Limerick ODCM.

e i e

4

, ,o , -- . . . .. .- - .

lL ' ODCM R v. : 12 ' ?

Paga 72

/- lI .

4/94 ,

~

D,3g ~

= . dose factor specific'to a given age-group a,vradionuclide .

11, pathway p, and organ j which can be'used to calculate radiation dose'(1) from an intake of a radionuclide,-in ;

arem/pci,' or (2) from exposure to a given concentration of a radionuclide in' sediment, in area /hr per.pci/m8 Values are listed by age group in. Table 1-1. j F = waste dilution flow rate of liquid effluent dilution n

flow / number of ! batches- (f t3 /sec) .

M, = dilution factor at point of exposure or at point of.

withdrawal of drinking water (dimensionless). . Values;are p ' graphically listed by receptor location in Figures 11.3.1-1 to 1.3.1-5. Value will be based on average monthly.

river flow.

Q1 = total release of'nuclide 'i' for time period'(C1).

y R,g = total dose for calculation time period to organ j'of individuals of age group a from all nuclides i in pathway b (mrom). l T, = radioactive half-life of nuclide 1 (days). -]

U, = usage factor specifying exposure-time or intake rate for ']'

an individual-of age group a associated with pathway p'

'hr/yr, liters /yr, or kg/yr).

Pcthway Infant Child Teen Adult -

l

- l Fish --

6.9* 16* 21* '

Patable Water

'(1/yr) 330' 510* 510' 730' j Shoreline 1

R; creation (hr/yr) --

14' 67* 12*

Shoreline R creation

'(hr/yr) --

90 6 600* 600* l 4

Reft

Regulatory Guide 1.109, Rev 1, Table E-5

EROL Table 5.2.A-3 w = shoreline width factor (dimensionless) = 0.2.

Ref: Regulatory Guide 1.109, Rev.-

1.

1.752E+5 = time period during which sediment i is exposed to contaminated water' (hrs) (midpoint of plant life = 20 yrs)

N _

I

i 2ll ODCM RIv. 12-Paga 73

.l: 4/94-

'Ai = radioactive decay constant of nuclide 'i' ( hr-2) 12 = delay time for potable water pathway in hours.to allow for .

nuclide decay during transport

, through the water purification plant-and the water distribution system, Ref:- Regulatory Guide 1.109,.Rev'.11, App. A.

., 24 = delay time for potable fish pathway-in_ hours to. allow for -

nuclide decay. during transport through the food chain, as well as-during food: preparation. <

Re f t . Regulatory _ Guide'1.109, Rev.

1, App. A.

1100 = factor to convert from C1/yr per 2

f t /sec to pCi/ liter.

110,000 = factor to convert from Ci/yr per ~

f t'/sec to pCi/ liter. .

and to account for proportionately

constant (100) used in sediment radioactivity model.

1 4

9 n _ _

$[ ODCM R5v. 12 Paga 74'

]) 4/94

.1.4' Liould Effluent' Dose Proiections ODCM 13.2.4" requires thatithe liquid radwaste treatment system-

.shall-be operable and appropriate portions of the systems used to' reduce the radioactive materials in liquid waste prior to-

.their discharge,when the projected' doses-due to the liquid effluent'to UNRESTRICTED AREAS would' exceed:

- 0.06 mrom/31 days to the total body or

- O.2 mrom/31 days to any organ.

The applicable' liquid radwaste treatment processing equipment for maintaining radioactive materials releases.ALARA are

-delineated in Figure 1.4-6. ,

Dose projections ~are made at least once per 31-days by the l j following equations:

D,, = (D3 /d)

31 days (1-8)

D,,, =

(D,,/d) :

31 days (1-9) where:

D, = the total body dose: projection for the current 31-day period-(arem).

1 D. = the total body dose. projection for the current _ j calendar quarter as determined by equation'l-5, 1-6,-and 1-7 (area).

D,,, = the maximum organ dose. projection for

'the current 31-day period (area).

D,, = the maximum organ dose'to date.for the current calendar quarter as determined by equations 1-

' ~

5, 1-6, and 1-7 (arem).

d = the actual number of days in.the current calendar quarter at the end of the release (days). The minimum time elapsed is seven (7) days.

31 days = the number of days of concern L

-l

.7 -

.ODCM:Rsv.-12

's

-[,

, peg 3 75- .

ll 4/94 \

I 2.0. GASE011S_XFFLUENTS 2.1 Radiation monitorina instrumentation and Controls-

^

The' gaseous affluent monitoring instrumentation and controls at

Limerick for, controlling monitoring radioactive material releases in accordance with'the,ODCM Part l'are: summarized as followrt

1) North Vent (Common):f The plant gaseous discharges,via this

. vent are monitored by two Particulate,= Iodine and Gas (PIG) ,

monitors IRY26-075A and RY26-075B) in parallel and'by-the- '

Wide Range Accident Monitor (WRAM) (RIX26-076). The PIGS ,

have separate Particulate, Iodine, and Gas sampling and '

monitoring channels but the Station ODCM Controls require.

, only particulate and iodine sampling and. noble gas-monitoring. The WRAM has extended range (via three channels) noble gas monitoring and particulate and iodine l- sampling capability. In addition, the:WRAM provides an L

isolation (Group A) of the large Drywell Purge and Vent valves. ,

2) South Vent (one Der uniti: The plant gaseous discharges.via

'- each South Vent are monitored by two redundant PIG monitors l

(RY26-285A,B). As is.the case of the North Vent, each' PIG ,

has separate particulate, lodine, and gas sampling and- ,

I monitoring channels but:the Station:ODCM Part I requires n only particulate and iodine sampling with gas monitoring.-

3) Hot Maintenance Shoo (Common): Due.to.the composition of ,

the radioactive materials in the affluent steam (i.e., very low potential for noble gas), this release point is sampled- t for particulate and iodine (PEI) monitors'(RY26-025). The PEI monitor has a separate particulate and iodine sampling and monitoring: channels but' Station ODCM Part I requires only particulate and lodine sampling.

2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION ODCM I3.3.7.3 requires that an alarm setpoint be established-for the noble gas- ef fluent monitoring channels (RY26-075A',B,;-

RY26-185A,B,; RY26-285A,B,; and RIX26-076) to' ensure that the release rate of. radioactive materials does not exceed-the limits of ODCM 13.3.2.a, which corresponds.to a dose rate'at the SITE BOUNDARY of 500 mrem /yr to the~ total body or 3000 mrem /yr to the skin. This specification also states that the dose rates from I-131, I-133, Tritium, and all radionuclides in 4 i

particulate form with half-lives greater than eight days; shall be limited to a maximum of 1500 mrem /yr to any organ .

(inhalation pathway only).

ODCM Part I limits are expressed in terms of dose rate, while l the instruments which monitor effluents produce data in units ,

of concentration or release rate. It is therefore'necessary to identify the isotopes and calculate the corresponding release rate which will result in the dose rate limit being reached at l

.. . . - - . . . - - , . - .- . ~

~

i "l2 nODCM rov. 12f s Pega 76 4/94 Ij_

the.. site' boundary.. This calculation is'made more_ complex by-

~the use of multiple release ~ points at LGS.

' Calculation' Bases The alarm setpoint calculation is performed monthlyLand'is based on analytical results of grab samples from the appropriate release point. The concentration ofEeach' identified radionuclide in the grab samples is determined,,and.

the data are used to perform a setpoint calculation.for that nuclide mix and release point.-

The highest calculated annual average concentration'(X/Q) for.

~

an area at or beyond the site boundary (1.lE-05sec/M , NE ~ 3 sector) is used in the setpoint calculation.

Maximum flow rates through the North and South vents are used

.in alarm setpoint calculations. This'is necessary since flow can vary. By using maximum values, any flow less than the 2 maximum will assure that the-monitor will alarm before release '

rate limits are exceeded.

4. For each release point the noble gas release which would cause a SITE BOUNDARY total body dose rate of 500 mrom/yr and a skin dose of 3000 mram/yr is determined.

The fractional contribution of noble gas is calculated for each release point. The fractional contribution to the whole body. ,

and skin dose rates due to noble gases is' calculated by taking !

the product of this fraction and the limiting release rate. :A comparison of this release rate for.whole body and skin dose 4 rates due to noble gas release is made to determine'if the ,

whole body or skin dose limit will'be most restrictive. It is expected that the whole body limit will always be most-restrictive, but the comparison is necessary to assure .

compliance with ODCM I. _The sum of the' contributions from each

. release point, independent 1y' calculated for Jodines and noble 4

gases, will equal the maximum instantaneous release rate allowed from the site.

The purpose of calculating the release rate which corresponds to the site boundary dose limit.is agt to determine an acceptable release rate, but to determine the maximum release

< rate which may be exceeded. It is nah intended that releases will be maintained at or near this limit, and in fact, requirements to maintain offsite doses As Low As Reasonably i Achievable (ALARA) are specified in ODCM I3.3.3 and ODCM .

I3.3.4.

d

--..--a - - - n- , - - - m -*

t f '

LODCM Rav. Pag 3 77 ll; 4/94 2.2.1- North' Vent' Noble' Gas Effluent Monitors' RY26-075A-3, BY26-075B-3, AND RIX26-076 .

The North ~ Vent Noble. Gas Effluent monitor high-high-setpoint is calculated monthly based'on the grab sample results performed in accordance with'ODCM.I3.3-3.. Due

'to the incorporation of the ALARA philosophy in the design and operation of the' Limerick effluent-systems,-

release point grab samples may not identify any

, radionuclides. In thisisituation, chemistry may use.

the.results ofLthe last grab sample which identified-radionuclides or use the default-setpoint which is.

. based on expected concentration ration as reported in~ ,

the UFSAR.

If any calculated alarm setpoint is less than the existing monitor setpoint,- the setpoint will; be reduced to the new value. If the calculated setpoint value is greater than the existing _value, the setpoint may remain at the lower value or-increased to the new value.

2.2.1-1 Setooint Determination The setpoint for the North Vent Noble. gas Effluent Monitor is set at or'below the j lesser of the NVSP,, OR NVSP,,, value. .

The Alert setpoint is not to exceed 1.1 E-:

04 pC1/cc,-per LGS UFSAR Table'll.5-2, using l the two unit maximum-North: Vent-flow-rate.

g p ws-

[VFw el [500] [ECml. )

m [3.447 5E9] E [ (C 3 ,) (Kj) ]

. I

[VF,wl [3000] [ECj,)

gp"8" [3. 447 5E9) E [ ( C 3 ,) (Lj +1.11Mj) )

where NVSP,,, = North Vent Setpoint - Noble Gas Whole Body (pCi/cc) ,

NVSP,,, = North Vent Setpoint - Noble Gas Skin (pC1/cc)~

VF,,, = Fractional contribution to site boundary noble gas dose rate from the North Vent as calculated-in equation 2-7. (unitiess).

500 = Total body dose rate limit (arem/yr) 3000 = Skin Dose rate limit (mrom/yr) s

. l' -ODCM Rev.-12 pig 3 78

l .4/94' Ec ow = Total noble gas activity from! North Vent grab sample-

-(pC1/cc)

~3.4475E9' = Conversion factor (pci) (cc) '

m3 ) (pCl)

= (1.1E-S'sec/m2 ) (1E6 pCl/pCl) (664,000 cfm) (1/60 min /sec) (2.832Ed cc/fc8)-.

(2-3) where:

1.1E-5 sec/m 3

=. highest annual average X/Q (NE Sector) .

4 1E6 pCi/pCi = units conversion 664,000 cfm = maximum North vent flow rate for two unit operation 1/60 min /sec = units conversion 2.832E4 cc/ft'

= units conversion C uw = concentration of noble gas nuclide 1,as determined by radioanalysis of North vent, grab sample (pci/cc)

K3 = Total body dose conversion factor for noble gas nuclide 1 (mram/yr per pci/m 3 , from Table 2-1).

L, = Beta skin dose conversion factor noble gas nuclide 1 (mrom/yr per pCim', per Table 2-1) .

M, = Gamma air dose conversion factor for noble gas nuclide 1 (mrad /yr per pC1/m , per 3

Table 2-1).

b

ll I ODCM'R:v. 12

Paga 79

.l 4/94 2.2.2 South Vent Noble' Gas Effluent Monitors -RY26-185A-3,

-EX26185B-3, RY26-285A-3, AND RY26-285B Each unit's South Vent Noble Gas Effluent monitor high-high

'setpoint is calculated monthly based on.the grab sample results-performed in accordance with ODCM I3.3-3. Due to the incorporation of the ALARA philosophy in the-design and-operation of the Limerick-effluent systems, release point grab samples may not identify any radionuclides. With.this situation, chemistry may use.the resultsLof,the grab sample '

which identified radionuclide or use the default setpoint which is based on expected concentration ratios.as reported.

in the UFSAR. If any calculated alarm setpoint is less than the existing monitor setpoint, the setpointiwill be reduced to the new value. If the calculation'setpoint value is greater than the existing value, the setpoint may ,

remain at.the lower value, or increased to the new value.,

2.2.2-1 Setpoint determination The setpoint.for the South Vent Noble Gas Effluent Monitor is set at the lesser of the SVSP and SVSP value. SVSP are caTEulated and SVSP'I" for EEch unit's SoutE* Vent. Th Alert setpoint'is-not to exceed 3.4 E-6 pCi/cc, per. LGS UFSAR Table 11.5-2, for each unit's South Vent Noble Gas channel,.using each unit's maximum South Vent flow g -rate.

When a containment purge occurs through one inch /two~ inch vent valves to the South Vent, a '

grab sample will be analyzed for' noble gas activity, and the setpoint for the containment purge will be calculated per this section. ..This setpoint will be compared to the existing' monitor setpoint.

II the calculated containment purge setpoint is less than the existing setpoint, THEN the setpoint will be reduced to the new value.

IE the calculated containment purge setpoint is greater than the existing setpoint, THEN the existing setpoint will be maintained. At the completion of the containment purge, the setpoint will be restored to the monitor setpoint that existed immediately' prior to the containment

! purge.

" '" (2-4)

SVSP" $ [1. 2149E9] E [ (Cjy) (Kj) ]

-l i

a

. l[ ODCM R v. 12 Pag 1 80

. ,* :l

, :4/94

s ,

(VF,ym) (3000) (ECs,,) i (2_g}

gygp" ,

' [1. 2149ES] E [ ( Cj,y) (Lj+1.11Mj) )

.., l where: .

SVS P,, = South Vent Setpoint - Noble Gas Whole Body (pci/cc)

SVSP,,, = South Vent Setpoint - Noble Gas Skin (pC1/cc)

V F,,, = Fractional contribution to site ='

i boundary noble gas dose rate from the Unit's South Vent as calculated in equation 2-8 or 2-8a (unitiess) 500 = Total body dose rate limit (arem/yr).

3000 = Skin dose rate limit (mres/yr) ;

EC3 , = Total noble gas activity from each unit South vent grab sample (pci/cc). j 1.2149E9 = Conversion factor (pci) (cc) '

(ma )(pcj),

= (1.1E-5 sec/m3 ) (1E6pCl/pci) (234,000 cfm) (1/60 min /sec) (2.83E+4 cc/ft3 ) -(2-6) where: j 1.lE-5 sec/m 3 = highest annual average ~X/Q (NE Sector)-

1 lE6 pC1/pC1 = units conversion j i

234,000 cfm = maximum South Vent flow rate ]

1/60 min /sec = units conversion j 1

2.832E4 cc/ft 3 = units conversion l C "'

= concentration of noble gas.nuclide i determined by radioanalysis of South Vent grab sample (pCi/cc)

K, = Total body dose conversion factor for noble gas nuclide 1 (arem/yr per pC1/m 3, from Table 2-1).

f l

t

ODCM R;v.^ 12- ~g l

Pcg3 81

,4 - l, 4/94 i

~

L3 = Beta-skin dose conversion ~ factor noble gas nuclide l' (mrem /yr. per' pC1/m ,: per8 Table 2-1).

M*

.=- - Gamma air dose conversion f actor for- 8 noble gas nuclide 1'(arad/yr per pCi/m ,

per Table 2-1).

2.2.3 Noble Gas-Effluent Fractional Contribution The noble-~ gas offluent fractional. contribution is-calculated monthly using results of the grab samples performed in accordaLau with ODCM'I3.3-3.

The results of this calculation are used.in equations 2-1, 2-2, 2-4, and 2-5. This methodology f '

assumes that the total body dose is limiting for noble gas releases.- If equations 2-1, 2-2, 2-4, and 2-5 show that the skin dose is limiting, fractional skin dose should be substituted for the whole body values used in equations 2-7, 2-8, and 2-8a.

2.2.3-1 Calculation of VF , VF , and VF,.

(2-7 )

VF" = E [ (Cjw) (Kj) 3 +E [ (C22,y) (Kj) } +E l(C32,y) (Kj) }

' ' (2-7 )

VF 18 " =

E [(Cjw) (Kj)) +E [ (C ,y) 32 (Kj) 3 +E [ (Cassy) (Kj) )

(2-7 )

VF*#" = E [(C3w) (Kj)) +E [ (C ,y) (Kj) } +E [(Car,y) (K;) }

32 l where:

VF,,, a fractional contribution to site boundary noble gas total body dose rate from the North Vent (unitiess).

VF ,,,

3

= fractional contribution to site boundary noble gas total body dose rate from the Unit 1 South Vent (unitiess).

VF,. = fractional contribution to site boundary noble gas total body dose rate from the Unit 2 South Vent (unitiess).

l

.- ;Y j'

-ODCM R0v.112

Pagal82-

'3

, lL 4/94-3 1

C,, = concentration'of noble-gas nuclide i as - q w ' determined:by'radioanalysis of, North Vent grab i isample (pci/cc)- l

, K3 = total body dose conversion' factor for noble' gas radionuclide i- (arem/yr per pC1/m 3) l Cn , = -concentration of noble gas nuclide l'as determined'by radionnalysis of Unit 1 South

, Vent grab sample (pci/cc) .

-1 C, 33

= concentration _of noble gas nuclide 1 as .

q determined by radioanalysis of Unit 2gSouth- 1 Vent grab sample.(pci/cc)

<- 2.2.4- Noble Gas Effluent Default Setnoint 1

This' methodology may be used when grab sample :

, results'from either the North Vent or the South l Vent do not identify any radionuclides. This- y methodology is based on expected release . .

concentration ratios as outlined in section 11.3-of the Limerick UFSAR.

2.2.4-1 North Vent. Noble Gas Monitors 1(RY26-

, 075A-3 and RY26-075B-3). . The default -

1 setpoint for the North Vent noble gas.

effluent monitor-is set-at or below the NVSP,, value $3.45E-5 pC1/cc. >

gp"" , (8.90E-1](500)(1.15E-6] (2 -9 )

[3. 4475E9] [500] [4. 30E-9]

Y c

where:

4 NVSP,, = Default. North Vent Setpoint - Noble Gas (pCi/CC)

= Default fractional contribution to site' boundary I

. 8.90E-1 noble gas total body dose rate from the North' Vent (unitless)

, 4.30E-9 (4. 3 0E-9 ) + (5. 31E-10) where:

4.30E-9 = Summation of the North Vent-concentration of.

noble gas nuclide i multiplied by the corresponding whole body dose factor.

(pCl) (mram) (m2)

(cc) (yr) (pC.f) ,

2.

l

,.,m, _

m-.

De .

^l! ODCM R v. 12 i Pcg> 83 1

!l' '

4/94 l

.l 5.31E-10. = Summation'of the South. Vent (Unit 1 5 2) concentration.of noble gas'nuclide i multiplied- R by.the corresponding whole body dose factor. :

l(pCl) (mrem) (m3 )

(cc) (yr) (pci) ,

' Reft a) Based on expected annual release from f UFSAR Table <11.3-1.

b) Based on maximum North' Vent flow of 664,000 cfm_and South Vent: flow of-234,000 cfm for Unit 1 and ,

Unit 2 vents.

c) ODCM II Table'2-1.

500 = Total body dose rate limit (mrom/yr) 1.15E-6 -= Total noble gas concentration from North Vent (pC1/cc)

Ref: a) Based UFSAR Table 11.3-1.

b) Based on maximum North Vent flow of 1 664,000 cfm ,

3.4475E9 = Conversion factor

' (pci) (ce) '

(m3 ) (pCl) ,

4.30E-9 = Summation of the. North Vent. concentration of noble gas'nuclide i multiplied by'the corresponding'whole body dose' factor.

(pCl) (mram) (m8 ) ?

(cc) (yr) (pci)

Reft a) Based UFSAR Table 11.3-1.

b) Based on maximum North vent flow of 664,000 cfm.

c) ODCM II Table 2-1.

P

i

.l ODCM R0v. - 12 l Pag 3 84 l/ 4/94 2.2.4-2 South' Vent Noble Gas Monitors (RY26-185A-3, RY26-285A-3, RY26-185B-3, and RY26-285B-3).-

The default setpoint for each Unit's South Vent noble gas effluent monitor is set:at or below the SVSP,, value (s 6.09E-6 pCI/cc) .

(5. 49E-2] [500] [7.14E-8) (2-10)

SVSP"" s [1. 2149 E9] [2. 65E-10]

where: ;

SVSP,, = Default South Vent Setpoint - Noble Gas (pCI/cc) 5.49E-2 = Default fractional contribution to site boundary noble gas total body dose rate from the South Vent (':ni+ less )

, 2 . 6 5E-10 (4 . 3 0 E-9 ) + ( 5. 31E-10 )

where -

2.65E-10 = Summation of the Unit's South Vent-concentration of noble gas nuclide i multiplied by the corresponding whole body'

- dose factor.

!; (pCl) (mrem) (m8)

(cc) (yr) (pci) ,

l i

4.30E-9 = Summation of the North Vent concentration of l noble gas nuclide i multiplied'by the

- I corresponding whole body dose factor.

(pci) (mrem) (m 3) )

(cc) (yr) (pCl) :

1 J

a.

3 .>&

ODCM R;v.;12

'l1

' Paga 85; S!.

4/94 5.31E-10-.= Summation of,the' South Vent l(Unit 1 & 2) concentration of-noble ~ gas.nuclide 1l multiplied by the corresponding whole body <

dose factor.

(pci) (mrem) (m3)

(cc) (yr) (pci) .

Refs a) Based on expected annual' release from UFSAR Table.11.3-1.

b) Based on maximum. North Vent flow of 664,000 cfm and South. Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.

c) .ODCM II Table 2-1.

500 = Total body dose rate limit (mrem /yr) 7.14E-8 = Total noble gas concentration from North Vent (pCi/cc)

Reft a) Based UFSAR Table 11.3-1.

b) Based on maximum North Vent flow of 664,000 cfm.

1.2149E9 = Conversion' factor (pci) (cc)

(m3 ) (pCl) .

Reft a) ODCM II equation 2 2.65E-9 = Summation of the North Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.

~

l

' (pci) (cc) ,

(m3 ) (pCl),

f l ..

Ref; a) Based UFSAR Table 11.3-1.

i b) Based on maximum North Vent flow of 664,000 cfm.

- c) ODCM II Table 2-1.

1 J-l'

3

'It 'ODCM R2v. 12 P2gs'86 i

l.. 4/94 2.2.5 . Wide Ranoe Accident Monitor Noble Gas Effluent' Monitor (RIX-26-076 *'

The Wide Range Accident Monitor (WRAM) noble gas-total effluent channel displays the North Vent noble gas release rate. .This monitor has Main Control Room Annunciation as'well as.a group 6A

^

isolation-function'on:the primary containment purge and vent valves. The isolation setpoint valve of 52.1 pCi/cc specified in Technical Specification 3.3.2-2 is based on the accident. .;

dose. limits for containment. purge during~an- 4 accident (Reft UFSAR Section 1.13).- For routine operations the total effluent alert and high setpoints are based upon the methodology of Sections 2.2.5-1 and 2.2.5-2. The setpoint units il are in microcuries per second using the two unit maximum North Vent flow rate of 664,000 scfm. The total effluent channel High setpoint is set at a value less than or equal to ten times the Alert .. .

setpoint (not to exceed thel 2.1 pCi/cc equivalent using the two-unit maximum North Vent flow rate).

For containment purge operations,.the high-setpoint is based on an isotopic analysis of the ^

i containment atmosphere using CH-1009 (Reft Section:

2.2.5-3). These values are always more conservative than the Technical Specification '

Table 3.3.2-2 required value of $ 2.lyci/cc..

If the calculated.setpoint value is less than the

~

1

, existing monitor setpoint, the setpoint will be~ l reduced to the'new'value. If the calculated I setpoint is greater than the existing-value, the setpoint may remain at the lower value, or increased to.the new value. j

-l I

1 4

A,? ' '

7,. '

ODCM R;v. 12- -

-l .

.Psg3 87:

j. !4/94 1r

'2.2.5-1 Routine Operations Alert Setnoint Determination For routine operations,'the Alert

.setpoint for the WRAM Noble Gas. total:

effluent channel is set 4at or below the e

lesser of the OR NVSP,,,.value.

NVSP*T's not to exceed The Alert setpoint 1.1 E-04 pC1/cc' equivalent,;using-the-two-unit maximum North Vent flow rate,. :

l per LGS UFSAR Table 11.5-2.--

[VFa] [500] [E Cj,]

ggp" g [3.447 5E9) E [ (C3 ,y) (Kj) ]

(2 -11) .

L e l

[VF 1 [30001 [ECj,1 yyj""" , [3.447 5E9] E [ (Cj,) (Lj + 1.11Mj) ]

g) c where:

NVSP,,, = North Vent Setpoint - Noble Gas Whole i Body (mci /cc)

NVSP,,, = North Vent.Setpoint- . Noble Gas Skin (MC1/cc) .

VF,,, = Fractional contribution to site boundary noble gas dose rate from the North Vent-as calculated in equation 2-7. -

(unitless).

500 = Total body dose rate limit (arem/yr)'

3000 = Skin Dose rate limit (arem/yr)

Ic i , = Total noble gas activity from North Vent

, grab sample (pci/cc) 3.4475E9 =

Conversion factor)

(pci) (cc) ' ,

j - (m3 ) (pCl),

= (1.1E-5 sec/m2 ) (1E6pCl/pci) (664,000 cfm) (1/60 min /sec) (2.832E4 cc/ft 3) (2 -3 )

where:

1.lE-5 sec/m3 = highest annual average X/Q (NE Sector) 4 lE6 pCi/pC1 = units conversion i

.1 l

ODCM R0v'. 12-P;gs 88

'l 4/94 664,000 cfm = maximum North Vent flow rate for-two unit operation i

1/60 min /sec = units conversion 2.832E4 cc/ft 3 = units conversion C,,, = concentration of' noble gas nuclide i as determined by radioanalysis of. North Vent grab sample (pC1/cc)

K, = Total body dose conversion factor for noble gas nuclide 1 (mrom/yr per pCi/m3 ,

from Table 2-1).

L*

= Beta skin dose conversion factor noble gas nuclide 1 (mrem /yr per pCi/m , per 3

Table 2-1).

M# = Gamma air dose conversion factor for noble gas nuclide 1 (mrad /yr per'pci/m , 3 per Table 2-1).

The setpoint values are converted from pCi/cc to pCi/sec using-the maximum two-unit North Vent flow rates ,

NVSP , =

[NVSP, ) (3.134E8] (2-14)

NVSP ,, = (NVSP,,,) [ 3.134E8 ] (2-15)

. where:

NVSP ny, = WRAM total effluent channel North Vent Setpoint'- Noble Gas Whole Body (pCi/sec).

NVSP usz = WRAM total effluent channel North Vent Setpoint - Noble Gas Skin (pC1/sec).

NVSP,,, = North Vent Setpoint - Noble Gas Whole-Body (pCi/sec).

NVSP,,, = North Vent Setpoint - Noble Gas Skin (pCi/sec).

3.134E8 =

Conversion factor (cc/sec).

= (664,000 scfm)(1/60 min /sec)

(2.832E4 cc/fta)

(2-16) i 1

l 1

l

r %

' l! s ODCM'R v. 12- .i Pcg3 89

l. 4/94.. .

/

2.2.5-2 Routine Operations-Hich'Setooint Determination .

!For routine operations,'the high:setpoint for-the WRAM: Noble Gas total effluent channel is set at or below-ten-times the lesser of the-routine- operations- NVSP, or NVSP, value.

NVHP, . =~ [ NVSP ) ' [ 10 ) (2-17)! I NVHP.,= '[NVSP, ) [10) .(2-18)-

where NVHP , = WRAM total affluent channel North Vent' '

High Setpoint Noble Gas Whole Body (pci/sec).

NVHP , = WRAM total effluent channel North Vent High Setpoint Noble Gas Skin (mci /sec).

NVSP, , = WRAM total effluent channel North Vent Setpoint - Noble Gas Whole Body-l (mci /sec). .

NVSP,. = WRAM total effluent channel North Vent' i Setpoint - Noble' Gas Skin 1(pCi/sec).-

10 = multiplication factor-to calculate'High' )

value (unitiess).

3 2.2.5-3 'Hiah Setooint Determination - Containment Purae Operations During routine purge. operations.Lvia. North Stack, the'setpoint will.be determined prior to initiation.of the. purge based on the containment noble' gas grab sample' required by; '

ODCM.13.3-3A. The WRAM high setpoint-is set '

at or below the lesser of the WRSP .OR .

WRSP value. At no time'will the setpoint :

be h7 geer then 6.58 E+8 pCi/sec (Ref :

Specification Table 3.3.2-2 limit of s 2.1 pCi/cc converted to mci /sec-(2.1 pCi/cc.is-based on maximum 2 unit North Vent flow ~l rate).

-[VF 1 [500] [ECj,]

'ggp"" g (2-19 ) .

[1.10E+1] E [ (C3 ,) (Kj) ~l I

(2-20)

WRSP*

s [1.10E2] E [ (Cj,) (Lj+1.1Nj) ] !

1 j.

4 x

b ..

.l-ODCM-R;v;"12

Pago 90 P l~ 4/94 1

ji where:

WRSP , = WRAMl Purge Setpoint - Noble Gas Whole-Body-(pC1/sec.).

WRSP . =' WRAM Purge Setpoint - Noble Gas.

Skin.(pci/sec.)

VF, = Fractional contribution.to site boundary noble gas dose rate from North Vent as-calculated in equation 2-7.-(unitiess).

500 = Total body dose rate limit-(area /yr).

3000 =- Skin dose rate limit (mrom/yr).

EC3 , -= Total noble gas activity from containment !

grab sample (pci/cc).

-l. 1.1El = Conversion factor

. . .l (pCl) (sec)

(pCl) (m3 ) .

4

, (1.1E-5 sec/m 3) (1E6pCl/pCl) (1/60 min /sec) (2.832E4 cc/ft 3) (2 -21) -

472 "1"~## I sec-fc3 j l

where:

1 1.1E-5 = highest annual average - ~X/Q (sec/m 3 ) (NE 1 sector).

I 1E6 = units conversion-(pCi/pC1) l 1/60 =

units conversion (min /sec)-

2.832E4 =

units conversion (cc/ft )3 472- = units conversion

' min-cc sec/fc3

= concentration of noble gas nuclide i as C,

3 determined by radioanalysis of' containment grab sample (pci/cc).

Ki = Total body dose conversion factor for noble -i gas nuclide l'(mram/yr per pCi/m3 from Table 2-1).

[Q

~'

-ODCM' rov. '12'

y -l-'

~

.Paga 91 l 4/94-L, = . Beta. skin dose conversion factor.for noble. <

gas nuclide.i.(mrom/yr.per pCi/m2 from Table 2-1)..

Mi = Gamma air dose conversion factor for noble .

gas nuclide'i (arad per pCi/m3 from Table 2-1).

2.3 Gaseous Ef fluent Dose Evaluation The Annual gaseous effluent dose evaluations are performed-using the computer based RM-21A report: processor.- -

Instantaneous Offsite Dose Calculations are. performed with l' the MesoRem:Jr Common Dose Model computer program.' The -

following sections describe the computational models, assumptions and bases. Emergency dose calculations. ara performed using the MesoRem Jr Common Dose Model computer program.

Monthly dose calculations are performed based on~1imiting sector average annual meteorological dispersion parameters. For the noble gas monthly dose: calculation, effluent release data are' based on the. latest grab sample 4 analysis for radionuclide composition and the hourly average effluent monitor response for total release activity. For the iodine and particulate monthly dose calculations, the effluent release radionuclide composition and release activity are based on tho' ,

continuous composite samples for the time period of the i dose calculation.

The quarterly dose calculations are.a summation of the applicable monthly dose results.

. The annual dose calculations are based on the actual meteorological conditions concurrent with the effluent-releases. Wind direction, temperature lapse rate,. ambient temperature,-ground level windspeed, and release elevation windspeed are provided for each hour of_the year. The .

meteorological dispersion values (X/Q, depleted X/Q, and D/Q) are calculated for each hour and linked with.the corresponding release data. The effluent release radionuclide composition and activity are~ based on the-same parameters as the monthly dose analyses.

i 1

I

1l[ ' , 'ODCM R2v.112 l Pcg3 92, .

i? l l- 4/94 l

'2.3.1 ' Site-Boundary Dose Rate - Noble Gases ODCM I3.3.-2.a limits the dose rate:at'the SITE BOUNDARY due to noble gas releases to $500 mrom/yr total body andL $3000 mrom/yr skin.- Radiation monitor alarm setpoints are established to ensure that these release limits are not. exceeded.1 In

, the event any gaseous releases from the; station. H results~1n an alarm setpoint being' exceeded, an ~

H evaluation of the SITE BOUNDARY. dose rate l

,, resulting from the release would be performed' .)

using'MesoRem Jr Common Dose Model Computer 4

li Program. 1 Simultaneous releases from the North and South h

. Vents are considered in evaluating compliance with- j the release-rate' limits'of ODCM I3.3.2.a:following I any releases exceeding the alarm setpoints.

Monitor indications (readings) are averaged over- ;

time periods not to exceed 15 minutes when '

determining noble-gas release rate based on :

4 correlation of the monitor reading and monitor '

sensitivity. The 15-min averaging allows for <

reasonable monitor respense to potentially changing radioactive material concentrations and to exclude potential electronic spikes in monitor readings that may be unrelated to radioactive material-releases. When identified, electronic spiking monitor responses are being excluded from' the dose calculation.

i NOTE: For administrative: purposes, more_

conservative alarm setpoints_than those-required to meet 10.CFR'20 Dose Rate limits are imposed. 'However, conditions exceeding these more: limiting alarm setpoints do not necessarily indicate' radioactive material release rates exceeding the dose' limits of' ODCM I3.3.2.a. Provided actual releases'do'

-not result in: radiation' monitor indications exceeding values based on the dose rata l

limits of ODCM I3.3.2.a, no further

, analysis'are required for demonstrating compliance with the' limits of ODCM I3.3.2.a.

c 3'

'^

w

? '7 ODCM R v. 12

'll J Pag ^. 93

. l; 4/94' The site boundary dose ~ rate from noble gas effluent releases.in the event of>a noble gas effluent setpoint exceeding =the value specified'in ODCM II sections 2.2.1 (or 2.2.4-1), 2.2.2 (or 2.2.4-2),'and 2.2.10'is calculated using_the methodology stated below. This methodology is based on actual meteorological dispersion.

l.

D,,,,= (53. 882) (X/0) '17[( (F,y) (Dj,y) + (Fj,y) (Oj,3y) + (F 28V) (0 :sv) 1 3 K J)' (2-22

,d I

17 E [ ((Fyy) (Ojyy) + (F2 SV) (Oj2,y) + (F SV) (D;ssy)]Lj] +

D,,,= { 53. 8 82) (X/0)

' 1,

' (SF) E [(Fyy) (Oj,y) + (F3 SV) (Oj,,y) + (Fa sv) (D J ssv) }J N (1'll)

,J a 3 ,

(2-23) where:

D em = Total Body Plume Dose Rate.(rem /hr)

D, =

Skin Plume Dose. Rate-(rem /hr) 53.882 = Units conversion factor Iem-m'-pCl-yr-min-cc

, pCi-br-mrem-m'-sec-f t'.

X/Q- = 1.1E-05 highest annual average relative concentration (NE Sector) (sec/m ) 3 F, =

North Vent Flow Rate (cfm) l' Q, = concentration of noble gas nuclide i during 3

period of release from North. vent (pci/cc)

F, 3

=

Unit 1 South Vent Flow Rate (cfm) l Q, 13

= Concentration of noble gas nuclide i during ,

-period of release from Unit 1 South Vent L (pci/cc).

l l F,, =

Unit 2 South Vent Flow Rate (cfm)

Q3 ,, = Concentration of noble gas nuclide i during period of release from Unit 2 South vent (pCi/cc). a l

, , . - ~ .

2'I,' ' : k l! ' ODCM R5v. 12;

o Pggs.94- R l v 4/94 w

l

=K_ 3

=- Total body dose' factor for' noble gas nuclide j

i. Values are listed in Table 2-1. . -;

I mram-m) 1

\ ,pCl-yr, 1

I L3 = Skin dose factor for'the beta contribution for noble : gas nuclide 1. Values are listed in Table 2-1.

mrem-m 3 pCi-yr .

1.11' = the average ratio of tissue to air energy absorption coefficients (ares /arad) (Ref Regulatory Guide 1.109 Section 2.2).

SF = 0.7 is the attenuation factor that accounts

. for the dose reduction-due to-shielding:

provided by residential structure (dimensionless) (Ref: . Regulatory Guide 1.109 Table E-15).

M3 = Gamma air dose factor-for noble gas'nuclide

' i.- Values are. listed in Table 2-1.

mrad-m3 pCl-yr .

4 2.3.2 Site Boundarv Dose Rate Radioiodine and Particulates ODCM I3.3.2.d limits the dose rate to $1500'mrom/yr to any organ (inhalation pathways.only) for I-131, I-133,'

. Tritium, and all. radionuclides in~ particulate form with

half-lives greater than 8. days in gaseous effluents. .

Compliance with ODCM 13.3.2.d is determined monthly by performance of ODCM II Section 2.3.4.

Simultaneous; releases from the North and South Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.b. . Release activity.

is based upon the results of the continuous composite sampler analysis performed in accordance with ODCM l Table I3.3-3.

4' 4

4 i=d =m - - ~ -

, ... ~. . . . . . ,. . . - , - .

g 'h g 'l > ODCM R v.:12

Prga 95 M j; 4/94 .;

h4 4 This methodology is based on the worst sector-(NE).

annual: average meteorological . dispersion but, if;

,' further refinement.is; required to meet the limits of

'ODCM I3.3.2.b, actual meteorological, data-from the time period of concern'may be used to calculate actual. 1

meteorological dispersion. l 2.3.3 Noble Gas Air Doses-ODCM 13.3.3 7 11mits.the air dose-due-to noble gases-

"' released in. gaseous affluents.(from bothtreactor units)- I to areas at or beyond the. SITE BOUNDARY to:.

.5 10 mrad gamma.for anyLquarter.

$ 20 mrad. beta for any quarter .

< $.20; mrad gamma:during any calendarfyear.

$ 40 mrad beta during any. calendar year As required oy ODCM 13.3.3.1 Surve111ance Requirement, these doses are calculated at-least onceLper 31; days using the results of the most recent grab samples for.

isotopic composition performed in accordance with.a l' ODCM Table.13.3-3-when release point. grab samples do:

not identify any radionuclides. Tota 1' release activity:

is based upon the hourly average affluent monitor response. .As identified, electronic spiking monitor responses are excluded from the release activity; .

' analyses. The monthly dose-calculation is performed-using the most limiting average annual'meteorologjcal' dispersion values. The quarterly doses-are based cm the summation of the: applicable monthly results. The; annual dose calculations are based upon actual release meteorological conditions'as described in Section?

g 2.3.5. The monthly dose calculations are performed;in ;

accordance with.the methodology below. l

. D, AIR = (0.114) (1.11E-5) (47 2) E [ (F,) (Cj,) +2 (F ,) (Cj,,) + (F ,) (C33 ,) ] Mj (2-24) .

i

. D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (Cj,) 2+ (F ,)32(C ,) +2(F ,) (C3 ,,) ] N 3 (2-25) where:

D gu, = Gamma air dose from noble gas releases (rad /hr)

D uan = Beta air dose from noble gas release (rad /hr) 0.114 = Units conversion rad-pCl-yr

,pCl-br-arad, 1.1E-5 = Highest average annual relative concentration 3

(NE Sector)(sec/m )

)

v

) .

ODCM R::;v. 12' 1f Paga 96

]. 4/94

, s 472 = Units conversion

' min /sec' sec-ft' F,, = . Average North Vent Flow rate for-period of release (cfm)

C1 ,y = Concentration of noble gas nuclide~1 from North-Vent effluent-(pci/cc)

F uw = Average Unit 1 South Vent flow rate for period' of release (cfm).

C,ig

= Concentration of noble gas nuclide 1 from-Unit'l' South' Vent affluent (pci/cc).

F,, = Average Unit 2 South-Vent flow rate for period of release (cfm)

C ,,,, = Concentration of puble gas nuclide i from Unit 2 South Vent ef fluerst (pci/cc)

M, a Gamma air dose factor for noble gas nuclide 1.

Values are listed in Table 2-1.

mrad-m' pCl-yr .

N, = Beta air ~ dose factor for. noble' gas nuclide 1.

values are listed in Table 2-1.

mrad-m3 pCi-yr ,

2.3.4 Radioiodine and Particulate Dose Calculations-ODCM I3.3.4 limits the dose (from both reactor

. units) to a MEMBER OF THE'PUBLIC from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8-days in gaseous effluents released to areas at or beyond-the SITE BOUNDARY to:

s 15 mrom to any organ during any calendar quarter s 30 mrom to any organ during any calendar year As required by ODCM I3.3.4.1 Surveillance

' Requirement, these doses are calculated at least once per 31 days using the results of the-

.v

.y . . - . . . .. ~ .

Y t

, y

~

.ll ODCM R0v. 12; i,

.. ; Paga"97- '

l:

4/94' s m

. . continuous. composite sample analysis performed in.

l' accordance with ODCM Table I3.3-3. Due to the incorporation of the ALARA. philosophy.in~the

- design and. operation of the Limerick effluent systems,1 these composite samples.may-not identify.

~

any radionuclides.- Total release. activity is based upon detectable concentration of the :)

continuous composite; samples and average <

appropriate vent. flow during the sampling period.

. -l D

The monthly dose calculation is performed using.-

the.most limiting average annual meteorological dispersion values. The quarterly doses:are based. -

on the summation-of the applicable. monthly

. results. The' annual dose calculationsLare basedL upon actual release meteorology.as described.in-

- Section 2.3.5. The monthly dose' calculations'are performed in accordance with the methodology.

below. ' Total organ dose is obtained by the summation of the organ dose from each pathway for-each receptor. ,

2.3.4-1 Ground Pathway Do m = (3.6E-6) (472) (1. 82K-9) E e .

as E ' ( (F,y) (Oj,y) + (F ,y) 2 (Dj2,y) + (F ,y) (Ogssy) .+ (Tm) (O2 .,) ] DF,,,,t,, ( T,) (2-26) 1 1e .

~

2.3.4-2 Veaetation Meat,' cow Milk, and Goat Mi1k Pathway Dym = (3.6E-6) (472) Z '

a

[ (F,y) (0 3,) + (F ,y) 3 (Oj,,y) + (F ,v) 2 (O lssv) + (F.,). (03 ) ] (1.1E-5) DFr,r,L,n +

(Tg):

as j E, (F,y) (Oj,y) + (F1 ,y) (Oj,,y) + (F ,y) (04,,v) + (F ) (03 ) ] (1. 82E-9 ) DF4r,L,n.

p (2-27) l

=

1

[ ODCM R v. 12 l

~'

Pago 98 l l 4/94 2.3.4-3 Inhalation Pathway ,

Dy,y = (3. 6E-6 ) (472) E t

?

,2 E [ (F,y) (0 3,) + (F 3,y) (0 ,y) 33 + (F,,y) (Ojssy) + (Fm) (03 ) } (1.1E-5) DFx,3,, +

(Te) l

, 3,

[,,I (Fnv) (O ny) f + (F isv) (Ojssy) + (Fasy) (Ojssy) + (Fm) (0j ) ] (1. OE-5) DFg ,3,,,

)

(2-28) ,

where D, = dose from ground pathway due to release of particulates and lodines (rem).

D,,, = dose from vegetation, meat,- cow milk, and goat milk, pathways due to releases of particulates, iodines, and tritium (rem)

, D,,, = dose from inhalation pathway due to release of particulates, iodines, and tritium (rem) 3.6E-6 = units conversion factor rem-Cl-sec hr-mrem-pci, 472 = units conversion factor

' min-ce'

,sec-f2:,

1.82E-9 = highest average annual deposition (ESE Sector)

_1_.

m8 E = summation for each release time period ,

t (unitiess).

F, = average North Vent flow rate during release (cfm).- '

[ Q, = concentration of nuclide I from North Vent i

effluent (pCi/cc).

v. , . - - . . .-

I

"ll ODCM Rnv.:12 "

pig 3 99

. l? 14/94 F uw = average. Unit 1 South Vent flow rateLduring ,

release (cfm).

= concentration of nuclide i from Unit.1-South =i

, Q u ,,

vent affluent (pci/cc). ,

4, , .

i Ig,, = average Unit 2 South Vent flow' rate during:

release (cfm).

Qumr

= concentration of nuclide i from Unit 2 South' <

Vent effluent-(pCi/cc).

F. = average' Hot Maintenance Shop flow rate during release;(cfm). >

Qu , = concentration of nuclide i from Hot Maintenance'

-effluent (pci/cc). ,

dose factor for organ type k, age group 1,.

DF 3 ,3, =

. pathway number n; dose factors are based on a computer program which is similar to the NRC-

-program GASPAR results from this program provide input data in the form of a-lookup.

table - values of DF un are provided in Table 2-2.

1 = isotope. number (1 through 35)(3 through 17 are

, noble gases).

K = organ type (1 through 8, where total body = 1, _

GI tract = 2, bone = 3, liver = 4, kidney = 5, thyroid = 6, lung ='7, skin = 8).

L = age group-(1 through 4, where adult = 1 ,-

teen = 2, child = 3, infant =.4).

N = pathway number (1 through 7).

T, =

time duration of release (hrs). ;

~e 1.1E-5 = highest average annual X/Q (NE. Sector)(sec/m 2).- _

1.0E-5 =

highest averag)e annual depleted X/Q (NE -

Sector)(sec/m .

2.3.5 &nnual Dose Evaluation ODCM I3.6 requires an Annual Dose evaluation be performed and reported in.accordance with-Regulatory Guide 1.21 in the Semiannual.

Radioactive Effluent Release Report submitted 60 days after the first of each year. This-dose 4 evaluation is processed by the RM-21A. In the event that this computer model is unavailable, this analysis can be performed using the same mathodology. The liquid portion of this annual l

, :v.

lf: ODCM R;v.112 PIga 100

-[ 4/94~

v dose calculation is' described'in Section l'.3 of '

ODCM II.- The annual gaseous dose calculation uses the same methodology described in Section 2.3.1, ,

2.3.'3,'and 2.3.4 with the exception of meteorology; which is based upon actual sector average' atmospheric dispersion values using the guidance of Regulatory Guide 1.111:(Section C.lc).

Finalized hourly values of wind direction, ground; ,

level and release elevation wind speed, ambient temperature, and temperature. lapse rate.(for P-G..-

stability class) are provided annually using the instrumentation specified in ODCM:I3.1-1.- These- -

values are calculated'for=each hour and linked to.

the corresponding hourly' averaged effluent release rate. Doses are then-calculated for each hour at the various receptors.of interest.(depending upon release direction). Radioactive material release rate is calculated as described in Sec'lons c 2.3.3

and 2.3.4. Dose at each receptor is. accumulated for the year and the maximum dose for plume, ..

inhalation, and ingestion pathways are reported.- <

l The. gaseous affluent dose receptors are listed in-Table 2-4 and the dose is calculated using the methodology below.

2.3.5-1 Plume Pathway 17 .i D,mu= (3. 6 E-6 ) (47 2 ) E (X/0) ' E [ (F,) (0j,) + (F2 ,y) (Ojj,y) + (F2 ,y) (03 ,,) ] . : j e e2 3 .J (e ]') (*U"t)(DFja) T e) (2 -29 )

I 2.3.5-2 . Ground Pathway .

(F,) (0 ,)3 + (F SV) (0;2,y) +

Darm = (3.6E-6) (472) E (X/0) g 3 (DFJm)' ( T )e ~

e . c2-3 (F ,y) (Ojs,y) + (F,.) (Djan) < i

. (2 -29 ) :

2.3.5-3 yeaetation. Meat. Cow Milk. Goat Milk-Pathway Dvrm = (3.6E-6) (472) E* .,

l

E [ (F,) (Oj,) + (F ,y) 2 (Oj,,y) + (F ,y) (Oj,,y) + (F,,) (Ojm ) ] [ (X/Oe) ] (DF J,r,L,s)

+

'l (T e) .

' ss E [ (F,) (0 ,)3 + (F ,y) 1 (Oj3,y) (F ,y)2 (Oj,,y) + (F ,) (0 m,)3 ] [D/0] e (DFj,,,z,,)

,f"is .

(2'-31) i I

J

S e 4 " J%

!j, ODCM R0v. Pcga 101

'l 4/94 2.3.5-4 Veaetation, Meat, cow Milk, Goat Milk Pathway Dy ,m = (3.6E-6) (472) E

) (03 ) ] [ (X/De) ] (DFf ,r,t,w) +

E [ (F,y) (Oj,y) + (F1,y) (Oj,,y) + (F ,y) (Oj,,y) + (F

-d'i <

(Te) as

[ (Fuy) (Ojuy) + (Fis v) (Oj2,v) + (F 2 ,y) (Djssy) + (F,) (03 ) ] [D/Ogj] (DFj,r,t,w) -

(2-32) where:

D,, = annual dose from plume pathway (rem)

D,, = annual dose from ground pathway (rem).

Dy ,, = annual dose from vegetation, meat, cow milk, and goat milk pathways (rem)

D,,, = annual dose from inhalation pathway (rem) 3.6E-6 = units conversion factor rem-Ci-sec hr-mrem-p C1 472 = units conversion factor

' min-ce

, sec-f c.

E = summation for each release time period t (unitiess).

(X/Q), = relative concentration for time period "t"

( sec/m') .

F, = average North Vent flow rate during release

, (cfm).

Q,,' = concentration of nuclide i from North Vent affluent (mci /cc).

F,1

= average Unit i South Vent flow rate during release (cfm).

Q,1, = concentration of nuclide i from Unit i South Vent effluent (pci/cc).

F an = average Unit 2 South Vent flow rate during release (cfm).

s

o[: ODCM'RIv.112' LPaga.102l

. 7~

-l ,

14/94' L Q,,, =- concentration'of nuclide i from Unit 2'. South Vent effluent (yC1/cc).

, decay constant of nuclide l. (sec-1) .

~

A1 =

dr = distance to receptor:"r".

u, = average windspeed for. time period "t"'

(m/sec).

i DF 3 ,,y, = dose factor for organ-type-k, age group 1, pathway number.n; dose factors are based on.

results of a computer program thatLis based on and is similar!to~the NRC program GASPAR; results from this program provide input data: ,

in the form of aclookup' table - values of DF,, are provided 1n Table 2-2.

^

i = isotope number (1 through 35)(3 through 17 are noble gases).

K = organ type (1'through 8, where total body = 1, GI tract = 2, bone = 3,L11verc= 4, kidney = 5,' thyroid 1= 6,11ung = 7, skin:=

8).

L = age group (l'through 4, where adult = l',

toen ='2, child = 3,. infant = 4).

N = pathway number (1 through 7). .

T,. =

time duration of. release (hrs). !

F,, = average Hot Maintenance Shop flow rate during release (cfm).

Q ,,,

i

= concentration of nuclide l'from Hot' Maintenance Shop effluent (pci/cc).:

(D/Q), = deposition concentration.for time period "t" (1/m8 ) .

( X/Q,,3 ) = relative depleted concentration for time:

period "t" (sec/m8 ) . ,

2.4 Gaseous Effluent Dose Proiaction

e. ODCM I3.3.5 requires the VENTILATION EXHAUST TREATMENT SYSTEM be used to reduce radioactive material. levels; prior to discharge when projected doses from both units to areas at and beyond the SITE BOUNDARY would exceed 0.6 mrom to 5

any organ in a 31 day period.

s e

4

l: 'ODCM R2v. 12: 1 j

Paga~103 Jll ;4/94 i

'? /

The applicable gaseous processing systems for maintaining _

radioactive material releases ALARA are the1 Gaseous

'Radwaste Treatment System and Exhaust Treatment System in Figures 2-1 and;2-2. ;

A dose projection is performed at'least once per 31-days by the following equation:

Dmaxp =-(Deax/d) = 31d (2-33) where:

Dmaxp. = maximum organ dose projection foricurrent 31-day' <

period (mrem)

Dmax = maximum organ dose to'date for current calendar- '

quarter as determined by~ equation (2-26)(2-27) or (2-28) (mrom).

d = number of days remaining in current calendar quarter. The minimum time elapsed is seven (7) days.

31d = the number of. days of concern..

3.0 Soecial Dose Analysis

.3.1 Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose or dose commitment to.any MEMBER OF THE PUBLIC, due to releasesiof

. radioactivity and radiation, from the uranium fuel' cycle P

shall lun limited to:

s 25 mrem whole body or any organ.except thyroid 5 75 mrem thyroid ,

ODCM I3.3.7.2 Surveillance Requirement requires that-cumulative dose contributions from direct radiation from operations be evaluated'when the calculated dose from the '

release'of radioactive materials in liquid or gaseous affluents exceed twice the~1imits of ODCM I3.2.3.a, 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or 3.3.4.b. The direct radiation contribution shall txe determined by the methodology' described below. .This methodology calculates-the direct radiation contribution which1then must be added to the dose or dose commitment determined in accordance with sections ODCM III.3.1, 2.3.3, and 2.3.4 to determine total dose from all pathways. This evaluation of direct '

radiation contribution is in accordance with ANSI /ANS 6.6.1-1979 Section 7. The error using this method is estimated to be approximately.8%. The following evaluation is performed for each receptor of concern.

D = D, - D, , - D. (3-1)

l i [ODCM Rsv. ll:2 Pag 2.104

.ll) 14/94 )

a. <

s

> where:

i

= cumulative dose-contribution from direct' D,,a i radiation at receptor 1-(arem).

NOTE 'Due to the statistics of radiation measurements and to- !

the conservation of effluent calculations it is 1 ma In this j plausible situation the the D,lue va .y yield a negative value..

for.D ,a shall be reported:as '

zero(0).

D,3, =. total dose at receptor of-interest.(as evaluated by TLD measurement)(nrem).

NOTE: If there is not a TLD location at the actual receptor location, a more conservative location will be used to evaluate Total' Dose'..

Dm, = mean of the background dose as evaluatedLby. l TLDs at background sites-(arem). H D = ef fluent contribution .to dose (as evaluated 'in ,

sections 2.3.3 and 2.3.4.1).: )

-I 3.2 Doses Due to Activities Inside the SITE BOUNDARY '

In accordance with ODCM I3.6, the Semiannual Radioactive affluent Release Report submitted within-60 days after January 1 of each year shall include an assessment of radiation dose from-radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE ECUNDARY. ,

There are three locations within the ' SITE BOUNDARY : ,

that are accessible to MEMBERS OF THE PUBLIC'for .

activities unrelated to the operation of Limerick .-

Station. These. locations are: 1) the railroad: tracks !

which run along the river within the SITE BOUNDARY;

2) the Limerick Atomic Information Center, on Longview Road next'to the 500kv substation;'and 3) Fricks Lock environmental laboratory, operated by'RMC !

Environmental Services,.Inc.' Of these three locations,.the railroad tracks are the closest to the j i plant confines.. The highest annual dose for the_three. -

locations should be determined by calculating' dose at D the railroad track location. I l

I J

l i

. . . . ~ . .-. .

4

~ODCM R;v.-12:

ll Pcg3 105'

~j' '4/94 i

i The following methodology is:used to evaluate dose at?

the railroad tracks, Information Center,-and Fricks :

Lock locations. This dose assessment is; based on the 1 results of the annual. dose evaluation outlined in ODCM l

~Section 2.3.5. The maximum dose calculated will be i

.l reported. l D,,, = D,, * #!O = 0.25 ( 3 -2 ) -

X/Osa .

e.

where:

Dem '= Dose to MEMBERS OF THE PUBLIC within the SITE, BOUNDARY in Sector"X" (mrem).

D. = Dose at SITE BOUNDARY in Sector "X" (arem).

X/Q , = Relative average annual atmospheric dispersion for year of interest at SITE BOUNDARY in Sector "X" . (sec/m8 ) .

X/Qu,_ = Relative average annual atmospheric dispersion-for year of interest at railroad, Information Center or Fricks Lock for distances listed below in Sector "X" (sec/m')

Sector Distance to Location (m)

Railroad Tracks:

S 300 S5W 225' SW 225 WSW 225 W 225 .

-WNW 345 J

(. NW 450 Information Center:

ESE 884 l Fricks Lock:

WSW '450 .l l

0.25 = maximum occupancy factor for railroad tracks, Limerick Atomic Information Center or Fricks Lock Environmental Laboratory (unitiess).

l l

1 1

e >

'll 'ODCM R0v. 12 Pega 106 l, '4/94 4.0 Radioloalcal Environmental Monitorina Proaram 4.1 Samolina Proaram

'The operational phase of the Radiological Environmental Monitoring Program (REMP) is conducted' in accordance with the requirements of.ODCM I3.4-3.

! The objectives of the program are:

-To provide data on measurable levels'of radiation and radioactive materials in the site. environs.

1N> evaluate the relationship between quantities of ~

radioactive materials released from LGS and resultant radiation doses to individuals from principal pathways of exposure.

The' sampling requirements (type of samples,1 collection-frequency, and analysis) and-sample locations are presented in Appendix B.

4.2 Interlaboratory Comoarison Proaram.

Technical' Specification 6.8.4.e.3 requires analyses be performed on radioactive material supplied as part of an

Interlaboratory Comparison.

Participation in an approved Interlaboratory Comparison ;

Program provides a check on the preciseness of measurements'of radioactive material in environmental samples. A summary of the Interlaboratory' Comparison. ,

Program results is provided in.the Annual Radiological Environmental Operating Report pursuant to ODCM 13.5.

l i

i L

t

p gapur.ep .aaw +exa u .. ..s s . r - w.- > -**, ea <- a x.s. e -- - u a 1 - ~ m .,, ~ ,

' _{ +

I f .,. A k ...

g t'

d TABLES-f '.

a e

+

4 t

9 f

s 4

s d

i l ,

1 I

t l

\.

J g

4 t=

~ '

ODCM Rsv. 12i PIga'107

- 4/94-TABLE 1-1 INGESTION INDIVIDUAL DOSELFACTORS (Dg ,j)

. For liquid effluents Units For All Ingestion Pathways are: '

mrem /pci a

6 h

e i

1

.s. -

, . - . . . , - . _ . . _ - - -. - .-- =

> ODCM Rsv. 12 Paga 108 4/94 u

-Table 1-1

. 'Licuid Dose Factors From Table E-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 l'.050E-07=1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07 tC14- 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 1 Na24 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 P32- 1.930E-04-1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E-05

'Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07

-Mn54 0.000E+00'4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E Mn56 0.000E+00 1.150E-07.2.040E-08 0.000E+00-1.460E-07 0.000E+00 3.670E-06 i 2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 I

~

Fo55 Fs59 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05

. Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 i -Ni63 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+0011.880E-06 Ni65 5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00 0.000E+00-1.740E-06

, Cu64 0.000E+00 8.330E-08 3.910E-08'O.000E+00 2.100E-07 0.000E+00 7.100E-06 i

, Zn65' 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 I Zn69 1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 I

Br83 0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08

! Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00-0.000E+00 4.090E l 4

Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+00 0.000E+00 4.160E-06 l Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-191 !

Rb89 0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 j

-Sr89 3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 l Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.190E-04 l i -Sr91- -5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 l Sr92 2.150E-06 0.000E+00 9.300E-08 0.000E+00 0.000E+00-0.000E+00 4.260E-05 a

Y90 9.620E-09 0.000E+00 2.580E-10 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 l l

Y92 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00-3.090E-05 4

, Zr97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 l Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 l 4 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.9908-06 j Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10.4.130E-07 ;

Tc101 2.540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21

'Rul03 1.850E-01 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0'.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05

.Te125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 1 Tol27m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05 i

Tal27 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4.480E-07 0.000E+00 8.680E-06 Te129m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4.800E-05 0.000E+00 5.790E-05 Tol29 3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08

ODCM Rsv. 12 2 Page 109 4/94 Table 1-1 (Continued)

' Liculd Dose Factors From Table E-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI ,

LTe131m 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E+00 8.400E-05 1Tc131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09

?To132 2.520E-06 1.630E-06 1.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05

-I130' 7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06

'I131 4.160E-06 5.950E-06 3.410E-06 1.950E-03 1.020E-05 0.000E+00 1.570E-06

.I132 2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00 1.020E-07

- I133 1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.310E-06 0.000E+00 2.220E-06 I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07 0.000E+00 2.510E-10 I135- 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.060E-06 0.000E+00 1.310E-06 Cc134 6.220E-05'1.480E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Cs136L 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 i- Cs137 7.970E-05'1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E Cs138 5.520E-08'1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 4

Bn139 9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11'3.920E-11 1.720E-07 Bn140 2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.180E-05 Bal4i 4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-17 Ba142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 i

Ln140 2.500E-09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 La142 1.280E-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 Co141 9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E ,

Ca143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 Co144 4.880E-07-2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187 1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0,000E+00 2.820E-05 Np239 1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-10 0.000E+00 2.400E-05 Y j

3 y m -m,g--m >- --y -

1. g-.4 y_ -m , , m- -- 7m,--- -

.ODCM Rsv. 12

'Paga 110 4/94 Table 1-1 (Continued)

Licuid Dose Factors '

From Table E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.060E-07 1.060E-07'1.060E-07 1.060E-07 1.060E-07 1.060E-07 C14 4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07

Na24 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06

'P32 2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07.

Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06-0.000E+00 1.210E-05 Mn56 0.000E+00 1.580E-07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 Fe55 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06.

Fa59 5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00 4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 '

Co60 0.000E+00 2.810E-06 6.330E-06-0.000E+00 0.000E+00 0.000E+00 3.660E-05 >

Ni63 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00 5.190E-06 '

Cu64 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07.0.000E+00 8.920E-06 Zn65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08.

Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+00 0.000E+00-0.000E+00 Br84 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00

Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 r Rb86 0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06 Rb88 0.000E+00 8.520E-08 4.540E-08-0.000E+00 0.000E+00 0.000E+00 7.300E Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00-8.430E-17 1

, Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 7

-Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92 3.050E-06 0.000E+00 1.300E-07.0.000E+00 0.000E+00 0.000E+00 7.770E-05 Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00.0.000E+00~1.130E-04 ,

Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 Y91 2.010E-07 0.000E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 4

Y93 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Zr95 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Zr97 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10.0.000E+00 1.270E-04 Nb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m 3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E '

Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05 Rul05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 ,

Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 Te125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05 Tol27m 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 i Te127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 l 1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 2 Ta129m To129 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880E-07 0.000E+00 2.450E-07

'Te131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-05 0.000E+00 9.390E-05 '

'Te131 2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-07 0.000E+00 2.290E-09 To132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05 i

i

. . .. _. ~. __ _ ._,. ___ _ _ _ _ _ _ __ _

ODCM Rav. 12 Pcga 111' 4/94

. Table 1-1-(Continued)

Licuid Dose Factors From Table E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:

BONE LIVER T. BODY THYROID KIDNEY. LUNG- GI-LLI I130 1.030E-06 2.980E-06 1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 ,

I131 .5.850E-06 8.190E-06 4.400E-06 2.390E-03 1.410E-05 0.000E+00 1.620E-06

.I132. 2.790E-07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0~.000E+00 3.180E I133 2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 I134 1.460E-07 3.870E-07 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09

'I135 6.100E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06' i- Cs134 8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06

'Cs136 8.590E-06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 Cs137 1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 Cs138 7~760E-08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 Ba139 1.390E-07 9.780E-11-4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E B3140 2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05 Ba141 6.710E-08 5.010E-11 2.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13 Ba142. 2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11.1.990E-11 9.180E-20 La140 3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 Ln142 1.790E-10 7.950E-11:1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E Ca141 1.330E-08 8.880E-09 1.020E-09 0.000E+00 4.180E-09 0.000E+00 2.540E-05 Co143 2.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05

, Cs144 6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.720E-07 0.000E+00 1.750E-04 Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05 Pr144- 4.300E-11 1.760E-11 2.180E-12 0.000E+00 1.010E-11 0.000E+00 4.740E-14

'Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187 1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E-05 m

)

i

, l i

\

ODCM Rsv. 12 Pcgn 112 4/94 Table 1-1 (Continued)

Llauld Dose Factors

.From. Table E-13 or Reg. Guide 1.109 i Ingestion Dose Factors For Child:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

. H3: 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 I

C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06'2.420E-06 2.420E-06 -

Na24 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 4

P32 8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05 L Cr51 0.000E+00 0.000E+00 8.900E-09 4.940E-09'1.350E-09 9.020E-09 4.720E-07 Mn54 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06 Mn56 0.000E+00 3.340E-07 7.540E-08 0.000E+00 4.040E-07 0.000E+00 4.840E-05

-Fe55 1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000E+00 3.450E-06 1.130E-06 Fs59 1.650E-05 2.670E-05'1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05 y CoS8 0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05 t Co60 0.000E+00 5.290E-06 1.560E-05 0.000E+00 0.000E+00 0.000E+00 2.930E 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06 Ni63

~Ni65 2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.000E+00 2.560E-05 Cu64 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E-05 Zn65 1.370E05 3.650E-05 2.270E-05 0.000E+00 2.300E-05 0.000E+00 6.410E-06 Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+0013.990E-06 >

Br83 0.000E+00 0.000E+00 1.710E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00

. Br84 0.000E+00 0.000E+00 1.980E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 9.120E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 Rb88 0.000E+00 1.900E-07 1.320E-07 0.000E+00 0.000E+00 0.000E+00 9.320E-09 Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09 Sr89 1.320E-03 0.000E+00 3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05 3 Sr90 1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04 Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05

, Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04 Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07 ,

6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00 0.000E+00 8.020E-05 Y91 Y92 3.600E-09 0.000E+00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040E-04

Y93 1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04

, Zr95 1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05 i -Zr97 6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00 1.530E-04 Nb95 2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 Mo99 0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m 9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E-06 ,

Tc101 1.070E-09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 '

Rul03 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05 Rul05 6.450E-08 0.000E+00 2.340E-08 0.000E+00 5.670E-07 0.000E+00 4.210E-05 Rul06 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04 Ag110m 5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05

.Tal25m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 Ta127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05 Te127 4.710E-07 1.270E-07 1.010E-07 3.260E-07 1.340E-06 0.000E+00 1.840E-05 Tol29m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 Te129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 J

Te131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 l Te131 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-07 0.000E+00 4.360E-07 Ta132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05 4

- _.- _ ______- _ _ _,, , ,, ,__ , . _, ,m - __ .- , , , , . . . . , ,

ODCM Rov. 12 Paga 113 4/94 Table 1-1 (Continued)

, . Liquid Dose Factors From Table E-13 or Reg. Guide 1.109 Ingestion Dose Factors For Child:

BONE LIVER .T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06 I131 -1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06

.I132 8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06 I133 5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134 4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 Co134 2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.270E-05 2.070E Cs136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5'.130E-06 2.270E-06 C3137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 Ca138 2.280E-07'3.170E-07 2.010E-07 0.000E+00 2.230E-07-2.400E-08 1.460E-07 Ba139- 4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E ,

Bn140- 8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05

! Bal4i 2.000E-07.1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 Bn142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 i La140' 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 L La142- 5.240E-10 1.670E-10 5.230E-11.0.000E+00 0.000E+00 0.000E+00-3.310E-05 Co141 3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 Ca143 " 6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05

! Co144 2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04

Pr143 3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147 2.790E-08 2.260E-08~1.750E-09 0.000E+00'1.240E-08 0.000E+00 3.580E-05 <

W187 4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239 5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E '

l I

1 l

-- - - - - - - - - . __J_-__________________

E

.ODCM Rsv. 12 l Paga 114-4/94 Table 1-1 (Continued)

Liould Dose Factors

<From. Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.080E-07 C14 2.370E-05 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06

. Na24 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 P32 1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 b 4 Cr51 0.000E+00 0.000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07

.Mn54 0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7.310E-06 r Mn56 0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05'

-Fs55 1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00 4.390E-06 1.140E-06 l Fa59 3.080E-05 5.380E- 05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05

CoS8 0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8.970E-06

[ Co60 0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.570E-05 Ni63 6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.950E-06 4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00 4.050E-05 Ni65 Cu64- 0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05 h Zn65 1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00-5.330E-05

[ Zn69 9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05 Br83 0.000E+00 0.000E+00 3.630E-07.0.000E+00 0.000E+00 0.000E+00 0.000E+00

.Br84 0.000E+00 0.000E+00 3.820E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 ,

Br85 0.000E+00 0.000E+00 1.940E-08 0.000E+00 0.000E+00 0.000E+00.0.000E+00 Rb86 0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 Rb88 0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00 4.850E-07 0.000E+00 2.860E-07 1.970E-07 0.000E+00 0.000E+00 0.000E+00 9.740E-08 i N389 Sr89 2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90 1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04 Sr91 5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92 1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00.2.070E-04 !

Y90 8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E-04 Y91m 8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E-06 .;

Y91 1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05

. Y92 7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 ,

I Y93 2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04~ '

i Zr95 2.060E-07 5.020E-08-3.560E-08 0.000E+00 5.410E-08 0.000E+00 2.500E-05 Zr97 1.480E-08 2.540E-09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E-04 :

, Nb95 4.200E-08.1.730E-06 1.000E-08 0.000E+00 1.240E-08 0.000E+00 1.460E-05 i Mo99 0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05 1 Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06 .

Tc101 2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07 Rul03 1.480E-06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05 *

-Rul05 1.360E-07 0.000E+00 4.580E-08 0.000E+00 1.000E-06 0.000E+00 5.410E-05 Rul06 2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04 '

Ag110m 9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05 Ta125m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05 i 5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00.2.360E-05

~

To127m .

j To127 1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 To129m 1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05 .

Te129 2.840E-07 9.790E-08 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 ,

{. Ta131m 1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04 '

Te131 1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 Te132 2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05 0.000E+00 3.810E-05 '

. , . . - . . . . - . .. - -. . . ~ . ,

a N ODCM Rsv. 12 I Paga 115-4/94 Table 1-1 (Continued)

Licuid Dose Factors !

From Table E-14 or Reg.1 Guide 1.109 l i

Ingestion Dose Factors For Infant:

BONE- LIVER T. BODY THYROID -KIDNEY LUNG GI-LLI

-I130- 6.000E-06 1.320E-05 5.300E-06 1.480E-03'1.450E-05 0.000E+00 2.830E-06 I131 3.590E-05 4.230E-05 1.860E-05 1.390E-02 4.940E-05 0.000E+00 1.510E-06 I132- 1.660E-06 3.370E-06 1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06 I133 1.250E-05 1.820E-05'5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06

-I134 8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06

.I135 3.640E-06 7.240E-06-2.640E-06 6.490E-04 8.070E-06 0.000E+00 2.620E C2134 3.770E-04 7.030E-04-7.100E-05 0.000E+00 1.810E-04 7.420E-05:1.910E-06 Cs136 4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05-2.050E-06 Cs137 5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 Cs138 4.810E-07 7.820E-07 3.790E-07 0.000E+00 3.900E-07 6.090E-08 1.250E-06 Bs139 8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 Bn140 1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 Bal4i 4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10 1.770E-10 5.190E-06 Bn142 1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9*.260E-11 7.590E-07 La140 2.110E-08 8.320E-09'2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E-05 La142 1.100E-09 4.040E-10 9.670E-11 0.000E+00 0.000E+00 0.000E+00 6.860E-05 Ca141 7.870E-08 4.800E-08 5.650E-09 0.000E+00 1.480E-08 0.000E+00 2.480E-05 Co143 1.480E-08 9.820E-06 1.120E-09 0.000E+00 2.860E-09 0.000E+00 5.730E-05 Co144 2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E-07 0.000E+00 1.710E-04 Pr143 8.130E-08 3.040E-08 4.030E-09 0.000E+00-1.130E-08 0.000E+00 4.290E-05 Pr144 2.740E-10'1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 Nd147 5.530E-08 5.680E-08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E l W187 9.030E-07 6.280E-07 2.170E-07 0.000E+00 0.000E+00 0.000E+00 3.690E-05 Np239 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05 L :

bl c

ODCM.Rsv.s12 ,

rc by j' Pag 3-116

~4/94 v , . .r Table 1-2.

Assumptions used-in Limerick Liquid

-Effluent. Dose. Evaluation.

Indav Description value L1: Fraction'of produce-from local garden 7.600E-01 3

' ! 2 Fraction of. leafy veg from local: garden - 1.000E+00 o 3 Soil density'in-plow layerf(kg/m**2) ,

2.400E+02

!4rFraction of activity retained on sprayed vegetation 2.500E-01 .

7.000E-01~

. ~

" 538hielding factor;for residential structures

6; Period-of buildup of activity.in soil;(hr) ,

'1.752E+051

7 Period of pasture grass exposure.to activity:(hr). 7.200E+02 ri 8 Period of crop exposure to activityc (hr). '1.440E+03:

! 1 H

9: Holding time in animalidrinking wateri pond (hr) . 'O.000E+00

- 10 Delay time.for ingestion of: grass by animals-(hr) 0.000E+00 l

, _11' Delay' time for ingestion'of stored! fee by. animals-(hr) 2.160E+03 )

n 12 Delay time for ingestioniof-leaf veg by= man-(hr)1 2.400E+01- ,

13 Delay-time for ingestion'of.other veg by man (hr)- -1.440E+03 l 14' Transport time milk-man (hr) .

4.800E+01 i 4.800E+02-g ~15-Time between slaughter and consumption of meat animalL(hr) 0 i 16, Grass yield, wet wt (kg/m**2) 7.000E-01 17,Other' vegetation yield, wet wt-(kg/m**2) .2.000E+00 f .18 Weathering rate constant for activity on vegetation (1/hr). 2.100E-03

,q

?

4 L19 Milk cow feed consumption rate (kg/ day wet) .5.000E+01 f 20 Goat' feed. consumption rate (kg/ day wet) 6.000E+00: ]

21 Beef Cattle ~ feed consumption rate (kg/ day wet) 5.000E+01 "l 22 Milk cow water consumption rate (1/ day) 6.000E+01 l 23 Goat water consumption rate (1 8.000E+00 l

'24 Beef cattle water consumption / rate day) (1 5.000E+01 g

~25 Enytl transit time'for water-ingestio/ n day)-

(hr) 1.200E+01~ j

.26 Enytl transit time for fish ingestion-(hr) 2.400E+01 '

-27 Enytl transit time for invertebrate ingestion (hr); 2.400E+01' 28 Enytl-transit time for shore exposure (hr) 0.000E+00 29 Water ingestion (1 yr) adult 7.300E+02

30. Water ingestion (1 yr) teen 5.100E+02 31 Water ingestion (1 yr) child 5.100E+02 32' Water ingestion (1/yr) infant 3.300E+02

'33 Shorefexposure (hr yr) adult . 1.200E+01:

34 Shore exposure (hr yr) teen 6.700E+01-35 Shore exposure (hr yr) child 1.400E+01 36 Shore exposure (hr/yr) infant .

0.000E+00

-37. Fresh water sport fish ingestion (k yr) adult 2.100E+ 01 -

=38 Fresh water sport fish ingestion (k yr) teen. 1.600E+01

'39LFresh water sport fish ingestion (kg yr) child- 6.900E+00 40 Fresh water sport. fish ingestion (kg yr) infant . 0.000E+00'

[41 Fresh water commercial fish ingestion (k yr) adult .2.100E+01 42 Fresh water commercial fish ingestion (k yr) teen 1.600E+01'

~43 Fresh water ~ commercial fish ingestion (kg yr) child 6.900E+00 44 Fresh water commercial fish ingestion (kg yr) infant 0.000E+00 45 Fresh water invertebrate ingestion (kg/ 5.000E+00-46 Fresh water invertebrate ingestion (kg/yr) yr) adult teen 3.800E+00

-47 Fresh water invertebrate ingestion (kg yr) child 1.700E+00 48 Fresh water invertebrate ingestion (kg yr) infant 0.000E+00 i

ODCM Rev. 12 Pcga 117 -

4/94 Table 1-2 Assumptions used in Limerick' Liquid Effluent Dose Evaluation Index Descriotiqn Value 49 Salt Water Sport Fish Ingestion (kg yr) Adult 2.100E+01 50- Salt Water Sport Fish Ingestion (kg yr) Teen 1.600E+01 51 Salt Water Sport Fish Ingestion (kg yr) Child 6.900E+00

t. 52 Salt Water Sport Fish Ingestion (kg yr) Infant 0.000E+00 1

53 Salt Water Commercial Fish Ingestion (kg/yr) Adult 2.100E+01 54 Salt-Water CommercialLFish Ingestion (kg/yr) Teen 1.600E+01 55 Salt Water Commercial Fish Ingestion (kg/yr) Child 6.900E+00 56 Salt Water: Commercial Fish Ingestion (kg/yr) Infant 0.000E+00-57 ' Salt Water Invertebrate Ingestion (kg yr) Adult 5.000E+00 4 58 Salt Water Invertebrate Ingestion (kg yr) Teen 3.800E+00 59 Salt Water Invertebrate Ingestion (k yr) Child' 1.700E+00 60 Salt Water Invertebrate Ingestion (kg yr) Infant _ 0.000E+00

61 Irrigated Leafy Vegetable Ingestion (kg yr) Adult 6.400E+01 62 Irrigated Leafy Vegetable Ingestion-(kg yr) Teen 4.200E+01 63 Irrigated Leafy Vegetable Ingestion (kg yr) Child 2.600E+01 64 Irrigated Leafy Vegetable Ingestion (k yr) Infant 0.000E+00 65 Irrigated Other Vegetable Ingestion (kg yr) Adult 5.200E+02-66 Irrigated Other Vegetable Ingestion (k yr) Teen 6.300E+02 67 Irrigated Other Vegetable Ingestion (k yr) Child 5.200E+02 68 Irrigated Other Vegetable-Ingestion (k yr) Infant. 0.000E+00 69 Irrigated Root Vegetable Ingestion (kg yr) Adult 5.200E+02 70 Irrigated Root Vegetable Ingestion (kg yr) Teen 6.300E+02

. 71 Irrigated-Root Vegetable Ingestion-(kg yr) Child 5.200E+02 72 Irrigated Root Vegetable Ingestion (k yr) Infant 0.000E+00 l

73 Irrigated Cow Milk Ingestion (1/yr) Adult 3.100E+02 74 Irrigated Cow Milh Ingestion (1 yr) Teen 4.000E+02

75 Irrigated Cow Milk Inge~stion (1 yr) Child 3.300E+02 l 76 Irrigated Cow Milk Ingestion (1 r) Infant 3.300E+02 77 Irrigated Goat Milk Ingestion (1 yr) Adult 3.100E+02

'78 Irrigated Goat Milk Ingestion (1 yr) Teen 4.000E+02 79- Irrigated Goat Milk Ingestion (1/yr) Child 3.300E+02 80 Irrigated Goat Milk Ingesti n (1/yr) Infant 3.300E+02 81 Irrigated Beef Ingestion (1 yr) Adult 1.100F+02 l 82 Irrigated Beef Ingestion (1 yr) Teen 6.500d+01

! 83 Irrigated Beef Ingestion (1 yr) Child 4.100E+01 84 Irrigated Beef Ingestion (1 yr) Infant 0.000E+00 l

- _ .-__._______._____._____L_______________ __ , , _ _

.~ .- _.- . . . . .. - - -.

e.

'ODCM Rsv.J12 1 Paga'118 >

4/94 ,j j' 1 Table 2-1 Dose Factors for Noble Gas I Total-Body ; Beta Skin Gamma Air Beta Air Dose Factor- Dose Factor' Dose Factor Dose Factor l Ki-(mrem /yr Li (mrem /yr ' Mil (mrad.yr. Ni (mrad /yr per per per per Ind2x Radionuclide pCi/m3 ) pCi/m3 ) pCi/m3 ) pCi/m3 )-.

'3 -Ar-41 8.84E-03 2.69E-03 '9.30E-03 3.28E-03 l

4 Kr-83m 7.56E-08 ------- 1.93E-05 2.88E-04:

5 Kr-85m 1.17E-03 1.46E-03' 1.23E-03 1.97E-03 6 Kr-85 1.61E-05 1.34E-03 1.72E-05' 1.95E-03 7 Kr-87 5.92E-03 9.73E-03 .6.17E-03 1.'03E-02; 8 Kr-88 1.47E-02 2.37E-03 1.52E-02 2.93E-03 H 1

9 Kr 1.66E-02 1.01E-02 1.73E-02 ~ 1.06E-02: :

10 Kr-90 1.56E-02 7.29E-03 1.63E-02' 7.83E-03

.. \

11 Xe-131m 9.15E-05 4.76E 1.56E-04 1.11E-03 ;

. )

12. Xe-133m 2.51E-04 9.94E-04 3.27E-04 1.48E-03 R l

. 13 Xe-133 2.94E-04 -3.06E-04 3.53E-04 1.05E-03 l l

14 Xe-135m 3.12E-03 7.11E-04 3.36E-03 7.39E-04 l l

15 Xe-135 1.81E-03 1.86E-03 1.92E-03 2.46E l 16 Xe-137 1.42E-03 -1.22E-02 1.51E-03 1.27E )

l 17 Xe-138 8.83E-03 4.13E-03 9.21E-03 -4.75E-03 q l

l J

, . ~ . . . a.

)

^' ODCM Rhv. ,

~Pcga.119

"3 4 . f;.. .4/94 y Q-TABLE 2-2'

~

~ INGESTIONf INDIVIDUAL DOSE FACTORS ~ ( D Fg ,t, ,)

1 For Gaseous Effluents i

UNITS FOR AIRBORNE PATHWAYS (Pathway Numbers'I and 7) are:

3 mrem-m /Ci-sec UNITS FOR DEPOSITION PATHWAYS (Pathway Numbers 2-6) are:

2 mrem-m /Ci ~ ,

s Pathway No. Pathway 1 Pltune '

2 Ground 3 Vegetable 4 Meat 5 Cow Milk 6 Goat Milk 7 Inhalation l

1 l

i-I l'

II .i 1

~

1 i.

l .:.. .

. - - ~ . . . _ - - - . -- -_- . -~ ~-

ODCM Rsv. 12 1 Pcgs 120.-

p 4/94 I

Table 2-2 l 4

' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 j For Pathway: Plume )

'T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: ~ 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tzsnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

. Infant:~0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' r For' Pathway: Ground . .

T. BODY GI-TRACT - BONE LIVER KIDNEY THYROID- LUNG SKIN-Adult: 0.00E+00 0.00E+00 0.00E+00 0~.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <

4 -Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

F " Child:. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00~0.00E+00 0.00E+00-Infant: - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable ,

1 T. BODY GI-TRACT BONE LIVER KIDNEY -THYROID LUNG SKIN i

! Adult: 6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00 ;

J Toon: 7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00

-Child: 1.21E+02 1.21E+02 0.00E+00 1.21E+02 1.21E+02 1.21E+02 1.21E+02 0.00E+00 j Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00_0.00E+00 4

For Pathway: Meat T. BODY GI-TRACT BONE LIVER. KIDNEY THYROID LUNG SKIN Adult: 7.98E+00 7.98E+00 0.00E+00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 Tecn: 4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00

, Child: 5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00-Tsan: 2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00

. Child 3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 ,

Infant: 5.87E+01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00

~

For-Pathway: Goat Milk T. BODY .GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN-

. Adult: 3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 Toon: 4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+01 4.99E+01 4.99E+01 0.00E+00 Child: 7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00-Infant: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1.20E+02 1.20R+02 0.00E+00 For. Pathway: Inhalation T. BODY GI-TRACT BONE L1VER KIDNEY THYROID -LUNG SKIN-Adult: 4.01E+01 4.01E+01 0.00E+00 4.01E+01 4.01E+01 4.01E+01 4.01E+01 0.00E+00 Tean: 4.03E+01 4.03E+01 0.00E+00 4.03E+01 4.03E+01 4.03E+01 4.03E+01 0.00E+00 Child 3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.00E+00 Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00 e

a w - , - - , -.,w ., m -_ ,. __ -y -._--_ m _ -- --_-.-c

,, ,,_-.y . . , - - ,,--.,-,n .- ,,-w,, ,, ,- , , _ - . , , . - - - . - -e.- -

1 ODCM Rnv. 12 I Paga 121 4/94 1

l Table 2-2 (ConLinued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 l

. For Pathway: Plume T. BODY GI-TRACT- BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcnn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 p child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Totn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4

Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 Tscn: 8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00 Child: 2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER. KIDNEY THYROID LUNG SKIN Adult: 1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 Tecn: 1.39E+03 1.39E+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 0.00E+00 Child: 2.61E+03 2.61E+03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tasn: 3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 >

Child: 8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 i Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 l l

For Pathway: Goat Milk !

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 l Tecn: 3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 {

8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03,8.13E+03 8.13E+03 0.00E+00 Child:

Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For' Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 Tesn: 1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 Child: 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.68E+02 8.39E+02 1.60E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00 l

1

ODCM R;v. 12 Pcga 122 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 TOCn: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Infcnt: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc;n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Tstn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN !

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 InfInt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:

Infcnt: 0.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.00E+000.0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

Te:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+000.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l

( i

ODCM Rav. 12 Pcga 123 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Tann: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Infcnt: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 Toon: 1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 child: 3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 Tecn: 1.03E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 Child: 1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 InfGnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 Tecn: 9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child: 1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Infcnt: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00 Adult:

Tacn: 1.09E+02 1 83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 Child: 2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E+00 Infcnt: 3.52E+02 1.03E+04 0.00E+v3 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 i For Pathway: Inhalation j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00 l Tacn: 4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 1 Child: 4.89E+00 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 l Infcnt: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00 1

ODCM R3v. 12 peg 3 124 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Mn54 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96?+07 1

Adult:

Tacn: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.9 E+0?

Child: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+C7 4.96E407 Infant: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00 ,

Tccn: 2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00 Child: 5.03E+06 1.59E+07 0.00E+00 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Meat l T. BODY GI-TRACT ~ BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.21E+04 5.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 Tccn: 2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00E+00 0.00E+00 Child: 3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.40E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00 0.00E+00 0.00E+00 Tenn: 5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+00 Child: 1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+b0 0.00E+00 0.00E+00 '

Tacn: 6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 Tosn: 2.66E+022.12E+030.00E+001.62E+034.03E+020.00E+006.29E+040.00E+00l Child: 3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00 Infant: 1.58E+02 2.24E+02 0.00E+00 8.03E+02 1.58E+02 0.00E+00 3.17E+04 0.00E+00 l

l I

- . . ~ - . . . . . .. . . - -- _ - . . .- --

ODCM Rsv. 12 Paga 125 4/94

. Table 2-2.(Continued)

"' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoSB .

For Pathway: Plume

. T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For-Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .

4 Adult: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 [

Taan: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Child: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 l'.16E+07 Infant: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07

! For Pathway: Vegetable 4 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .

i Adult - 1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .

Taan 2.72E+06 1.63E+07 b.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Child: 5.43E+06 1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1

For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I -Adult: 7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

1 Child: 8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

[ ' Adult: 2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .i Child: 7.96E+04 1.52E+05 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

! Adult: 6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00 F

Tecn: 8.80E+01 3.02E+03 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child: 1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00

! Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00 w

ODCM R3v. 12 Paga'126 4/94

Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE Fe59 ,

For Pathway: Plume .

l T. BODY GI-TRACT ~ BONE LIVER KIDNEY THYROID LUNG SKIN i

= Adult:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.Tcan:. 0.00E+00 0.00E+00 0.00E+00 0.00E+00~0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I LInfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 >

For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Sr.IN

Adult: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 ,

Tasn: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06.9.80E+06 !

^

Child: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Infant: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06

, For Pathway: Vegetable d

. T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG ' SKIN Adult: 2.80E+06 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 Tasn: 4.28E+06 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child: 8.69E+06 1.32E+07 1.08E+07 1.75E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+00 ,

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Meat 1 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG . SKIN >

Adult: 4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 Toen: 3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 child: 5.43E+06 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN :

Adult: 4.79E+05 4.17E+06 5.32E+05 1.25E+06 0.00E+00'O.00E+00 3.49E+05 0.00E+00 Teen: 8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child: 1.74E+06 3.63E+06 2.15E+06 3.48E+06 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infant: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00' 4

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. LUNG SKIN Adult: 6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00' Tosn: 1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 Child: 2.25E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 I Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 <

For Pathway: Inhalation ,

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 Tcon: 4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 child: . 29E+02 2.24E+03 6.56E+02 1.06E+03 0.00E+00 0.00E+00 4.02E+04 0.00E+00 Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00

. . . - . . - . . - - - . . . _ . . . ~ . . . - -

q Y 1:

.ODCM Rsv. 12 J Pega 127 ;

4/94' Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Co60 l

, For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN. ,

Adult: 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Taan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i ' Child: 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Tecn: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Child: 7.09E+08 7.09E+08 7.09E+08-7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 LInfant: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Taon: 1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 {

f

.For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. LUNG SKIN Adult: 3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Tasn: 2.46E+06 1.42E+07 0.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 >

l .For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ,

Adult: 6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Tecn: 1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1

. Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn:

Child: 1.41E+055.37E+05 2.86E+05 8.14E+05 0.00E+00 0.00E+00 9.70E+04 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 4.68E+05 4.31E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

J H

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.69E+02 9.03E+03 0.00E+00 3.65E+02.0.00E+00 0.00E+00 1.89E+05 0.00E+00 l '

Tesn: 6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 child: 7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00.;

Infant: 3.73E+02 1.01E+03 0.00E+00 2.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00

)

l i

ODCM Rev. 12 Pagm 128 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zn65 FOr Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 T2On: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Infcnt: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00 TcCn: 2.43E+07 2.25E+07 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 Child: 4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E+00 0.00E+00 0.00E+00 )

TCOn: 8.54E+06 7.75E+06 5.27E+06 1.33E+07 1.17E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk ;

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 4.15E+075.79E+072.89E+079.20E+076.15E+070.00E+000.00E+000.00E+00(

TO:n: 7.19E+07 6. 63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 l Child: 1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00' Infant: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00.

For Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00, TsOn: 8.63E+06 7.83E+06 5.33E+06 1.85E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00' Child: 1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 2.22E+07 4.07E+07 1.40E+07 4.81E+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 T;cn: 1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00' Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00

. , . ~ - . . - - - . -

l ODCM Rsv.~12

'Paga 129 ,

.4/94 )I e 2-2 '(Continued)'

' INDIVIDUAL DOSE FACTORS FOR ja,,20US EFFLUENTS -- FOR ISOTOPE: Kr83m 1

- For Pathway: Plume T. BODY' GI-TRACT BONE LIVER KIDNEY THYROID RLUNG SKIN '

Adult: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Tson: -1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9~39E-02 4.75E-01

' Child: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.6SE-03 1.68E-03 9.39E-02 4.75E-01 Infant: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 For Pathway: Ground

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1' -Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Tann: . =0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Vegetable >

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00_

l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN li Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

, Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tean: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .

l %

~.. . . - - . . - - - . - - . - . - . . - .- . .

'ODCM Rzv. 12~

Paga 130 4/94 Table 2-2 (Continued) -

' INDIVIDUAL' DOSE' FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr85

, For: Pathway: Plume T. BODY GI-TRACT . BONE LIVER KIDNEY THYROID LUNG SKIN _ >

' Adult: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01.4.29E+01

. Tcen: 3.57E-01'3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01

Child: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 tInfant: 3.57E-01.3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-0114.29E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN.

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00~0.00E+00

' Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Vegetable .

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j -Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN- '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

- For Pathway: Cow Milk !

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2

Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+C. 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation ;

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ;

4 Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I

I

-m w- -w-- - m -- _ _ ,_ . _ _ , , , , , _ _ . _ . _ _ _ , , _

__ . _ m . - ._ , _. . . . ._ _. . . - . . _ _ _ _ _ . _

ODCM Rsv. 12-Page 131

'4/94 Table'2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE

Kr85m

~For Pathway: Plume-T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG. SKIN

, Adults. 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01'7.66E+01

,Tesn:' 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2'.60E+01 2.60E+01 2.66E+01 7.66E+01 Child:' 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01.,

1- . Infant: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY' THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For. Pathway: Meat l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .

.Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Infant: 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tean: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY' THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00:

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+GO 0.00E+00 0.00E+00

! Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 9

n a

~ - , -

i ODCH Rcv. '12. 1 Paga 132 4/94 i

Table 2-2 (Continued) )

l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr87' l l

For Pathway: Plume T. BODY GI-TRACT ' BONE LIVER KIDNEY THYROID HLUNG SKIN

-Adult: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02.1.35E+02 4.60E+02 Tain: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 l Child: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Infant: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 )

JFor. Pathway: Ground - .

SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00LO.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat .

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG. _ SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i 4

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.~00E+00 0.00E+00 L Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID . LUNG SKIN Adult: 0.00E+00 0.00E+00 0400E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

}

ODCM Rsv. 12 ._

-Paga 133 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr88 For. Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID = LUNG SKIN

. Adult:: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02.3.27E+02 4.50E+02

.Tosn: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02

Child: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02

-Infant: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02

For Pathway: Ground T. BODY GI-TRACT- BONE LIVER KIDNEY THYROID LUNG SKlN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 r Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00.0.00E+00 J Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

'Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN. .

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

ODCM-Rsv. 12-Paga 134 4/94 Table 2-2-(Continued)

. INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS'-- FOR ISOTOPE! Kr89 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I

-Adult: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3 68E+02 3.68E+02 3.72E+02 7.46E+02 .

.Tssn:' 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02.3.72E+02 7.46E+02 Child:- 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 1 Infant: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 l 1

.For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN.

= Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 00E+00 0.00E+00 0.00E+00 For Pathway: Vagetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.COE+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tasnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

1 For. Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00~0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0. DOE +00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.For Pathway: Inhalation

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Taan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 L

l

. . .- - .~ - , . -. . _. . . . . -

ODCM Rsv. 12 Paga 135

, 4/94 l Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr89

_ For' Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult:~ .0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

.TOsn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: . 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Z+00'O.00E+00 0.00E+00 0.00E+00 LFor Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Tasn: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Child: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02

-Infcnt: 6.62E+02 6.62E+02 6.62E+02 6.62E+02.6.62E+02 6.62E+02 6.62E+02 7.68E+02 For Pathway: Vegetable 4- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.42E+06 4.14E+07 2.58E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Tcan: 1.20E+07 5.00E+07 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 2.91E+07 3.95E+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Tacn: 1.42E+05 5.90E+05 4.95E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

! For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG . SKIN

Adu?.t: 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecu: ;

Child: 3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 :

Infant: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT. BONE LIVER KIDNEY THYROID LUNG SKIN

- Adult: 1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

, Tesn: 3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 :

Child: 7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Infant: 1.47E+07 1.06E+07 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Inhalation i

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 Tecn: 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00

" Child:- 5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00 ;

1

- , - ~ . , ,. _ _ _ _ ~

ODCM Rsv. 12 Pag 3 136 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr90 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 T :n: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Child: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Infcnt: 3.46E+02 3.46E+02 3.46E+02 S.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tann: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

. ~ . . - - _ . - . ___ _

ODCM Rev. 12' Paga 137 4/94 l

i Table 2-2 (Continued)

^

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr90 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN !

4 Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn:

' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: ~0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.09E+10 1.54E+09 1.22E+10 0.00M+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

, Adult: 4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

4 For Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 3.51E+09 4.14E+08 1.43E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

Toen: 5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j i

For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN !

I Adult: 1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

ODCM Rsv.~12. H Pago 138 i 4/94 I Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: 2r95

~ For' Pathway: Plume T. BODY GI-TRACT BONE- LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Tacnt- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

-Child 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 i

> Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

(

For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN r i Adult: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Tasn:. 7.48E+06 7.48E+06.7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 1 Child: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 InfEnt: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 5 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00 Tosn: 1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00-Child: 2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN-Adult: 7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00'O.00E+00 0.00E+00-Tcan: 5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00 Child: 9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 Child:

Infant: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 7.66E-01 2.57E+03 3.53E+00 1.11E+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00 Child: 1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 2.52E+00 1.77E+03 1.46E+01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00 Toen: 9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child: 1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.89E+03 0.00E+00 7.07E+04 0.00E+00 Infant: 6.44E+02 6.88E+02 3.66E+03 8.83E-02 9.85E+03 0.00E+00 5.55E+04 0.00E+00

. , , . . . - . -- - -~ -. - . - , - --

ODCM Rev.'12 Pags 139 4/94 i F

e ' Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR' GASEOUS EFFLUENTS -- FOR ISOTOPE: Sb124

~

I For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY -THYROID LUNG SKIN

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00

- - Taan s ' O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

'- Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground L T.LODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 7 '

i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-For Pathway: Vegetable I T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 LTecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

'For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult: - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+LO 0.00E+00 0.00E+00.0.00E+00 '

L Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . *SE+00 0.00E+00 0.00E+00 I Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+CS <+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.; +00 0.00E+00 0.00E+00 For Pathway: Cow Milk

, T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ,

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY ' THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Toan Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

t

l ODCM Rov. 12 i Pcg3 140 4/94 l l

Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: I131 ,

1 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 i Tecn: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 l '

Child: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Infcnt: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.43E+05 2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 Tecn: 4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 child: 5.83E+05 9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39E+08 0.00E+00 0.00E+00 '

Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00 ,

Tcon: 6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Child: 9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk )

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00 l Tccn: 3.98E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 ;

Child: 7. 34E+06 1.15E+06 1. 28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0. 00E+00 l Infant: 1.39E+07 1.13E+06 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.00E+00 '

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00 Tce.1: 4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 Child: 8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00, Infant: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00 TOcn: 8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 Child: 8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00

~ ODCM Rev. 12 Paga 141 4/94 Table 2-2 (Continued)

-INDIVIDUAL' DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe131m For Pathway: Plume T. BODY. GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Tecn: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Child: 2.03E+00 2.03E+00 2.03E+00 2.03E+00-2.03E+00 2.03E+00 2.38E+C0 1.89E+01 Infant: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 l'.89E+01 ,

t

-For Pathway: Ground _

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

_Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00Et00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

! For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l- Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00:

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG . SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat M!lk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.:00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

[

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N

ODCM Rov. 12

.Paga 142

< 4/94 x

Table 2-2 (Continued).

JINDIVIDUAL' DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE I133' ForfPathway: Plume

.T. BODY GI-TRACT BOF2 LIVER KIDNEY THYROID LUNG SKIN

-Adult: 0.00E+00 0.00E+00 0.0SE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 E : Child:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

" Adult:- 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Taan: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infant: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00-Tocn: 6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00 child: 1.06E+04 1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN >

Adult: 2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00 0.00E+00 ,

Tecn: 1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00'O.00E+00 Child: 2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0~00E+00 .

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.07E+04 6.12E+04 3.91E+04 6.81E+04 1.19E+05 1.00E+07 0.00E+00 0.00E+00 Tacn: 3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child: 8.12E+04 8.65E+04 1.74E+05 2.15E+05 3.58E+05 3.99E+07 0.00E+00 0.00E+00 Infant: 1.56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway: Goat Milk ,

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 Tecn: 4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 '

Child: 9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00 Infant: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 Toon: 1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E+00 0.00E+00 Child: 2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 Infant: 1.78E+02 6.83E+01 4.20E+02 6.08E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00 I

d

.s ,,. ,, , . - ~ -

ODCM RDv. 12 Paga 143 4/94 Table 2-2 (Continued)

Xe133 i JNDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: l For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN !

Adult: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 l Tc;n: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 l Child: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infant: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00*

Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

~.- _ . . . . .

hv -

ODCM Rsv. 12 Paga 144 ,

z 4/94 ,

f -Table 2-2 (Continued) I I'NDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS ---FOR ISOTOPE: Xe133m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID - LUNG- SKIN LAdult: ' 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 1Taen: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00.6.03E+00 3.96E+01

-Child: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 '

Infant: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00~ 5.57E+00 6.03E+00 3.96E+01 ,

ForfPathway: Ground .

4 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID . LUNG SKIN-

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Infant: 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00',

For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN. ..

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Infant: . 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat .

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

.Adulti- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

j Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j j l For Pathway: Cow Milk i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. LUNG SKIN- H Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I

! Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk .

T. BODY GI-TRACT BONE LIVER KIDNEY . THYROID LUNG SKIN

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 3 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

i i

ODCM Rsv.'12 Paga 145 i 4/94 !

Table 2-2 (Continued)

-INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs134 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childs' O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4

L :For Pathway: Ground 2

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08

< ' Tocn : - 2.11E+08 2.11E+08 2.11E+08 2.11E+08.2.11E+08 2.11E+08 2.11E+08 2.46E+08.

i- . Child: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 ,

Infant: 2.11E+08 2.11E+08 2.11E+08 2.11E+08-2.11E+08 2.11E+08 2.11E+08 2.46E+08 .

For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07~0.00E+00 Tacn: 2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 ,

Child: 1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00

- Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00

, For Pathway: Meat 4 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.38E+07 5.10E+05 1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00 <

1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 Taan:

Child: 5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk .,

T. BODY GI-TRACT BONE LIVER KIDNEY' THYROID LUNG. SKIN ,

f t Adult: 2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00

Tecn: 2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5.22E+07 0.00E+00 Child: 1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 Infant: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 4

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 i Toon: 5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child: 4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00

' Infant: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00 .

.For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 i Tson: 1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00 Child: 7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 '

Infcnt: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00 4

+

rr s- - -

-,w-e-+ --

r -- m---. . - - .

~ . . . - ---. - - . - - - -

ODCM Rsv.? l2 Paga 146' ]

~

4/94- '

i Table +2-2 (Continued) l INDIVYDUAL DOSE FACTORS FOR GAnEQUS EFFLUENTS -- FOR ISOTOPE: Xe135m For Pathway Plume T. BODY :GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ~

Adult:: 6.92Ef01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Tasn:- 6.92Et01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02

' Child:- 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01-6.95E+01'1.05E+02

, Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01.6.92E+01 6.92E+01 6.95E+01 1.05E+02

-For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN >

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t

Adult:

Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0'O 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN:

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

-For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <

Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk )

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN-Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

ODCM Rav. 12

+

Paga:147 ;

4/94 J s

-Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135

-For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG- SKIN i .

~ Adult: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 '

. Tesn : - 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Child 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Infant: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 For Pathway:' Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID. LUNG SKIN.

1 Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk

. T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

" 'For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 a

ODCM Ruv. 12 Pcga 148 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs136 For Pathway: Plume ;

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tc;n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt- 0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

For Pathway: Ground l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 l Tc;n: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 j Child: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 i Infcnt: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 0.00E+00 l Tocn: 2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 '

Child: 2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 1 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05E+05 0.00E+00 6.92E+04 0.00E+00 l Toen: 4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84E+05 0.00E+00 6.05E+04 0.00E+00 Child: 5.50E+05 2.99E+04 3.09E+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Cow Milk f T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ]

Adult: 1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 j Tocn: 2.26E+07 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 l Child: 3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 !

Infcnt: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 l Tctn: 6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 i Child: 1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.00E+00 Infcnt: 1. 24E+08 5.D 6E+06 1.13E+08 3. 3 3E+08 1. 33E+08 0. 00E+00 2. 71E+07 0. 00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUN SKIN Adult: 3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E 0.00E+00 Tcen: 4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63 0.00E+00 1 Child: 3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61 2 0.00E+00 Infnnt: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.7 2 0.00E+00

ODCM R2v. 12 Pcgs 149 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs137 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Tann: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Child: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Infcnt: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 TOcn: 1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 Child: 1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00E+00 2.80E+06 0.00E+00 TcGn: 6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 Child: 3.92E+06 1.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Tacn: 1.29E+08 5.27E+06 2.78E+08 3.70E+08 1.26E+08 0.00E+00 4.90E+07 0.00E+00 Child: 9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00 Infont: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 Tacn: 3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00 Child: 2.84E+08 1.21E+07 2.01E+09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 Infant: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 For Pathwa : Inhalation BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 TOOn: 7E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00

! Child: E+03 1.15E+02 2.87E+04 2.62E+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00

\ Y

- ODCM Rsv.-12 Paga 150 4/94 Table 2-2 (Continued)

- IMDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe137 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:. 3.15E+01-3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 TOOn: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Child: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02'

' Infant: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID- LUNG SKIN.

iAdult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00-

- Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY- THYROID LUNG- SKIN Adult: ~ 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

- Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Ch! d: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 u Intent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Goat Milk I T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN !

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0,00E+00 0.00E+00 0.00E+00 0.00E+00 !

Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00~

~ For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 L

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 f

4

% l

ODCM Rav.~12 Paga 151 4/94

' Table 2-2 (Continued)

. INDIVIDUAL DOSE FACTORS FOR GASEOUS' EFFLUENTS -- FOR' ISOTOPE: Xe138 L For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN _

' Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02. , 4 Tscn: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02.1.98E+02.3.58E+02 i Child:- 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02

. Infant:'1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02

'For Pathway: Ground 1 I

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )

For Pathway: Meat -l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk ,

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Adult:

Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00.

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00' Adult:

Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

ODCM Rsv. 12 Paga 152 4/94 Table 2-2 (Continued)

INDIVIDUAL-DOSE FACTORS FOR GASEOUS EFFLUENTS ~-- FOR-ISOTOPE: Baldo For Pathway: Plume i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tazn: - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 Adult: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 !

Tacn: 6.27E+05.6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05_l

Child: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 j Infant: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05

< For Pathway: Vegetable 1 T. BODY GI-TRACT BONE- LIVER KIDNEY THYROID LUNG SKIN

Adult: 1.36E+05 4.29E+06'2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 Tesn: 1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00 Child: 3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat u T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tacn: 2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.00E+00 3.75E+02 0.00E+00

Child: 4.90E+04 4.25E+05 8.40E+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

! Adult: 3.37E+04 1.06E+06 5.15E+05 6.47E+02 2.20E+02'O.00E+00 3.70E+02 0.00E+00 Tasn: 5.99E+04 1.43E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 Child: 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 I Infant: 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 For Pathway: Goat Milk !

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00

Tasn: 7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child: 1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Infant: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+02 0'00E+00 .

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

- Adult: 8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 Tecn: 1.12E+02 7.25E+03 1.73E+03 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 Child: 1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infant: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00 1

_-=.-m_

ODCM Rnv. 12 Paga 153 4/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce141 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDFET THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcnn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Tann: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Child: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Infcnt: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 Tcan: 5.57E+02 1.39E+07 7.26E+03 4.85E+03 2.28E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.29E+02 1.08E+07 1.74E+04 8.67E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 Tenn: 1.63E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 Tosn: 1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 5.62E+01 2.47E+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 1.48E+00 3.68E+04 1.C3E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00 child: 3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SK V Adult: 4.84E+01 3.80E+03 6.31E+02 4.29E+02 1.99E+02 0.00E+00 2.46E+05 0.0Ge+00 Tenn: 6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: 9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00 Infcnt: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00 N

ODCM Rsv. 12 Paga 154 1 4/94 1

Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS'FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce144 l

.For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

Tczn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Infcnt 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j For Pathwe;, Ground l T. BODY GI-TRACT BONE LIVER KIDNEY . THYROID LUNG SKIN l Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06~2.12E+06 2.45E+06 Tocn: 2.12E+062.12E+062.12E+062.12E+062.12E+062.12E+062.12 Child: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+06.2.12E+06 2.12E+06 2.12E+06 2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID' LUNG SKIN l Adult: 4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00 !

Tsen: 7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 !

Child: 1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN "

Adult: 1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00 Tsen: 1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 child: 2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Tacn: 6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00.0.00E+00 0.00E+00 Infant: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ,

Adult: 4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00 Tson: 7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02=0.00E+00 0.00E+00 0.00E+00 Child: 1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00-Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+02 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E+04 0.00E+00 2.46E+05 0.00E+00 Tosn: 8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4.24E+05 0.00E+00_;

Child: 1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00-Infant: 5.59E+03 4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00

~ , .. - . . . . - .- -- - - - . . . .

s ODCM Rsv. 12 Pagn 155 14/94 TABLE 2-3 ,

, Assumptions Used in Limerick Gaseous Effluent Dose ~ Evaluation

'Index Description Value l

.\

f 1- Fraction of produce from local garden 0.76. 1 2 ; Fraction of leafy vegetable from local garden 1.00.

3 Soil density in plow layer-(kg/m**2) 240.0 ;

4 . Fraction of deposited particulates retained on vegetation 0.20 L5 Fraction of deposited, iodines retained on vegetation 1.0

6. Shielding factor of residential structures. 0.7 i 7 Period of buildup of activity in soil (hr) 175200.~01 ;

8. Period-of pasture grass exposure to-activity (hr) 720.0 9 Period of crop exposure to activity (hr) 1440.0 10- Transport time milkman (hr) .

48.0 11 ' Delay time.for ingestion of grass in( animals (hr) 0.0. -

l- ~12. Delay time for ingestion of stored feed by animals (hr) 2160.0 l 13 Delay time for ingestion of: leafy vegetable by man (hr) 24.0

~14 . Delay time for ingestion of other vegetable by man (hr) 1440.0 L 15 Time between slaughter and consumption of meat animal (hr) 480.0

16 Grass yield, wet.wt (kg/m**2) .

0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 i e 18 Weathering rate constant for activity on veg (1./hr) .0.0021 '

i 19 Milk cow feed consumption rate (kg/ day wet) .50.0 20 Beef cattle consumption rate (kg/ day wet) 50.0 ,

21 Goat feed consumption rate.(kg/ day wet) 6.0

' 22 - Plume exposure adult (hr/yr) . 8760.0 23 Plume exposure teen (hr/yr) 8760.0 24- Plume exposure child (hr/ r) 8760.0 25 Plume exposure infant (hr yr) 8760.0

.26 Ground exposure adult (hr yr) 8760.0 27 Ground exposure teen (hr/yr) 8760.0 28 Groundexposure exposureinfant r) child (hr/y/yr) 8760.0

29. Ground (hr 8760.0 30 Inhalation exposure adult (m**3/ 8000.0 -

31 Inhalation exposure teen (m**3/ r) yr) 8000.0 .

32' Inhalation exposure child (m**3 r) 3700.0 '

33 Inhalation exposure infant (m**3 1400.0 34 Leafy veg exposure adult (kg/yr) yr) 64.0 35 Leafy veg exposure teen (kg/yr) 42.0 36 Leafy veg--expbsure child (kg/yr) 26.0 37 Leafy veg exposure infant (kg/yr) 0.0 38 Non-leafy veg exposure adult (kg/yr) 520.0

.39 Non-leafy veg exposure teen (kg/yr) 630.0 40 Non-leafy veg exposure child (kg/yr) 520.0 41 Non-leafy veg exposure infant (kg/yr) 10 . 0

-42 Root veg consumption rate adult (kg/yr) 0.0

,43 Root veg consumption rate teen (kg/yr) 0.0 44 Root.veg consumption rate child (kg/yr) 0.0

J <

'ODCM'Rsv. 12. >

Paga'156

4/94 ,

TABLE 2-3 (Continued)

Assumptions Used-in Limerick Gaseous Effluent Dose Evaluation Ind2x: Description value 45 Root ~veg consumption rate infant'(kg/yr) 0.0

~46- Cow milk consumption rate adult (1/yr) 310.0.

47 Cow milk consumption rate teen (1/yr) 400.0 48 Cow milk _ consumption rate child (1/ r) 330.0 49 Cow milk consumption rate infant (1 yr) 330.0 50- . Goat' milk consumption rate adult (1 yr) 310.0

-51 Goat milk consumption rate teen.(1/yr) .400.0

'52' : Goat milk consumption rate child (hr/yr) 330.0-53 Goat milk consumption rate infant (hr/yr) 330.0 54 Meat consumption rate adult (hr/yr) 110.0 55- Meat consumption rate teen (hr/ 65.0 56 Meat consumption rate child (hr/yr) yr) 41.0

57. Meat consumption rate infant (hr/yr) 0.0 58 Fraction of year animals on pasture .0.75 59' Fraction of feed from pasture when on pasture 0.88' .

60 Fraction of year leafy veg grown 0.42 61 Atmosphere hydrogen concentration (gm/m**3) 8.0

)

1 1

)

_ _ _ _ . _ _ _ _ _ _ . _ _ _ ____\ _ _ _ _ _ _ _ _ _ _ _ _ . . _ _ _ _ _ _ _ _ . _

-i X ODCM RLv.112 . 1 Pega 157 cl 4 4/94' (

TABLE 2-4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)

Plume Ground Inhalation vegetation- Meat Cois Goat-Pathway

,DirQction

- Pathways Pathway Pathway. iPathway~-

' ' N. 805 2414 3414 7562 0 .

-NNE 805 1609 1585 0.- 0 NE 965 ~3218 1097 '4183 0 ENE 965' 2414 3871 0 .

0

- E' 805 1770 1890 6758 0 ESE- 965 805 4511 -1770 1770'

SE 1609 3862 7241- 7241' 'O SSE 1609 1609 7224 7241 .

0:

S 1287 1931- 3018 37011 5654 SSW- 1609 1609 1433 2896. 0-

-SW- .

965 1287 -2835 4827. 0'

'WSW 1287 1287 2134 2255- 0

.W 965 2574 4084 0 0 WNW 1126 1440 0 0 0:

I

~NW 1126 2574 6660 O _. 7401

.NNW: 1448 1931 6325 0 0' I

4

.j 4

e c~.- - _. .--.

, n -- , , , ,

ODCM Rev. 12 Page 158 4/94 APPENDIX A 1

a

A

" ODCM R v. 12 P;.ga 159 4/94 TABLE A-1

. Technical Specification /ODCM Matrix ODCM ODCM Tschnical Section I. Equation Soecification* Requirement 'Section II 3.3.7.11 3.2.1 1-1 1-2

'l-3 '

1-4 3.3.7.12 3.3.1 2-1 (or 2-9) 2-2 (or-'2-9) 2-4.(or 2-10); ,

2-5 (or 2-10) 3.11.1.1 3.2.2 1-1 1-2

' 1 1-4 3.11.1.2 3.2.3 1-5 1-6 1-7 3.11.1.3 3.2.4 1-8 1-9

. 3.11.2.1 3.3.2 22 E-23 3.11.2.3 3.3.4 2-26 2-27 2-28 3.11.2.2 3.3.3 2-24 2-25 3.11.2.4 3.3.5 2-33 3.11.2.7 3.3.6 2-4 2-5 I e

Transferred to ODCM via T.S. amendment # 48:for Unit 1 and 11 for. Unit 2.

3

ODCM Rtv. 12 Paga 160 4/94..

' TABLE ~A-1 Technical-Specification /ODCM Matrix ODCM ODCM TCchnical Section I Equation

- Specification

Requirement Section II

- 6.9.1.8 3.6 1-5 1-6 1-7

'2-24 2-25 2-26 2-27 2-28 3.11.4 3.3.7 3 3.12.1 3.4.1 Section II App. B 6.9.1.7 3.5 1-5 3.12.3 3.4.3 1-6 1-7 2-29 2-30 2-31 2-32 3-2 l

I l

-l CTransferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.

ODCM R';v.'12 _

~

161-

9. .:.

Paga'4jg4 i

APPENDIX B RADIOLOGICAL ENVIRONMENTAL-MONITORING PROGRAM -

SAMPLE TYPE, LOCATION, AND ANALYSIS l-

.l

.- . . , s . - ,

ODCM R1v.'c12 S O-

- Page 162._ -;-

5 4/94-P' age .'1' of J 4 -

TABLE.B-1 DCM - Limerick Generating Station-f Radiological Environmental Monitoring _ Program .

Station Code Location Collection Method Analyses.

Pathway I. Direct 36S2 0.6 miles N of site 1 set of four (4) TLDs -Gemma dose 2E1 5.1 miles NNE of site- from each location'at quarterlyj 3S1 0.6 miles NNE of site least quarterly 4El' 4.6 miles NNE of site SS1 0.4 miles NE of site SH1 C 25.8 miles NE of site i 6C1 2.1 miles ENE of' site -

7S1 0.5 miles ENE of site 4

7El 4.2 miles ENE of site 9C1 2.2 miles E of site 10S3 0.5 miles E of site 10E1 3.9 miles E of site jd 10F3 5.5 miles ESE:of site 11S1 0.5 miles ESE of site ,

13C1 2.9 miles SE of site 13E1 '4.3 miles SE'of site 14S1 0.6 miles SE offsite 15D1 3.2 miles SE1of' site 16S2 0.6 miles SSE of site ,

17B11 .1.6 miles.S of site -

4 18G1 C '12.9 miles S of' site 18S1 0.3 miles S of site' 19D1 3.6 miles S of'aite 2CD1 3.1 miles.SSW of site 20F1 5.2 miles'SSW of site 21S1- 0.5 miles-SSW of site 23S2 0.5 miles'WSW of site C = Control Stations

. . _ . _ __m .-_um_____.____ . _ _ . _ . . ._._.s_-. -.m___..._m_s_._m._ _ _ _ _ . _ _ .m m_.m._. _m __ .m_ _ __ _ _ _ _.._______m.____m._.__m_._-...___m'_.__.-___-_____ -

um -_ ' _ _

w ODCM R v. 12 Pag 3 163 4/94 Page 2 of 4 TABLE B-1 Pathway Station Code Location Collection Method Analyses I. Direct 24D1 3.9 miles SW of site Collected quarterly Gamma dose (cont.) 25S1 0.5 miles SW of site guarterly ,

25D1 4.0 miles WSW of site 26S3 0.4 miles W of site 28D2 3.8 miles W of site 29S1 0.5 miles WNW of site 29El 4.9 miles WNW of site 31D1 3.0 miles NW of site 31D2 3.9 miles NE of site 32S1 0.6 miles NW of site 34S2 0.6 miles NNW of site 34E1 4.6 miles NNW of site 35F1 4.2 miles N of site II. Airborne 10S3 0.5 miles E of site Approximately 1 cfm Gross beta analysis Particulates 11S1 0.5 miles ESE of site continuous flow through on each weekly sample.

14S1 0.6 miles SE of site glass fiber filter which Gamma spectrometry 13C1 2.9 miles SE of site is collected weekly. shall be done when l 22G1 C 17.6 miles SW of site gross beta exceeds ten times the yearly mean of control station value.

ODCM R;v. 12 Prg3 164 .l 4/94 Page 3 of 4 TABLE B-1 Pathway Station Code Location Collection Method Analyses II. Airborne (cont.)

Particulates (cont.) Gross beta analysis done 224 hr after sampling to allow for Radon and Thoron daughter decay.

Gamma isotopic analysis on monthly composite.

Iodine 10S3 0.5 miles E of site A TEDA impregnated flow- Iodine 131 11S1 0.5 miles ESE of site through cartridge is con-14S1 0.6 miles SE of site nected to air sampler and 13Cl 2.9 miles SE of site is collected weekly at l 22G1 C 17.6 miles SW of site filter change.

III. Water 24S1 C 0.3 miles SSW of site Sample collected from a Gamma isotopic continuous water sampler, analysis monthly; Surface 13B1 1.8 miles ESE of site monthly. In event sampler H-3 on quarterly is inoperable, weekly grab composite.

samples will be collected until sampler returned to service.

Sediment 16C4 Vincent Dam, down- A sediment sample is taken Gamma isotopic stream of discharge semi-annually. analysis.

r ODCM Rcv. 12 P ge 165 4/94 Page 4 of 4:

TABLE B-1 Pathway Station Code Location Collection Method Analyses IV. Ingestion Milk 22F1 C 9.8 miles SW of site Sample of fresh milk is Gamma isotopic and-1081 1.1 miles ESE of site collected from each farm I-131 analyses on each 25B1 1.3 miles WSW of site biweekly when cows are on sample.

21B1 1.8 miles SSW of site pasture (April through October), monthly at other times.

Drinking

15F7 5.2 miles SSE of site Sample collected from a Gross ~ beta and gamma 28F3 C 5.9 miles WNW of site continuous water sampler- isotopic monthly, 7-15F4 7.8 miles SE of site monthly. In event sampler H-3 on quarterly 16C2 2.4 miles SSE of site in inoperable, weekly grab composite.

samples will be collected until sampler returned to service.

Fish Gamma isotopic 16CS 1.9 miles SSE of site Two species of recrea- analyses on edible 29C1 C 3.2 miles-WNW of site tionally important fish portions.

(Predator and bottom feeder) sampled in season or semiannually if not seasonal.

Food .

. Gamma-isotopic and Products Two offsite locations of highest Samples of three (3) dif- analysis. -

predicted annual average ground ferent kinds of broad leaf i

level D/Q and one location vegetation monthly when -

l (15-30 km distance) in the least available if milk sampling i prevalent wind direction as deter- is not performed I mined using the results of the most recent annual Landuse Survey.'

1

q r.

T J

l r

e.

1 V

f. -

i.

k i

b-FIGURES t

l; F ,

1

- --A - - _ _ _ . _ _ _ _ _ _ _ _ _ , _ , , _,, ,,, _

- ;7 UNIT 2 Reactor Encl. .

/ East Exhaust Stack El 416' -

7000 cfm Particulate / lodine Radiation Monitor Ak '

y 23854 q;) ,

Clean up area

+

Mk Jk l ir , 7 Mc )'

^ 8""

sa

{~M7

( Decon tItra- Dag Filter f \ Shower sonic '

Bag Filter cleaner k Grinder lf 1P Bag Filter Grinder A JL JL JL JL JL JL Glove Vacuum Box- Blast Ultrasonic Pump Repair Ultrasonic Valve Repair Ultrasonic Lathe Lathe .

Cleaner Cleaner Area Cleaner Area Philadelphia Electric Comp.

Umerick Generating Station General Repair Area Units 1 & 2 Gassous Eftfuent Flow Diagrain llot Maintenance Shop _,_

7 EXHAUSR FAN

[ FILTER ODCM, Rev.12 Page 166 4/94

j' l l -

i o 274

, r t

u s 169

_ o o t

n o e .n 1/

l F lc n t n m pio v 4 g E ert mta ee Rg l

n i st r

ot s ma' p p" CS ot 2

t n a

_ e ua u t c u im" u cg& emk ,P -

r n luac M a a i

f eh q

f r a eh E t it c a EaSf gt C RxE R x E l er Eni t

e s sD h t

i D O

en u t

a O owu

. iG h eoo aF S l

lpk

. ei c G dt 3, l a en r

ihU g

b P y *

)

, d s2 g

, na( )

gy aGr o (

2

, eet ,

,nl i A

,, ib n

, d o o 4 \,

ploNM .

) I 3 I

, ( I t s 0

{) n u V

e o

u -400.M x. 4 F a 4000,MF n. i 4 h2 1 n 1 it 4

3 CM 4CM t 5 uit 4no 2 on -

S .UEl.C t s n u e o 0 V u 0 0 h1 1 '1 n 0, Fa M x. 0 M n. _.

t it 0.F i

)%

ut4n oi n o 4 3 CM 4CM 5

SUl.C E 2

) > k

) ) )

3 s 2

( t (

l [ i' t

'dna(s )2 la aGr u [ [

eet o

)

c nl 2

(

it ib in rd oo a

PloNM h e

)

2

(

g e

r u

r s o o o lc t l

F n n E e g t m

n i t r

ots nt e r le ua u s t cu aa mas ip pu t

u ma f '

eh eh R xE Rx o h E

EqCE x

> l' lll jjl {l l j lj(l! -

+ -- -

i North Vent Oss Monhos -

unne t a m N Wide ,

Elew. 4:l' 7 d Mid a H!gh

/\ Partieuiate Range MNd.

andsod'"*

to. Rang. y. Monitor Particulate, lodine a continuo e b Fitter Noble Gas Normal N Range Mordtore / Sample Oes Monito' Pump

+ y (3) Turbine Enclosure Enhaust

[h 684.000 CFM Turbine Enclosure

' Y l

Turbine Enclosure Exhaust I3I d (2) (2) Equip. Compart Enhaust l

, Mecharical Vac. Pump I Turbine Enclosure Equip. Compart Embaue III (23 + '

(2) Battery Roon Exhaust Mech. Vac. Pump Steam Packing Exhauster l

Steam Pack. Enhavetor '

A Redweste Encl. Enhaust D/W Purge Radwaste Encl. Equip.

l (2) Y Compartment Enhauster Stendby Gee Treat. Sys. f UI- Gaseous Radweste Tremtment j sois ,

4 Urdt I condenser offgas (2) $

4 3 y ** Unit 2 Condenser Offges Fume Hood Exhaust Control Area Exhaust g a 4 Philadelphia Electric Comp.

7 (2) Limerick Generating Station (2) Units 1 & 2 Gaseous Effluents Flow Diagram North Stack ODCM, Rev.12 unit t Charcoor sysi.m Page 168 g Exhaust Fan V/g

/ Filter " unit a chareoni s r. tem 4/94

~

. ~ . _ _

-

o'o 4 L.D. TANK -

Laundry G FE RE-i G

Drain (LD) L.D.

.D Subsystem _) b SAMPLE -

>^

TANK To Cooting Tower

-> L.D. TANK l t) Bt wd wn Line 10 GPM (Nom.) -

(Release Point) 2 FD From Chem. -

Waste Tank SAMPLE l,d

' TANK #1 FD __g FD FD FD pgoo, _g _ ,

Drain (FD)

LL ECTIoM 1 g FILTER > DEMIN SAMPl.E l g TANK FDCT) TANK #2 >

Subsystem ^ n

To Condonsnia FD _ _p to Waste to Wasta 200 GPM Storage lunk

_) SURGE -- -- Studge Tank Studge lank (Nom)

-TANK ,,

ED .

'F

-> SAMPLE l d

,r TANK A

'V

, /

ED j_ _ g ED ED Equipment coittcison g FILTER DEMIN

~ ~ ~

Drein (ED) -TANK Subsystem ,r ED

_) SAMPLE -

_, surge ---

>' * * * ' ' " ' ***'* "8

-Studge Tank Studge Tank TANK f

To FDCT Philadelpida Elect:Ic Comp.

FE-63-053 Limerick Generating Station Chem Waste " RISH 83-Ot 2 OK604 Units 1 & 2 n .

(CW)

Subsystem TANK. I v

\] Liquid Effluent -

Flow Diagram -

ODCM, Rev.12

-Page 169 4/94

~

,7 ODCM R:;v.12 Paga 170-FIGURE B-1 4/94 ENVIRONMENTAL SAMPLING LOCATIONS ON-SITE OR NEAR i THE. LIMERICK GENERATING STATION 1-N NNVV NNE f

I j

NW/

n Ye w am A S2 NE

/ =: s ,e;, :-

w . a: 3 , S.e:'. 23

~

IN

. _: ,...+l WN 5 2 h j 62;; j $ ENE

/'N .

2.x% R g 4 *

1:

2951 '

'f " ;:S"M' w ii,:,KF"SgQ_v

/*

m x to !

"A w' OS3 10S3/ E W

g'

! ~ti

! N, .

. \ gi ~ 1 S1 23S2 j

WSW M 2ss, *=

a

- ESE i

\

a e.

'S,s Em ej g

I .... ._ ,.

SW 21W '

/ ,

.S=

9 SE i 1

1 SSW SSE

, S SITE BOUNDARY 36S2 EVERGREEN & S AN ATOGA RD. 20S1 LGS DISCHARGE AREA 3S1 S AN ATOG A RD. 21S1 LGS IMPOUNDING BASIN SS1 POSSUM HCL' 0W RD.

. 23S2 TRANSMISSION TCWER I

j 7S1 LGS TRAINING CENTER 24S1 LCS INTAKE I

1053 KEEN RD. 25S1 SW SECTOR 11S1 LGS INFORM ATION CNTR. 26S3 MET. TOWER #2 i 14S1 LONGVIEW RD. 29S1 WNW SECTOR 16S2 LONGVIEW RD. 32S1 NW SECTOR

! 18S1 R AILRO AD TRACKS 34S2 MET. TOWER,#1

..r,

ODCM R*,v.12' Pngc 171-FIGURE B-2 4fg4 AIRBORNE AND TLD ENVIRONMENTAL SAMPLING LOCATIONS-AT INTERMEDIATE DISTANCES FROM LIMERICK GENERATING STATION -

N NNW NNE i NW NE l

5F1 2E1 34E1 ,

WNW N 1D2e e

4E1

ENE 31

51 9E1 ,

29 .

g' 6- 7El e

28D2

2 1 9C1, 25D1

a 10E1 7B1 3

10F3

< A e

l 24D1 15D e 20D1 e E1 WSW ESE 19D1

~ 20F1 e T'6 F*1 SW SE SSW SSE g

ten mile radius 2B1 SANATOGA SUBSTATION 13E1 VAUGHN ROAD 26B1 OLD SCHUYLKILL RD l 2BD2 W. CEDARVILLE RD j 2E1. LAUGHING WATERS GSC 15D1 SPRING CITY SUBSTATION 4E1 NElFFER ROAD 16F1 PIKELAND SUBSTATION 2SB1 YOST ROAD l

6C1 POTTSTOWN AIRPORT 1781 LINFIELD SUBSTATION 2SE1 HIGH SUBSTATION 7E1 PHEASANT ROAD 1901 SNOWDEN SUBSTATION 31D1 LINCOLN SUBSTATION SC1 REED ROAD 2001 ELLIS WOODS ROAD 31D2 POPLAR SUBSTATION

^

10E1 ROYER$ FORD ROAD 20F1 SHEEDER SUBSTATION 34E1 YARNELL ROAD 10F3 TRAPPE SUBSTATION 24D1 PORTERS MILL SUBSTATION 35B1 PLEASANTVILLE RD 13C1 KINO ROAD 25D1 HOFFECKER & KEIM ST. 35F1 RINGING ROCKS SUB

e. .e****JD 1

ODCM R*.v.12'

<- zp-

"Paga-172 ~

~

4/94.

- FIGURE : B-3

- AQUATIC AND TERRESTRIAL ENVIRONMENTAL SAMPLING

< LOCATIONS AT INTERMEDIATE DISTANCES FROM LIMERICK

'- GENERATING STATION N-

-NNW NNE:

(

s I NW NE.

SE1 e

E N E--

WNW 28F3 3

29C1 e 10F2 E W , e 1081

\ 6B2 l 21 e 6'C2 3B1

\

e l 25C1 e *- 605 s

188~

18d WS ESE

, \ +

2 18C1 F

e 5F7 j SW 15F4

S E'

'l SSW g SSE tan mile radius .

1081 FARM IN ESE SECTOR 19B1 FARM IN SSW SECTOR-10F2 PERKIOMEN CREEK 2181 FARM IN SW SECTOR f

1381 VINCENT DAM 22C1 FARM IN SW SECTOR 15F4 PHIL. SUB. WATER CO. 22F1 FARM IN SW SECTOR 15F7 PHOENIXVILLE WATER CO. 25C1 FARM IN WSW SECTOR 1682 LINFIELD BRIDGE 28F3 POTTSTOWN WATER AUTH. ,

i

! 16C2 CITIZENS HOME WATER CO. 29C1 POTTSTOWN VICINITY 'f 16C4 VINCENT POOL 33A2 UPSTREAM OF LGS 4 l

16C5 VINCENT POOL 36E1 FARM IN N SECTOR 18C1 FARM IN S SECTOR m

. :.-- ~

1 w w ,

ODCM Rsv.12

?

S r ,

' Prg3 173-FIGURE B.4 4/94 ENVIRONMENTAL SAMPLING LOCATIONS AT REMOTE

< DISTANCES FROM LIMERICK GENERATING STATION N

NNW -

NNE-NW NE e ;

5H1-WNW "

G1 [

h e J W e'9G1- E C.~.'

-/-%

e * \.

l WSW 22G1 1 G1 13H2 ~[

C9 ' H4

\ , .........

SW SE SSW SSE fif ty mile radius .

5H1 BIRCH SUBSTATION

, SG1 FARM IN E SECTOR 13H2 BELMONT WATER WORKS 13H4 PECo BUILDING 18G1 PLANEBROOK SUBSTATION l_ ,

22G1 MANOR SUBSTATION

.32G1 FRIEDENBERG SUBSTATION i _

l

ODCM R$v.12 Paga 174 4/94 REFERENi&S.

l

1. Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, October 1977.

2. Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, July 1977.

3. Regulatory Guide 1.112, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C.

g g

20555, April 1976.

4. Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of g

Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory i

Commission, Washington, D.C. 20555, April 1977.

1

5. U.S. Nuclear Regulatory Commission, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Boiling Water Reactors (BWR-GALE Code)," USNRC Report NUREG-0016, Washington, D.C. 20555, April 1976.

g

6. U.S. Nuclear Regulatory Commission, "XOQD0Q, Program for the Methodological Evaluation of Routine Effluent Releases at Nuclear g

Power Stations," USNRC Report NUREG-0324, Washington, D.C. 20555, September, 1977.

7. Title 10, " Energy," Chapter I, Code of Federal Reaulations; Part 20, Appendix B, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977.

8. Title 10, " Energy," Chapter I, Code of Federal Reaulations; Part 100, U.S. Government Printing Office, Washington, D.C. 20404, January 1, j

1977.

g

! 9. Title 40, " Protection of Environment," Chapter I, Code of Federal Reaulationq, Part 141, U.S. Government Printing Office, Washingtun, D.C. 20402, January 1, 1977.

10. Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power I Plants," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, June 1974.

i l

1

ODCM R;v.12 Paga 175 4/94 o- REFERENCES

11. Title 40, " Protection of -Environment," Chapter I ,- C o d e of Federal Reaulations, Part 190, Federal Register, Vol.-42, No. 9, Washington,,

D.C. 20402, January 13, 1977.

12. U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates,"

_Section-2.3.4, Standard Review Plan for the Review of Safety Analysis ReDorts for Nuclear Power Plants LWR Edition, USNRC Report NUREG-75/087, Washington, D.C. 20555, November 1975.

13 . - U.S. Nuclear Regulatory Commission, " Preparation of Radiological Effluent Technical' ' Specifications for Nuclear Power ~ Plants," USNRC t

Report NUREG-0133, Washington,-D.C.:20555, October 1978.

14. Letter From Thomas E. Marley, Director Office of Nuclear Reactor- ,

Regulations, To Thomas E. Tipton Vice President and Director:

Operations, Nuclear Management: and Resources Council, 6/30/93.

15. ANSI N42.14-1991 (Revision'of ANSI N42.14-1978) " Calibration and-Use of Germanium Spectrometers For the Measurement of Gamma-Ray Emission Rates of Radionuclides", Sect. 6.2.2

16. EML' Procedures Manual, H.L. Volchok and G. dePlangue, Editors,'U.S.

Dept. Of1 Energy (Revised Annually)

17. L.A. -Currie, " Limits For Qualitative Detection and -Quantitative.

Determination - Application to Radiochemistry", Analytical Chemistry,.

Vol. 40, pp. 586-593'(TABLE II), 1968

18. NUREG/CR-4007, " Lower Limit of Detection:~ Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by LJA. Currie (Chapter II, Sect. D.2; j Chapter III, Sect. C.1), September 1984 i

19. Tech. Spec. Section 1.24 (Definitions)

20. USNRC Generic Letter, 89-01 -

'

ML20080N117

Text

Navigation menu

Search